<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Curr Neuropharmacol</journal-id>
<journal-id journal-id-type="iso-abbrev">Curr Neuropharmacol</journal-id>
<journal-id journal-id-type="publisher-id">CN</journal-id>
<journal-title-group>
<journal-title>Current Neuropharmacology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1570-159X</issn>
<issn pub-type="epub">1875-6190</issn>
<publisher>
<publisher-name>Bentham Science Publishers</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31161981</article-id>
<article-id pub-id-type="pmc">7052824</article-id>
<article-id pub-id-type="publisher-id">CN-17-1071</article-id>
<article-id pub-id-type="doi">10.2174/1570159X17666190603170511</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Synaptic Elimination in Neurological Disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Cardozo</surname>
<given-names>Pablo L.</given-names>
</name>
<xref ref-type="aff" rid="aff1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>de Lima</surname>
<given-names>Izabella B. Q.</given-names>
</name>
<xref ref-type="aff" rid="aff1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maciel</surname>
<given-names>Esther M.A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Silva</surname>
<given-names>Nathália C.</given-names>
</name>
<xref ref-type="aff" rid="aff1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dobransky</surname>
<given-names>Tomas</given-names>
</name>
<xref ref-type="aff" rid="aff2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ribeiro</surname>
<given-names>Fabíola M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">a</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff><target id="aff1" target-type="aff"><sup>a</sup></target>Laboratório de Neurobioquímica, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas,  <institution>Universidade Federal de Minas Gerais</institution>, <addr-line><city>Belo Horizonte</city></addr-line>, <country>Brazil</country>; <target id="aff2" target-type="aff"><sup>b</sup></target>DB Biotech, <addr-line><city>Kosice</city></addr-line>, <country>Slovakia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>Address correspondence to this author at the Universidade Federal de Minas Gerais. Av. Antônio Carlos, 6627, Pampulha, Belo Horizonte, Brazil, Instituto de Ciências Biológicas, N4-189, Postal Code: 31270-901; Tel: +55 31 3409-2655; E-mail: <email xlink:href="fmribeiro@icb.ufmg.br">fmribeiro@icb.ufmg.br</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>11</month>
<year>2019</year>
</pub-date>
<volume>17</volume>
<issue>11</issue>
<fpage>1071</fpage>
<lpage>1095</lpage>
<history>
<date date-type="received">
<day>26</day>
<month>2</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>23</day>
<month>4</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>31</day>
<month>5</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 Bentham Science Publishers</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/legalcode">
<license-p> This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (<uri xlink:href="https://creativecommons.org/licenses/by-nc/4.0/legalcode">https://creativecommons.org/licenses/by-nc/4.0/legalcode</uri>), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.</license-p>
</license>
</permissions>
<abstract>
<p>Synapses are well known as the main structures responsible for transmitting information through the release and recognition of neurotransmitters by pre- and post-synaptic neurons. These structures are widely formed and eliminated throughout the whole lifespan via processes termed synaptogenesis and synaptic pruning, respectively. Whilst the first pro-cess is needed for ensuring proper connectivity between brain regions and also with the periphery, the second phenomenon is important for their refinement by eliminating weaker and unnecessary synapses and, at the same time, maintaining and fa-voring the stronger ones, thus ensuring proper synaptic transmission. It is well-known that synaptic elimination is modulated by neuronal activity. However, only recently the role of the classical complement cascade in promoting this phenomenon has been demonstrated. Specifically, microglial cells recognize activated complement component 3 (C3) bound to synapses tar-geted for elimination, triggering their engulfment. As this is a highly relevant process for adequate neuronal functioning, dis-ruptions or exacerbations in synaptic pruning could lead to severe circuitry alterations that could underlie neuropathological alterations typical of neurological and neuropsychiatric disorders. In this review, we focus on discussing the possible in-volvement of excessive synaptic elimination in Alzheimer’s disease, as it has already been reported dendritic spine loss in post-synaptic neurons, increased association of complement proteins with its synapses and, hence, augmented microglia-mediated pruning in animal models of this disorder. In addition, we briefly discuss how this phenomenon could be related to other neurological disorders, including multiple sclerosis and schizophrenia.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>Synaptic elimination</kwd>
<kwd>synaptic plasticity</kwd>
<kwd>microglia</kwd>
<kwd>complement cascade</kwd>
<kwd>alzheimer’s disease</kwd>
<kwd>multiple sclerosis</kwd>
<kwd>schizophrenia</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1" sec-type="intro">
<label>1</label>
<title>INTRODUCTION</title>
<p>Synapse maintenance and elimination are essential mechanisms underlying synaptic plasticity in the central nervous system (CNS), as both processes are likely involved in learning and lifelong memory processing and storage [<xref ref-type="bibr" rid="r1">1</xref>-<xref ref-type="bibr" rid="r4">4</xref>]. Not surprisingly, these phenomena have been long known to rely on neuronal activity. In fact, studies from the 1970s demonstrated that monocular deprivation affected the decision regarding which synapses are kept or pruned [<xref ref-type="bibr" rid="r5">5</xref>-<xref ref-type="bibr" rid="r9">9</xref>]. Sensory deprivation significantly disrupts eye-specific segregation, with the intact eye occupying a much greater thalamocortical projection compared to the deprived one [<xref ref-type="bibr" rid="r8">8</xref>]. Meanwhile, pharmacological experiments clearly show that inhibiting one eye activity by tetrodoxin injection impaired eye-specific segregation in fetal cat dorsolateral geniculate nucleus (dLGN) [<xref ref-type="bibr" rid="r9">9</xref>].</p>
<p>Equally remarkable are the differences in the spatiotemporal regulation at which these events occur. Indeed, all brain regions experience a sharp increase in synapse formation at early post-natal stages, followed by a period of synaptic pruning [<xref ref-type="bibr" rid="r10">10</xref>, <xref ref-type="bibr" rid="r11">11</xref>]. The pruning of overly produced synapses is highly important to maintain the stronger connections, while eliminating the weaker ones, ensuring adequate propagation of information. Interestingly, it has been shown that brain regions involved in sensory information, such as the thalamus, auditory and visual cortices, mature earlier than those responsible for higher cognitive processing, such as the hippocampus and the pre-frontal cortex [<xref ref-type="bibr" rid="r10">10</xref>-<xref ref-type="bibr" rid="r18">18</xref>]. While the first ones reach their adult levels at late childhood, with their pruning period spanning from mid-to-late infancy, the latter regions only do so at early adulthood, since synaptic elimination only surpasses synaptogenesis rates from puberty onwards [<xref ref-type="bibr" rid="r10">10</xref>, <xref ref-type="bibr" rid="r11">11</xref>, <xref ref-type="bibr" rid="r14">14</xref>].</p>
<p>Until the last two decades, little was known regarding the main mechanisms related to synaptic elimination. Perhaps, the most notable discovery in that matter has been the involvement of glial cells and immune molecules in its regulation [<xref ref-type="bibr" rid="r19">19</xref>-<xref ref-type="bibr" rid="r22">22</xref>]. Given the importance of this event throughout life, it is not surprising that interference in synaptic pruning regulation could lead to neuropathological alterations. This review aims to provide an updated view of the principal molecular mechanisms encompassing synaptic pruning, focusing later on its possible involvement in relevant neurological disorders.</p>
<sec id="sec1.1">
<label>1.1</label>
<title>Molecular Mechanisms of Synaptic Elimination</title>
<p>Synaptic pruning is a phenomenon that heavily relies on activity, with both long-term potentiation (LTP) and long-term depression (LTD) inducing morphological changes at the synaptic level [<xref ref-type="bibr" rid="r13">13</xref>, <xref ref-type="bibr" rid="r23">23</xref>, <xref ref-type="bibr" rid="r24">24</xref>]. While LTP promotes spine turnover and synapse stabilization [<xref ref-type="bibr" rid="r13">13</xref>, <xref ref-type="bibr" rid="r25">25</xref>], LTD, on the other hand, leads to spine shrinkage and loss, enhanced varicosities turnover and their separation from dendritic spines Fig. (<bold><xref ref-type="fig" rid="F1">1</xref></bold>) [<xref ref-type="bibr" rid="r13">13</xref>, <xref ref-type="bibr" rid="r24">24</xref>, <xref ref-type="bibr" rid="r26">26</xref>, <xref ref-type="bibr" rid="r27">27</xref>]. It is worth mentioning that LTD can be induced by two distinct molecular mechanisms: N-methyl-D-aspartate receptor (NMDAR)-dependent and metabotropic glutamate receptors (mGluR)-dependent LTD [<xref ref-type="bibr" rid="r28">28</xref>]. In the NMDAR-dependent LTD (NMDAR-LTD), after glutamate activation of the receptor, there is a modest Ca<sup>2+</sup> influx that triggers a yet-unknown intracellular kinase activation. This kinase phosphorylates the GluR2 subunit of α-amino-3-hydroxy-5-methylisoxazole propionic acid receptor (AMPAR) at Ser-880, leading to its endocytosis, thus reducing the amount of AMPAR available in the spine surface and leading to LTD. In addition, this Ca<sup>2+</sup> influx activates calcineurin, which, in turn, activates the protein phosphatase 1 (PP1). PP1 dephosphorylates the AMPAR subunit GluR1 at Ser-845, strongly reducing AMPAR conductance [<xref ref-type="bibr" rid="r28">28</xref>]. On the other hand, mGluR-dependent LTD (mGluR-LTD) requires the activation of group I mGluRs (mGluRI), namely mGluR1 or mGluR5, members of the G-protein coupled receptor (GPCR) superfamily. Upon their activation, G<sub>q</sub> and G<sub>α11</sub> proteins trigger a series of events ultimately leading to protein kinase C (PKC) activation. Then, PKC phosphorylates GluR2 also at Ser-880, prompting AMPAR internalization and LTD [<xref ref-type="bibr" rid="r28">28</xref>].</p>
<p>Interestingly, LTD-triggered spine shrinkage is reversed by the NMDAR antagonist APV and independent of AMPAR endocytosis [<xref ref-type="bibr" rid="r24">24</xref>,<xref ref-type="bibr" rid="r29">29</xref>]. Moreover, genetic deletion of GluN1 and GluN2B, two NMDAR subunits, promotes reduced spine density and impaired LTD in the cortex and hippocampus [<xref ref-type="bibr" rid="r30">30</xref>]. Notwithstanding, while NMDAR is involved in both LTD and spine shrinkage, biochemical evidence suggests these events are triggered by distinct signaling pathways Fig. (<bold><xref ref-type="fig" rid="F1">1</xref></bold>) [<xref ref-type="bibr" rid="r24">24</xref>, <xref ref-type="bibr" rid="r31">31</xref>]. More recently, Henson and colleagues [<xref ref-type="bibr" rid="r32">32</xref>] have demonstrated an augmentation in unpaired synapses upon NMDA application to mixed hippocampal and cortical cultures, providing extra evidence for the NMDAR role in synaptic elimination Fig. (<bold><xref ref-type="fig" rid="F1">1</xref></bold>) [<xref ref-type="bibr" rid="r32">32</xref>]. On the other hand, an important role of mGluRI in LTD-mediated synapse elimination has been identified [<xref ref-type="bibr" rid="r33">33</xref>-<xref ref-type="bibr" rid="r35">35</xref>]. Surprisingly, it has been found that in mice lacking mGluR subtype 1 (mGluR1) not only is LTD impaired, but also these animals display deficits in surplus pruning of climbing fibers (CFs) synapses onto Purkinje cells (PCs) in the cerebellum [<xref ref-type="bibr" rid="r33">33</xref>, <xref ref-type="bibr" rid="r34">34</xref>]. Moreover, mGluR1<sup>-/-</sup> and mGluR5<sup>-/-</sup> animals show higher synapse number than their wild-type (WT) littermates in the dLGN and layer IV of the cortical cortex, respectively [<xref ref-type="bibr" rid="r36">36</xref>, <xref ref-type="bibr" rid="r37">37</xref>]. Pharmacological evidence also indicates that chemical LTD induction by mGluRI agonist application leads to an overall reduction in synaptic strength, followed by persistent synapse elimination Fig. (<bold><xref ref-type="fig" rid="F1">1</xref></bold>) [<xref ref-type="bibr" rid="r38">38</xref>, <xref ref-type="bibr" rid="r39">39</xref>]. Equally remarkable, this effect only happens when LTD is induced repeatedly.</p>
<p>Despite the relevance of these two types of LTD in mediating synaptic morphological changes, little is known about whether they act in concert to drive synaptic loss. Nonetheless, recent evidence shows that LTD weakens synapses with the ones with lower glutamatergic release probability being selectively eliminated in the following 7 days of stimulation, an effect that is spread to their closest neighbors [<xref ref-type="bibr" rid="r40">40</xref>]. In addition, NMDAR-dependent synaptic weakening and spine shrinkage occurs after 1 h of LTD induction. Notably, mGluRI activation is only required when this phenomenon occurs in large spines [<xref ref-type="bibr" rid="r41">41</xref>].</p>
<p>Even though the literature presents more evidence for mGluR- and NMDAR-LTD involvement in spine shrinkage and synaptic elimination, other molecular circuits take  part in this process as well. For instance, semaphorins 7A and 5B are known to promote synaptic pruning while  semaphorin 3A is thought to prevent it [<xref ref-type="bibr" rid="r42">42</xref>, <xref ref-type="bibr" rid="r43">43</xref>]. Moreover, γ-aminobutyric acid (GABA)ergic inhibition has been proposed to be involved in synaptic loss during CFs elimination in the cerebellum and at puberty in the female hippocampus [<xref ref-type="bibr" rid="r44">44</xref>, <xref ref-type="bibr" rid="r45">45</xref>]. Also, glutamatergic receptors δ1 and δ2 interact with neurexins in a process mediated <italic>via</italic> Cbln2 and Cbln1, respectively, promoting the formation and maintenance of synapses in the CNS [<xref ref-type="bibr" rid="r46">46</xref>, <xref ref-type="bibr" rid="r47">47</xref>]. It is also worth citing the novel role played by the β-catenin/N-cadherin complex in the synapses. Throughout development, those spines that accumulate higher amounts of β-catenin/N-cadherin are preferably maintained and form stable spines, while those neighbor spines with lower levels of this protein complex are eliminated in an activity-dependent fashion [<xref ref-type="bibr" rid="r48">48</xref>]. These two proteins are also found pre-synaptically, functioning in the neocortex by stabilizing synapses and reducing their excessive turnover [<xref ref-type="bibr" rid="r49">49</xref>]. Despite having mentioned the main known mechanisms underlying synaptic pruning, additional mechanisms could also prove relevant (for more information on this topic, please refer to [<xref ref-type="bibr" rid="r1">1</xref>]).</p>
</sec>
<sec id="sec1.2">
<label>1.2</label>
<title>Immune Molecules Play a Central Role in Glial-mediated Synaptic Pruning</title>
<p>The most notable recent finding concerning synaptic pruning is the discovery that immune molecules mediate synaptic elimination in the brain. Although erstwhile, the brain was considered an immune-privileged organ, at the dawn of the 21<sup>st</sup> century, it was shown that the immune system is involved in synaptic pruning. In a pioneer work, Huh and colleagues [<xref ref-type="bibr" rid="r50">50</xref>] argued that Class I Major histocompatibility complex (MHC-I) is expressed in neurons throughout the development in an activity-dependent manner, being necessary for adequate dLGN eye-specific segregation and sustained NMDAR-LTD. Later studies, aiming at understanding this phenomenon, have demonstrated that MHC-I molecules colocalize with dendritic spines and that MHC-I knockout (KO) animals display increased frequency of excitatory post-synaptic currents (mEPSCs) in both hippocampal</p>
<p>and visual cortical neuronal cultures [<xref ref-type="bibr" rid="r51">51</xref>]. This phenomenon is accompanied by an increase in pre-synaptic terminal buttons size and vesicular number, which, according to the authors, could reflect altered synaptic scaling in MHC-I KO animals. In addition, mice lacking two MHC-I molecules, H2-D<sup>b</sup> and H2-K<sup>b</sup>, has been demonstrated to display impaired visual cortex and dLGN synaptic plasticity and eye-specific segregation [<xref ref-type="bibr" rid="r52">52</xref>-<xref ref-type="bibr" rid="r54">54</xref>]. Strikingly, this phenotype is accompanied by disrupted synaptic elimination and impaired LTD, which is rescued by inducing H2-D<sup>b</sup> expression Fig. (<bold><xref ref-type="fig" rid="F1">1</xref></bold>) [<xref ref-type="bibr" rid="r53">53</xref>]. Accordingly, blockade or complete deletion of PirB, an MHC-I receptor, phenocopies the elevated spine density and LTD impairments observed in the visual cortex and hippocampus of MHC-I KO animals Fig. (<bold><xref ref-type="fig" rid="F1">1</xref></bold>) [<xref ref-type="bibr" rid="r55">55</xref>-<xref ref-type="bibr" rid="r58">58</xref>]. Albeit these findings are observed in younger animals during specific periods, evidence suggests that these MHC molecules and PirB are later upregulated in microglia and neurons, especially during aging [<xref ref-type="bibr" rid="r59">59</xref>]. Thus, these MHC molecules appear to play a role in synaptic plasticity during learning processes, memory formation and aging, events closely associated with synapse turnover [<xref ref-type="bibr" rid="r4">4</xref>]. Furthermore, it is worth mentioning that MHC-I molecules are found to colocalize with the complement component C1q, another immune factor widely involved in synaptic elimination and expressed at the same developmental periods throughout mice lifespan [<xref ref-type="bibr" rid="r54">54</xref>, <xref ref-type="bibr" rid="r60">60</xref>].</p>
<p>The direct involvement of the classical complement cascade in synaptic pruning has been elegantly demonstrated firstly in the dLGN [<xref ref-type="bibr" rid="r19">19</xref>]. Throughout the development, immature astrocytes secrete transforming growth factor β3 (TGF-β3) [<xref ref-type="bibr" rid="r20">20</xref>], leading to upregulation of all C1q subunits in retinal ganglion cells (RGCs) Fig. (<bold><xref ref-type="fig" rid="F1">1</xref></bold>), with C1q localizing in close proximity with dendritic spines during the peaking pruning period [<xref ref-type="bibr" rid="r19">19</xref>]. When C1q is knocked out, mice display deficient dLGN eye-specific segregation due to impaired synaptic elimination [<xref ref-type="bibr" rid="r19">19</xref>]. This phenotype has been replicated in KO animals for C3, a protein downstream of C1q in the classical complement cascade and also found to colocalize with synapses Fig. (<bold><xref ref-type="fig" rid="F1">1</xref></bold>). Since activated C3 is recognized by the complement receptor 3 (CR3), which is solely expressed in microglia in the brain parenchyma, and that microglia makes contact with synaptic structures [<xref ref-type="bibr" rid="r21">21</xref>], it has been hypothesized that surveillant microglia might be implicated in synaptic pruning [<xref ref-type="bibr" rid="r22">22</xref>] Fig. (<bold><xref ref-type="fig" rid="F1">1</xref></bold>). In fact, microglial cells actively engulf C3-tagged synapses, a phenomenon dependent on neuronal activity, given that intraocular injection of TTX elevated microglia-mediated pruning [<xref ref-type="bibr" rid="r61">61</xref>]. Interestingly, microglial CR3 activation has also been associated with LTD induction, further adding evidence for the complement involvement in synaptic plasticity [<xref ref-type="bibr" rid="r62">62</xref>]. In addition, biochemical investigations suggest that complement-mediated pruning is probably associated with apoptotic-like mechanisms [<xref ref-type="bibr" rid="r63">63</xref>-<xref ref-type="bibr" rid="r66">66</xref>].</p>
<p>These studies opened up an avenue of investigation aiming at demonstrating that microglia is a key player in this synaptic plasticity mechanism. For instance, mice bearing homozygous deletion for the CX3CL1 receptor (CX3CR1), exclusively found in microglia, display delayed synaptic elimination in the hippocampus, which is accompanied by long-lasting electrophysiological and behavioral deficits [<xref ref-type="bibr" rid="r67">67</xref>, <xref ref-type="bibr" rid="r68">68</xref>]. This observation could be in part explained by the reduced number of microglial cells multiplying or migrating into the CA1 region during the synaptic pruning period, although it is also possible that disrupted apoptotic-like mechanisms play a role as well [<xref ref-type="bibr" rid="r67">67</xref>, <xref ref-type="bibr" rid="r69">69</xref>]. Moreover, loss of progranulin (GRN) in microglia, a protein involved in lysosomal and autophagy cargo degradation [<xref ref-type="bibr" rid="r70">70</xref>, <xref ref-type="bibr" rid="r71">71</xref>], leads to increased synaptic pruning in thalamocortical circuits [<xref ref-type="bibr" rid="r70">70</xref>]. Interestingly, microglial cells are more activated in GRN KO mice, leading to increased C1q and C3 secretion, which could account for the excessive synaptic elimination observed. On the other hand, elevated GRN levels block synaptic pruning, with mice displaying higher synaptic density in the hippocampus [<xref ref-type="bibr" rid="r72">72</xref>]. Similar findings are observed in mice deficient for Atg7, a protein required for autophagy, suggesting that this process is also needed for efficient microglia-mediated synaptic pruning [<xref ref-type="bibr" rid="r73">73</xref>]. Also, it is relevant to take in consideration that microglial activities are dependent on astrocyte-secreted interleukin 33 (IL-33), as animals deficient in this protein have disrupted synaptic elimination Fig. (<bold><xref ref-type="fig" rid="F1">1</xref></bold>) [<xref ref-type="bibr" rid="r74">74</xref>]. Furthermore, microglial cells also play important roles in synapse formation throughout development, since animals depleted of this cell type display significant electrophysiological and synaptogenic impairments [<xref ref-type="bibr" rid="r75">75</xref>].</p>
<p>In addition, other studies have also fostered the investigation of new immunological signaling pathways in this phenomenon. Recently, CD47, a transmembrane immunoglobulin superfamily protein, has been shown to act as a protective signal preventing synaptic engulfment by microglia Fig. (<bold><xref ref-type="fig" rid="F1">1</xref></bold>) [<xref ref-type="bibr" rid="r76">76</xref>]. This protein localizes preferentially at pre-synaptic terminals of more active synapses, signaling to microglial cells <italic>via</italic> SIRPα Fig. (<bold><xref ref-type="fig" rid="F1">1</xref></bold>). Meanwhile, Bjartmar and colleagues [<xref ref-type="bibr" rid="r77">77</xref>] have provided the first evidence for neuronal pentraxins (NPs) participation in synaptic elimination. Deletion of NP-1, NP-2 and NP receptor (NPR) leads to increased synaptic numbers in the dLGN [<xref ref-type="bibr" rid="r77">77</xref>]. Notwithstanding, according to Koch and Ullian [<xref ref-type="bibr" rid="r78">78</xref>] these unpruned structures are comprised mostly of silent synapses, which do not contain AMPAR receptors, being unable to display AMPAR-mediated transmission and, hence, exhibit defective synaptic maturation. Another group of molecules thought to render synapses more mature in this context are the C1q-like proteins (C1qls) [<xref ref-type="bibr" rid="r79">79</xref>, <xref ref-type="bibr" rid="r80">80</xref>]. These proteins signal <italic>via</italic> BAI3 in the CNS [<xref ref-type="bibr" rid="r80">80</xref>] and promote synapse formation and maintenance in the medial pre-frontal cortex (mPFC), since knocking down their expression levels leads to significant synaptic puncta reduction [<xref ref-type="bibr" rid="r79">79</xref>]. Surprisingly, a deeper inspection of the transcriptomic data produced by Chen <italic>et al</italic>. [<xref ref-type="bibr" rid="r81">81</xref>] indicates that NPs are upregulated in the CA1-CA3 hippocampal regions during LTP, while C1ql1 show significant downregulation. At first, this data seems odd, as LTP is implicated in synapse stabilization [<xref ref-type="bibr" rid="r25">25</xref>]; nevertheless, it is also possible that NPs and C1ql1 are involved in the elevated synaptic turnover observed in this phenomenon [<xref ref-type="bibr" rid="r24">24</xref>].</p>
<p>Perhaps one of the most curious findings concerning microglial participation in synaptic plasticity mechanisms has come from the work developed by Weinhard and coworkers [<xref ref-type="bibr" rid="r82">82</xref>]. By analyzing the CA1 region of the hippocampus in newborn mice at post-natal day 15 (P15), these authors have identified that microglial cells do not phagocytose the whole synapse. Instead, these cells only engulf and uptake pre-synaptic material in a process of partial phagocytosis, so-called trogocytosis, in a complement-independent fashion. Additionally, microglia promote the protrusion of new filopodia from mature dendritic spine contacts [<xref ref-type="bibr" rid="r83">83</xref>]. Despite the novelty of this work, it should be taken with caution. First of all, the lack of complement-mediated synapse removal might be an exclusive feature of the CA1 region in the hippocampus. Indeed, this seems to be the only region protected from age-dependent synaptic density decline in the whole hippocampus [<xref ref-type="bibr" rid="r84">84</xref>]. Moreover, for all other hippocampal regions, deletion of C3 rescues this phenotype, suggesting a prominent role of the classical complement cascade in developmentally regulated synaptic elimination. Finally, other mechanisms could replace microglia-mediated spine engulfment in CA1. For example, astrocytes have been shown to prune synapses <italic>via</italic> MERTK- and MEGF10-mediated phagocytosis in the dLGN [<xref ref-type="bibr" rid="r85">85</xref>] and it is still unclear whether this phenomenon takes place in the hippocampus as well.</p>
<p>Since disruptions in synaptic pruning have been associated with an increased burden in neurological disorders, in the next sections, we are going to concentrate our discussion in the evidences for its involvement in the neuropathological alterations observed in Alzheimer’s Disease (AD), Multiple Sclerosis (MS) and Schizophrenia (SCZ). Our major focus will be given to findings implicating immunological factors and glial cells as driving forces for altered synaptic elimination in each one of these diseases.</p>
</sec>
</sec>
<sec id="sec2" sec-type="other1">
<label>2</label>
<title>SYNAPTIC PRUNING IN NEUROLOGICAL DISORDERS</title>
<sec id="sec2.1">
<label>2.1</label>
<title>Alzheimer’s Disease</title>
<p>Dementia is a syndrome that affects approximately 50 million people worldwide and its most common cause is AD, which responds for 60-70% of all cases [<xref ref-type="bibr" rid="r86">86</xref>-<xref ref-type="bibr" rid="r88">88</xref>]. The first case of AD was described by the German psychiatrist Alois Alzheimer, who identified the symptoms as progressive cognitive impairment, memory loss, language disability, spatial and temporal disorientation, hallucinations and delusions [<xref ref-type="bibr" rid="r89">89</xref>]. This disease is also characterized by evident cerebral atrophy and neurodegeneration, affecting cortical and subcortical regions, with greater synapse than neuronal loss [<xref ref-type="bibr" rid="r90">90</xref>-<xref ref-type="bibr" rid="r96">96</xref>]. Additionally, other hallmarks of AD found in the brain of affected patients are extracellular senile plaques, intraneuronal neurofibrillary tangles, gliosis, microglial activation and neuroinflammation [<xref ref-type="bibr" rid="r97">97</xref>-<xref ref-type="bibr" rid="r105">105</xref>].</p>
<p>These senile plaques are the result of oligomeric amyloid β (Aβ) peptide aggregation. Cleavage of amyloid precursor protein (APP), a cell surface receptor [<xref ref-type="bibr" rid="r106">106</xref>], occurs naturally in the brain, generating soluble APPα when APP is processed by α-secretase [<xref ref-type="bibr" rid="r107">107</xref>]. However, cleavage of APP by β-secretase and γ-secretase leads to the production of pathogenic Aβ forms of 40 and 42 amino acid residues, termed Aβ<sub>1-40</sub> and Aβ<sub>1-42</sub>, respectively [<xref ref-type="bibr" rid="r108">108</xref>-<xref ref-type="bibr" rid="r110">110</xref>]. The presence of a qualitatively altered allele of γ-secretase results in higher production of Aβ<sub>1-42</sub>, which is more susceptible to aggregation and toxicity [<xref ref-type="bibr" rid="r111">111</xref>] and is associated with higher pathogenicity compared to Aβ<sub>1-40</sub>, which is the most abundant isoform produced in healthy brains [<xref ref-type="bibr" rid="r112">112</xref>].</p>
<p>Interestingly, the load of soluble oligomeric Aβ has been implicated in the synaptic loss observed in AD patients, even enabling the distinction between them and subjects with profuse plaques and tangles but with no symptoms of dementia [<xref ref-type="bibr" rid="r113">113</xref>]. Studies employing AD mouse models have shown that increased levels of soluble Aβ correlate with the decrease in synaptic density [<xref ref-type="bibr" rid="r114">114</xref>]. Notably, soluble Aβ represents the main factor contributing to the synaptotoxic and neurotoxic effects observed in AD [<xref ref-type="bibr" rid="r115">115</xref>, <xref ref-type="bibr" rid="r116">116</xref>], leading to severe impairments in synaptic plasticity [<xref ref-type="bibr" rid="r117">117</xref>-<xref ref-type="bibr" rid="r120">120</xref>]. These oligomers are responsible for blocking hippocampal and cortical LTP [<xref ref-type="bibr" rid="r119">119</xref>-<xref ref-type="bibr" rid="r123">123</xref>], while also inducing LTD [<xref ref-type="bibr" rid="r119">119</xref>, <xref ref-type="bibr" rid="r120">120</xref>, <xref ref-type="bibr" rid="r124">124</xref>, <xref ref-type="bibr" rid="r125">125</xref>], spine and neuronal loss [<xref ref-type="bibr" rid="r120">120</xref>, <xref ref-type="bibr" rid="r125">125</xref>, <xref ref-type="bibr" rid="r126">126</xref>]. The underlying mechanism appears to involve changes in glutamatergic neurotransmission mediated mainly by mGluRI and NMDAR Fig. (<bold><xref ref-type="fig" rid="F2">2</xref></bold>). Further studies have demonstrated that the activation of NMDAR localized extrasynaptically (eNMDAR) is an important event involved in Aβ synaptic toxicity [<xref ref-type="bibr" rid="r117">117</xref>, <xref ref-type="bibr" rid="r120">120</xref>, <xref ref-type="bibr" rid="r124">124</xref>, <xref ref-type="bibr" rid="r126">126</xref>-<xref ref-type="bibr" rid="r128">128</xref>]. This activation of eNMDAR triggers nitric oxide (NO) production in neuronal cultures exposed to Aβ oligomers [<xref ref-type="bibr" rid="r129">129</xref>]. In turn, NO promotes Cdk5 activation <italic>via</italic> S-Nitrosylation and its downstream signaling cascade leads to spine loss Fig. (<bold><xref ref-type="fig" rid="F2">2</xref></bold>) [<xref ref-type="bibr" rid="r130">130</xref>]. Injection of these forms of Aβ in rodents has been proven as a useful model of mimicking synaptic pathology and by extension, the cognitive deficits found in AD [<xref ref-type="bibr" rid="r131">131</xref>-<xref ref-type="bibr" rid="r134">134</xref>]. These findings further reassert the role of soluble Aβ forms in the synaptic changes key to the etiology of AD.</p>
<p>Early synaptic loss is well established as a key feature of AD. For instance, studies have shown 38%, 14% and 44-55% reduction in the number of synapses in biopsies of AD patients at the temporal and frontal cortices and the hippocampus, respectively [<xref ref-type="bibr" rid="r94">94</xref>, <xref ref-type="bibr" rid="r135">135</xref>-<xref ref-type="bibr" rid="r138">138</xref>]. Since then, other studies using distinct approaches endorsed the central role of synaptic loss in the pathology of AD. Further analysis using <italic>post-mortem</italic> tissues from AD patients confirms a decline in the synaptic number in the temporal, parietal and frontal lobes [<xref ref-type="bibr" rid="r139">139</xref>-<xref ref-type="bibr" rid="r141">141</xref>]. Also, a reduction of synaptic contacts have been noticed in the outer molecular layer of the hippocampal dentate gyrus, the CA1 region and the precuneus [<xref ref-type="bibr" rid="r142">142</xref>]. Moreover, presynaptic protein levels can also be used to estimate synaptic terminal loss [<xref ref-type="bibr" rid="r143">143</xref>]. The expressions of proteins such as synaptophysin, syntaxin, secretoneurin, PSD95 and glutamatergic vesicular transporters and receptors are shown to be significantly diminished in AD patients and in animal models [<xref ref-type="bibr" rid="r113">113</xref>, <xref ref-type="bibr" rid="r144">144</xref>-<xref ref-type="bibr" rid="r150">150</xref>]. Notably, this PSD95 reduction has been shown to be driven by degradation <italic>via</italic> proteasome, a process mediated by NMDAR activity and that takes place exclusively at glutamatergic synapses [<xref ref-type="bibr" rid="r151">151</xref>]. A correlation between the cognitive shortcoming of AD patients and reduced expression level of synaptic proteins such as synaptobrevin, synaptotagmin and Rab3a has also been described [<xref ref-type="bibr" rid="r152">152</xref>], although results obtained in different studies may vary according to brain region and protein analyzed [<xref ref-type="bibr" rid="r143">143</xref>]. Furthermore, it has been suggested that synaptic loss is the strongest correlate with the cognitive deficits found in AD and might be a process restricted to excitatory synapses [<xref ref-type="bibr" rid="r147">147</xref>, <xref ref-type="bibr" rid="r148">148</xref>, <xref ref-type="bibr" rid="r150">150</xref>, <xref ref-type="bibr" rid="r151">151</xref>, <xref ref-type="bibr" rid="r153">153</xref>-<xref ref-type="bibr" rid="r155">155</xref>].</p>
<p>Neurofibrillary tangles (NFT), another key feature of AD, are mainly made of paired helical filaments of the</p>
<p>phosphorylated microtubule-associated protein tau (MAPT). This MAPT causes the expansion of senile plaques and exacerbates the formation of plaque-associated dystrophic neurites containing its misfolded form [<xref ref-type="bibr" rid="r156">156</xref>]. In addition, NFT located in pyramidal neurons correlates with changes in morphology and decreased the density of dendritic spines [<xref ref-type="bibr" rid="r157">157</xref>]. Nonetheless, previous reports indicate that accumulation of MAPT at spines, rather than NFTs, are linked to the onset of tau-related pathologies in AD [<xref ref-type="bibr" rid="r101">101</xref>, <xref ref-type="bibr" rid="r102">102</xref>, <xref ref-type="bibr" rid="r158">158</xref>-<xref ref-type="bibr" rid="r162">162</xref>]. Accordingly, oligomeric Tau promotes the reduction of synaptic markers and impair mitochondrial function [<xref ref-type="bibr" rid="r162">162</xref>]. These effects are mediated <italic>via</italic> Tau relocation from axons to dendrites upon its phosphorylation [<xref ref-type="bibr" rid="r159">159</xref>]. Indeed, Hoover <italic>et al.</italic> [<xref ref-type="bibr" rid="r159">159</xref>], using a transgenic model mimicking Tau phosphorylation <italic>in vivo</italic>, have shown that this post-translational modification leads to LTP and memory formation impairments. Moreover, they have observed that hyperphosphorylated Tau dissociates from microtubules and is mislocalized to dendritic spines. This leads to reduced AMPAR and NMDAR surface levels in these structures, impairing appropriate glutamatergic transmission, which could account for the observed phenotypes and synapse loss often found in AD models even before NFT deposition [<xref ref-type="bibr" rid="r159">159</xref>]. Interestingly, this role of Tau in modulating synaptic plasticity is required for Aβ-induced synaptic defects, with both proteins being found at the same post-synaptic compartment [<xref ref-type="bibr" rid="r158">158</xref>, <xref ref-type="bibr" rid="r160">160</xref>, <xref ref-type="bibr" rid="r163">163</xref>]. Intriguingly, reducing Tau levels in a dose-dependent manner in a mouse model of AD has been shown to be neuroprotective, significantly dampening Aβ-excitotoxic effects by preventing NMDAR and PSD95 uncoupling, thus securing proper LTP induction, preventing neuronal loss and improving memory formation and locomotor coordination in behavioral tests [<xref ref-type="bibr" rid="r161">161</xref>, <xref ref-type="bibr" rid="r164">164</xref>].</p>
<sec id="sec2.1.1">
<label>2.1.1</label>
<title>Overheating the Developmental Engine in AD: When Complement-mediated Synaptic Pruning Becomes Harmful</title>
<p>It is well known that AD etiology shares environmental and genetic risk factors [<xref ref-type="bibr" rid="r165">165</xref>-<xref ref-type="bibr" rid="r166">166</xref>]. The majority of the cases of AD are sporadic and affect elder individuals (Late Onset AD, abbreviated as LOAD), while the remaining, which is about 5% of the cases, have an autosomal dominant inheritance pattern, occurring before 65 years of age (Early Onset AD, shortened as EOAD) [<xref ref-type="bibr" rid="r167">167</xref>]. It has been shown that in several EOAD patients, there is greater expression and release of Aβ<sub>1-42</sub> peptide, which aggregates more rapidly in insoluble amyloid fibrils [<xref ref-type="bibr" rid="r168">168</xref>-<xref ref-type="bibr" rid="r171">171</xref>], frequently giving rise to the brain plaques that characterize the disease [<xref ref-type="bibr" rid="r172">172</xref>]. In addition, the risk of developing AD is highly associated with the expression pattern of distinct isoforms of the apolipoprotein E (ApoE) gene in both EOAD and LOAD patients, whose protein product binds with high avidity to Aβ Fig. (<bold><xref ref-type="fig" rid="F2">2</xref></bold>) [<xref ref-type="bibr" rid="r173">173</xref>-<xref ref-type="bibr" rid="r175">175</xref>]. Indeed, while the presence of ApoE2 allele is protective [<xref ref-type="bibr" rid="r176">176</xref>, <xref ref-type="bibr" rid="r177">177</xref>], the number of ApoE4 allele copies is proportional to the risk of developing LOAD and inversely correlated with the age of onset and years of survival [<xref ref-type="bibr" rid="r174">174</xref>-<xref ref-type="bibr" rid="r176">176</xref>, <xref ref-type="bibr" rid="r178">178</xref>]. Moreover, recent research has also demonstrated that the ApoE4 isoform stimulates greater APP transcription compared to other isoforms, thereby increasing Aβ levels [<xref ref-type="bibr" rid="r179">179</xref>]. Also, homozygous ApoE4 carriers display elevated production of Aβ oligomers, which might be implicated in dendritic spine dysfunction and severe memory impairment [<xref ref-type="bibr" rid="r180">180</xref>]. Several lines of evidence indicate that ApoE is highly relevant to AD development, making this gene a suitable candidate to study synaptic loss in this disorder. Using transgenic mouse models expressing distinct human ApoE alleles, authors have shown that the ApoE4 isoform produces the greatest reduction in both pre- and post-synaptic markers density, dendritic spine number and dendritic arbor complexity in the cortex, amygdala and hippocampus [<xref ref-type="bibr" rid="r181">181</xref>-<xref ref-type="bibr" rid="r186">186</xref>]. Furthermore, transcriptomic data obtained from human induced pluripotent stem cells (hiPSCs)-derived neurons bearing the ApoE4 allele indicates that genes involved in synaptic regulation are among those most differently expressed compared to those of ApoE3 neurons [<xref ref-type="bibr" rid="r187">187</xref>]. Amongst them, C1ql3 and neuronal pentraxin 2 are downregulated in ApoE4 neurons, which is very interesting as these genes might be involved in synaptic elimination. Likewise, distinct ApoE alleles have been found to interfere with astrocytic synaptic pruning capacity [<xref ref-type="bibr" rid="r188">188</xref>]. Interestingly, murine astrocytes expressing the human ApoE2 isoform show greater synapse phagocytosis compared to those cells expressing ApoE3 and ApoE4, with the latter displaying the lowest engulfment index [<xref ref-type="bibr" rid="r188">188</xref>]. This compromised ability of astrocytes in eliminating senescent synapses by ApoE4 mice leads to the accumulation of C1q in the hippocampus, especially in aged animals Fig. (<bold><xref ref-type="fig" rid="F2">2</xref></bold>). If this augmented C1q targets senescent synapses, this could trigger higher synaptic engulfment by microglia. However, more studies will be needed to clarify this issue. It is also important to mention that early reports indicate enhanced microglial activation in an ApoE4 dose-dependent manner, with AD homozygous individuals displaying greater numbers of activated microglia in the frontal and temporal cortices compared to homozygous ApoE3 patients [<xref ref-type="bibr" rid="r189">189</xref>]. Taking in consideration that Aβ comprises an inflammatory stimulus to the brain [<xref ref-type="bibr" rid="r190">190</xref>, <xref ref-type="bibr" rid="r191">191</xref>] and that ApoE4 microglia exhibit increased activation [<xref ref-type="bibr" rid="r189">189</xref>] and augmented levels of proinflammatory transcripts [<xref ref-type="bibr" rid="r187">187</xref>], these data argue in favor of a prominent role for ApoE4 in mediating neuroinflammation in AD.</p>
<p>Neuroinflammatory mediators have also been associated with the pathology of AD. The presence of the membrane attack complex (MAC) and the immune activation of microglia have been shown to be better correlated with the number of synapses than the load of neurofibrillary tangles and Aβ deposition [<xref ref-type="bibr" rid="r192">192</xref>]. Another finding worth mentioning is that the decreased level of complement defense 59, a protein that prevents MAC assembly, in the cortex and hippocampus of AD patients correlates with the reduction in synaptophysin [<xref ref-type="bibr" rid="r193">193</xref>]. These data further highlight the association of the complement system and AD development. In addition, previous reports indicate that C1q and C3, two components of the classical complement cascade, display age-dependent upregulation in the hippocampus and cerebral cortex [<xref ref-type="bibr" rid="r194">194</xref>]. This rise in C1q and C3 levels is even greater in AD models, suggesting their involvement in disease progression Fig. (<bold><xref ref-type="fig" rid="F2">2</xref></bold>). Indeed, genetic deletion of C1q and C3 in AD mouse models promotes reduced neurodegeneration, plaque deposition, gliosis, and microglia activation, as well as increased expression of synaptic markers [<xref ref-type="bibr" rid="r195">195</xref>, <xref ref-type="bibr" rid="r196">196</xref>].</p>
<p>Later studies helped to clarify the association between synaptic loss and reactivation of the synaptic pruning process during the course of AD [<xref ref-type="bibr" rid="r197">197</xref>]. For instance, Hong and colleagues [<xref ref-type="bibr" rid="r198">198</xref>] have demonstrated the detrimental role of the complement system and microglia in AD early synaptic loss. Increased deposition of C1q and C3 at synapses of hippocampus and cortex is observed in the human APP (hAPP) transgenic mouse model of AD, leading to accentuated synaptic engulfment by microglial cells before the onset of plaque deposition Fig. (<bold><xref ref-type="fig" rid="F2">2</xref></bold>). This effect is mediated by oligomeric Aβ, since its intracerebroventricular injection prompts the deposition of C1q and C3 in the hippocampus of WT mice [<xref ref-type="bibr" rid="r198">198</xref>]. In contrast, ablation of the complement receptor CR3 reduces the synaptic loss and the number of phagocytic microglia [<xref ref-type="bibr" rid="r198">198</xref>]. Similar results are observed in Tau-P301S transgenic mice [<xref ref-type="bibr" rid="r199">199</xref>]. In these animals, neurodegeneration and hippocampal atrophy are present only after 12 months of age, while gliosis and synaptic dysfunction are detected in 6-month-old animals. Proteomic data indicate progressive accumulation of C1q at synapses, especially at the post-synaptic compartment, at the same age it is possible to identify excessive hyperphosphorylated Tau in these structures [<xref ref-type="bibr" rid="r199">199</xref>]. This evidence led the authors to hypothesize that the reduction in synaptic markers in the hippocampus is related to exaggerated pruning by microglial cells. In fact, this has been shown to be the case, as treatment of cultures with anti-C1q antibody inhibited microglia-mediated synaptic elimination. In contrast, other proteomics studies failed to identify the enrichment of complement components in the hAPP mouse model and in AD patient <italic>post-mortem</italic> brain samples [<xref ref-type="bibr" rid="r200">200</xref>, <xref ref-type="bibr" rid="r201">201</xref>]. These contradictory data indicate that more studies should be conducted to fully clarify the role of the complement cascade in AD, aiming at distinguishing whether the progressive C1q accumulation at synapses, found by Dejanovic <italic>et al</italic> [<xref ref-type="bibr" rid="r199">199</xref>], is a sole consequence of the disorder or is also affected by the aging process.</p>
<p>Remarkably, Litvinchuk <italic>et al</italic> [<xref ref-type="bibr" rid="r202">202</xref>] have provided the first evidence for the participation of C3a, one of the two C3 cleavage products, and its cognate receptor C3aR in AD synapse loss, using the Tau-P301S mouse model. While C3b acts as an opsonin and signals <italic>via</italic> CR3 in microglia, C3a is usually implicated in triggering inflammatory signaling (for more information about AD neuroinflammation and the classical complement cascade, refer to [<xref ref-type="bibr" rid="r203">203</xref>]). In this study, genetic deletion of C3aR has led to a significant reduction in astrogliosis and microgliosis, while also rescuing LTP deficits, enhancing synaptophysin and PSD-95 levels and blocking neurodegeneration in the hippocampus. In addition, authors have also shown that C3a rendered microglia more activated, as indicated by enhanced synaptic markers uptake and CD68 staining, an effect attenuated in the double mutant (C3a KO/Tau-P301S) mouse model. It is also important to mention that C3a/C3aR pathway disruption in the Tau-P301S mice reduces tumor necrosis factor α (TNF-α), IL-1β and IL-6 back to WT levels [<xref ref-type="bibr" rid="r202">202</xref>]. Moreover, in the same study, RNA-seq analysis revealed that both microglia and astrocytes display neurotoxic features, a phenotype partly rescued by C3aR deletion. Interestingly, this microglial transcriptomic profile corroborates the data found by Karen-Shaul <italic>et al</italic> [<xref ref-type="bibr" rid="r204">204</xref>], indicating that during AD progression microglial cells assume a more proinflammatory and activated profile, thus contributing to the neuroinflammation observed in this disorder. On the other hand, the astrocytic transcriptomic profile partially resembles the features of A1 reactive astrocytes characterized by Liddelow and collaborators  [<xref ref-type="bibr" rid="r202">202</xref>, <xref ref-type="bibr" rid="r205">205</xref>]. A1 astrocytes are shown to impair synaptic formation and neuronal electrophysiological properties, while also upregulating C3 mRNA levels [<xref ref-type="bibr" rid="r205">205</xref>]. Given that microglial cells are the major source of C1q in the brain [<xref ref-type="bibr" rid="r206">206</xref>], that this protein is accumulated in AD mouse models and the proinflammatory profile displayed by microglia in AD, one could suppose that these activated microglia could lead to the formation of reactive A1 astrocytes [<xref ref-type="bibr" rid="r205">205</xref>]. These two neurotoxic glial cells could be, at least in part, responsible for both the synaptic defects and neurodegeneration observed in AD. Finally, recent data indicate a prominent role for mGluR1 activation in increasing C1q expression at dendritic spines, favoring their uptake by microglial cells in the hippocampus of mice injected with Aβ<sub>1-40</sub> oligomers [<xref ref-type="bibr" rid="r207">207</xref>]. This phenomenon relies on fragile X mental retardation protein (FMRP) dephosphorylation, allowing local translation of FMRP-silenced mRNAs Fig. (<bold><xref ref-type="fig" rid="F2">2</xref></bold>). Since mGluR1 activation is also involved in LTD induction, this data provides important evidence connecting LTD and complement-dependent synaptic elimination. Altogether, these results suggest a prominent role of the complement cascade in mediating early synaptic loss in AD.</p>
</sec>
<sec id="sec2.1.2">
<label>2.1.2</label>
<title>Other Synaptic Pruning-related Molecules also Contribute to Exaggerated Synaptic Loss in AD</title>
<p>Other synaptic pruning-related molecules have also been established as contributors to AD development. For instance, caspase-3, a classic proapoptotic factor, is elevated in AD brains, being specially enriched at the post-synaptic density [<xref ref-type="bibr" rid="r208">208</xref>]. In line with this evidence, D’amelio <italic>et al</italic> [<xref ref-type="bibr" rid="r209">209</xref>] have demonstrated that caspase-3 triggers AMPAR dephosphorylation <italic>via</italic> calcineurin in an AD mouse model, without any obvious cell death. This reduction of AMPAR at spines leads to increased LTD and diminished hippocampal apical dendritic spine levels in 3-month old mice, triggering subsequent learning and memory deficits [<xref ref-type="bibr" rid="r209">209</xref>]. These abnormalities are rescued by intrahippocampal administration of the caspase-3 inhibitor, z-DEVD-fmk, suggesting the participation of apoptotic-like mechanisms in AD early synaptic elimination and making this pathway an interesting target for future therapeutic interventions. On the other hand, the human ortholog of PirB, LilrB2, comprises a high affinity Aβ receptor [<xref ref-type="bibr" rid="r210">210</xref>]. This MHC-I receptor also mediates altered synaptic plasticity and memory deficits often observed in AD models. Indeed, its genetic deletion in mouse hippocampal slices rescues LTP induction by oligomeric Aβ. Moreover, transgenic AD animals with PirB ablation perform better in memory tasks, compared to diseased animals bearing intact PirB copies. In contrast, IL-33 is reduced in AD patients’ brains [<xref ref-type="bibr" rid="r211">211</xref>]. Interestingly, when this cytokine is administered to hAPP mice, it rescues LTP induction, while also improving Aβ clearance by microglia, making IL-33 an interesting therapeutic target [<xref ref-type="bibr" rid="r212">212</xref>]. Despite IL-33 importance in inducing microglia-mediated synaptic pruning, its effects might not be specific to this phenomenon, as IL-33 may simply activate microglial phagocytic capacity, which could explain why this cytokine is able to enhance Aβ uptake and degradation.</p>
<p>Neuronal pentraxin 1 (NP-1), progranulin (GRN) and the CX3CL1/CX3CR1 also take part in AD neuropathological events. NP-1 levels, for example, are elevated in the hippocampus and plasma of AD individuals [<xref ref-type="bibr" rid="r213">213</xref>]. Likewise, NP-1 is upregulated in neuronal cultures treated with Aβ, where it mediates cell death and reduction of synaptophysin levels [<xref ref-type="bibr" rid="r214">214</xref>]. Intriguingly, progranulin levels in the blood and cerebrospinal fluid (CSF) increase with disease progression, correlating with cognitive decline and memory disturbance [<xref ref-type="bibr" rid="r215">215</xref>, <xref ref-type="bibr" rid="r216">216</xref>]. Despite this, genetic deletion of GRN in hAPP mouse models worsens cognitive behavior, also leading to elevated numbers of activated microglia in the hippocampus, higher TNF-α and IL-1α mRNA levels and increased deposition of C1q at dendritic spines [<xref ref-type="bibr" rid="r217">217</xref>, <xref ref-type="bibr" rid="r218">218</xref>]. This effect seems to be mediated by microglial cells, as specific deletion of GRN in this cell type leads to increased plaque burden and decreased phagocytic index [<xref ref-type="bibr" rid="r217">217</xref>]. In contrast, overexpression of this molecule prevents Aβ-mediated cell toxicity, diminishes plaque deposition and rescues neurodegeneration and memory deficits [<xref ref-type="bibr" rid="r217">217</xref>]. Therefore, these data may indicate that increased progranulin levels throughout the course of AD might reflect an attempt to reestablish the proper homeostatic process by increasing microglial clearance of Aβ, thus diminishing plaque accumulation. On the other hand, the role of CX3CL1/CX3CR1 is less well defined. While CX3CL1 is downregulated in the CSF and brain of AD patients, no change has been reported for its receptor level compared to healthy individuals [<xref ref-type="bibr" rid="r219">219</xref>, <xref ref-type="bibr" rid="r220">220</xref>]. Moreover, deficiency in either membrane-anchored CX3CL1 or in its receptor increases Aβ phagocytosis, reducing plaque deposition [<xref ref-type="bibr" rid="r221">221</xref>, <xref ref-type="bibr" rid="r222">222</xref>]. However, the lack of CX3CR1 has been shown to increase Tau pathological effects <italic>via</italic> elevated p-Tau levels [<xref ref-type="bibr" rid="r220">220</xref>, <xref ref-type="bibr" rid="r221">221</xref>]. In addition, literature data are controversial regarding the activation status of CX3CR1<sup>-/-</sup> microglia in AD. While Lee and colleagues [<xref ref-type="bibr" rid="r222">222</xref>] report reduced microglial activation and TNF-α mRNA levels in APP/PS1;CX3CR1<sup>-/-</sup> mouse model, Cho <italic>et al</italic> [<xref ref-type="bibr" rid="r220">220</xref>] demonstrate the opposite in hAPP;CX3CR1<sup>-/-</sup> mice. Therefore, what is the precise role of CX3CL1/CX3CR1 in AD neuroinflammation is still a matter of debate, while its role in AD synaptic elimination remains insofar unknown. Taken together, these data support the involvement of several modulators of synaptic elimination in AD progression.</p>
<p>Despite the vast majority of studies aiming at understanding synapse loss in AD has focused on investigating elevated synaptic elimination, an interesting alternative hypothesis that might explain the reduced synapse numbers observed is disrupted synaptogenesis. Interestingly, researchers have found that soluble Aβ leads to increased pre-synaptic Ca<sup>2+</sup> levels, promoting higher phosphorylation levels of Ca<sup>2+</sup>/calmodulin-dependent protein kinase IV (CaMKIV) and, ultimately, impairing activity-dependent synaptogenesis [<xref ref-type="bibr" rid="r223">223</xref>]. In addition, Levi <italic>et al</italic>. [<xref ref-type="bibr" rid="r224">224</xref>] demonstrated that human ApoE4 transgenic mice display deficient environmental-stimulated synaptogenesis, resulting in learning and memory formation deficits, compared to human ApoE3 transgenic mice. These evidences imply that impaired synaptogenesis could also play an important role in AD development and progression. However, whether the reduction in synapse number observed in this disease is due to diminished synapse formation, increased synaptic elimination or both is a matter that remains to be investigated.</p>
<p>Given the importance of synapse loss in AD development, therapies aiming at restoring normal synaptic levels or preventing their loss could benefit individuals affected by this disorder. For example, using a gene delivery system, Kampen &amp; Kay [<xref ref-type="bibr" rid="r225">225</xref>] overexpressed progranulin in an AD transgenic mouse model. In this study, it is possible to observe that GRN expression leads to reduced Aβ plaque burden, astrogliosis and microgliosis, as well as increased synaptic density in the hippocampus. In another report, daily injections of the Heat-shock protein 90 (HSP90) inhibitor 17-AAG prevent Aβ-driven synapse loss and memory deficits <italic>in vivo</italic>, likely by pre- and post-synaptic proteins upregulation, hence strengthening the existing synapses [<xref ref-type="bibr" rid="r226">226</xref>]. Interestingly, Resveratrol, a Sirtuin 1 activator, protects rats exposed to oligomeric Aβ from displaying disturbed memory acquisition and LTP induction [<xref ref-type="bibr" rid="r227">227</xref>]. These effects are probably mediated by neurogenesis and blockade of microglial and astrocytic activation, substantially reducing neuroinflammation [<xref ref-type="bibr" rid="r228">228</xref>, <xref ref-type="bibr" rid="r229">229</xref>]. These two Resveratrol effects combined could contribute to increase neuronal and synaptic number in AD patients’ brains, while also dampening the neurotoxic effects mediated by reactive glial cells. Thus, this drug comprises one of the most promising candidates for AD treatment in the near future. Finally, clinical trials using intranasal insulin applications have been successful in ameliorating cognitive functions of patients exhibiting mild to moderate AD [<xref ref-type="bibr" rid="r230">230</xref>]. Insulin works by preventing Aβ-derived diffusible ligands binding to neuronal surface, resulting in significant diminished spine loss [<xref ref-type="bibr" rid="r231">231</xref>]. It is worth mentioning that this strategy is currently under Phase II/III clinical trials (ClinicalTrials.gov Identifier: NCT01767909).</p>
</sec>
</sec>
<sec id="sec2.2">
<label>2.2</label>
<title>Multiple Sclerosis</title>
<p>Multiple Sclerosis (MS) is one of the most frequent demyelinating CNS disorders, affecting around 3 million people worldwide [<xref ref-type="bibr" rid="r232">232</xref>]. Patients bearing this neurological disorder often present motor, cognitive, visual and sensory deficits throughout the course of the disease, which worsens with aging [<xref ref-type="bibr" rid="r233">233</xref>-<xref ref-type="bibr" rid="r237">237</xref>]. These symptoms are widely viewed as the result of extensive white matter demyelination, associated with blood-brain barrier disruption, leading to massive inflammatory infiltration, followed by astrogliosis and microgliosis, neuronal injury, extensive excitotoxicity and neuroinflammation [<xref ref-type="bibr" rid="r233">233</xref>, <xref ref-type="bibr" rid="r234">234</xref>, <xref ref-type="bibr" rid="r238">238</xref>-<xref ref-type="bibr" rid="r242">242</xref>].</p>
<p>Even though most researchers have focused on the inflammatory aspects concerning white matter demyelination and its associated lesions, gray matter alterations have been regarded as an important aspect in MS, especially concerning the development of cognitive deficits [<xref ref-type="bibr" rid="r241">241</xref>]. For instance, it has been shown that decreased cognitive processing is associated with cortical lesions and atrophy in several brain regions [<xref ref-type="bibr" rid="r243">243</xref>], including the basal ganglia [<xref ref-type="bibr" rid="r244">244</xref>], thalamus [<xref ref-type="bibr" rid="r244">244</xref>, <xref ref-type="bibr" rid="r245">245</xref>], sensorimotor, entorhinal and cingulate cortices [<xref ref-type="bibr" rid="r246">246</xref>], cerebellum [<xref ref-type="bibr" rid="r247">247</xref>], amygdala [<xref ref-type="bibr" rid="r248">248</xref>] and hippocampus [<xref ref-type="bibr" rid="r249">249</xref>, <xref ref-type="bibr" rid="r250">250</xref>]. One of the mechanisms responsible for this phenotype is the extensive neuronal and glial cell loss present in the MS lesions and the extensive demyelination of cortical structures [<xref ref-type="bibr" rid="r250">250</xref>-<xref ref-type="bibr" rid="r253">253</xref>]. As such, several studies have identified that proinflammatory cascades, induced by both peripheric and activated CNS resident immune cells, are associated with augmented apoptosis in MS patients and in the Experimental Autoimmune Encephalomyelitis (EAE) mouse model [<xref ref-type="bibr" rid="r252">252</xref>-<xref ref-type="bibr" rid="r256">256</xref>]. Thus, TNF-α has been found to induce oligodendrocytes programmed cell death in a caspase-independent fashion [<xref ref-type="bibr" rid="r254">254</xref>]. Moreover, Interferon γ (IFN-γ) promotes the cell death of oligodendrocytes and also of microglial cells, contributing to the reduction in myelination and gray matter volume observed in MS patients [<xref ref-type="bibr" rid="r255">255</xref>, <xref ref-type="bibr" rid="r256">256</xref>]. In addition, IL-1β and glutamatergic excitotoxicity have also been demonstrated to activate apoptosis, triggering neuronal cell death <italic>via</italic> the p53 cascade [<xref ref-type="bibr" rid="r257">257</xref>], while augmented oxidative stress, due to increased reactive oxygen species production, is also implied to take part in the cell loss that takes place in MS [<xref ref-type="bibr" rid="r258">258</xref>]. Furthermore, the classical complement cascade plays a significant role in the induction of apoptosis of neuronal cells in MS. In fact, early reports have provided evidence that animals lacking the complement component C3 in an EAE model have milder disease phenotypes compared to their WT littermates, including decreased demyelination and diminished number of infiltrated macrophages and T cells [<xref ref-type="bibr" rid="r259">259</xref>]. Subsequent studies not only corroborate this data [<xref ref-type="bibr" rid="r260">260</xref>, <xref ref-type="bibr" rid="r261">261</xref>], but also indicate the involvement of C5 in mediating cell death in an acute EAE model [<xref ref-type="bibr" rid="r262">262</xref>]. Additionally, recent findings obtained by Watkins <italic>et al</italic> [<xref ref-type="bibr" rid="r263">263</xref>] have shown increased C1q, C3b and C9 expression in the gray matter lesions in the cortex. These authors have also found elevated levels of microglial cells positive for the complement receptors CR3, C3aR and C5aR. Altogether, these data strongly suggest the formation of the membrane attack complex in  the CNS cells of MS patients, leading to their death by apoptosis.</p>
<sec id="sec2.2.1">
<label>2.2.1</label>
<title>Synaptic Elimination might be Central for the Cognitive Decline During MS Progression</title>
<p>Synaptic elimination is an important neurodegenerative process that appears to take place in the CNS parenchyma of MS individuals and to lead to extensive the cognitive decline. As such, <italic>post-mortem</italic> analysis of MS patients and EAE mouse models have provided evidence for decreased synapse number in the hippocampus, insular, frontotemporal and occipital cortices, and striatum [<xref ref-type="bibr" rid="r250">250</xref>, <xref ref-type="bibr" rid="r264">264</xref>-<xref ref-type="bibr" rid="r267">267</xref>]. In addition, the staining intensities for synapsin I, synaptophysin and PSD-95 are also reduced in the hippocampus of MS patients and in EAE mice [<xref ref-type="bibr" rid="r266">266</xref>, <xref ref-type="bibr" rid="r267">267</xref>]. Even though these results and the involvement of the classical complement cascade in MS could suggest increased synaptic pruning, direct evidence for such a phenomenon in MS is sparse. Indeed, Machalidou and colleagues [<xref ref-type="bibr" rid="r268">268</xref>] have found increased C1q and C3d immunoreactivity in all hippocampal regions in the brain of MS patients. Also, they have demonstrated that these two complement factors colocalize with synaptophysin, both in neuronal synapses and inside activated microglia, indicating these cells are engulfing complement targeted synapses. These data suggest that synaptic pruning contributes to the diminished synapse density observed in MS patients. Conversely, CD47, which acts as a “don’t-eat-me” signal, preventing phagocytosis of synapses by microglia, is downregulated in chronic MS lesions [<xref ref-type="bibr" rid="r269">269</xref>, <xref ref-type="bibr" rid="r270">270</xref>]. Intriguingly, when CD47 is deleted in an EAE mouse model, the disease fails to develop to its full extent [<xref ref-type="bibr" rid="r270">270</xref>]. In contrast, when this molecule is blocked during the disease course, it worsens EAE development in treated animals, on which it is possible to observe increased myelin phagocytosis by murine macrophages [<xref ref-type="bibr" rid="r270">270</xref>]. Although these studies did not access CD47 role in synaptic pruning, its downregulation during MS progression could prompt both activated microglia and infiltrating macrophages to excessively prune synapses due to inefficient recognition of this protective signal.</p>
<p>On the other hand, Freria <italic>et al</italic>. [<xref ref-type="bibr" rid="r271">271</xref>], upon analyzing spinal cord synapses, found that increased MHC-I expression in both astrocytes and microglia correlates with decreased immunostaining for synaptophysin, suggesting that MHC-I levels are inversely related to synaptic density. Genetic studies indicated that a cohort of MS patients possesses higher frequency of two progranulin alleles (rs9897526 A and rs5848 T) that are associated with increased disease severity and decreased progranulin expression levels [<xref ref-type="bibr" rid="r272">272</xref>]. In marked contrast, Vercellino <italic>et al</italic> [<xref ref-type="bibr" rid="r273">273</xref>] have provided evidence for strong expression of progranulin in activated microglia, macrophages and neurons around cortical lesions in MS patients. Moreover, they also show higher CSF progranulin levels in patients displaying the progressive form of the disease, compared to those in clinical remission. Adding more confusion to the role played by progranulin in MS, De Riz and colleagues [<xref ref-type="bibr" rid="r274">274</xref>] have argued that this factor does not play a significant role in this disease since they have found its CSF levels to be more correlated with aging than with MS <italic>per se</italic>. Despite progranulin importance in synaptic elimination, there is a lack of substantial evidence for the participation of progranulin in MS synapse loss, especially because only a few studies have aimed at investigating its role in this disease. In addition, previous reports indicate increased brain, CSF and serum levels of CX3CL1 in MS patients compared to healthy individuals [<xref ref-type="bibr" rid="r275">275</xref>, <xref ref-type="bibr" rid="r276">276</xref>]. Since CX3CL1 expression in astrocytes does not differ between MS patients and controls [<xref ref-type="bibr" rid="r277">277</xref>], it is possible that increased CSF levels of this chemokine could come, at least in part, from neuronal origin or increased release of soluble CX3CL1 from the astrocytic plasma membrane. Furthermore, data points out that CX3CL1 expression in the brain is regulated by adenosine signaling and that blocking CX3CL1 impairs EAE development, especially dampening lymphocytes migration into the brain parenchyma [<xref ref-type="bibr" rid="r278">278</xref>]. Also, CX3CR1 deletion markedly decreases Natural Killer cell influx into the brain in EAE [<xref ref-type="bibr" rid="r278">278</xref>]. It is also worth mentioning that neuronal pentraxin receptor (NPR) is upregulated in MS patients, which might indicate that neuronal pentraxins are somehow involved in this disease progression [<xref ref-type="bibr" rid="r279">279</xref>]. However, whether these immune molecules are implicated in the enhanced synaptic elimination observed in MS patients is still unknown. Even though these data do not conclusively point to a direct association between increased synaptic elimination and disease progression, the altered levels of the aforementioned molecules in MS might indicate this could be the case.</p>
<p>Regarding deficient synaptogenesis, a phenomenon that could also explain the observed reduction in synaptic staining intensities in MS patients and EAE mouse models, little is known. Indeed, one of the fewest evidences pointing in this direction indicates a negative correlation between synapse number and paralysis severity in an EAE mouse model [<xref ref-type="bibr" rid="r280">280</xref>]. In this study, proinflammatory cytokines released by T cells have been shown to either augment the production of secreted protein acidic and rich in cysteine (SPARC) or inhibit SPARC-like 1 (SPARCL1) synthesis. While SPARCL1 promotes the formation of excitatory synapses, SPARC blocks it [<xref ref-type="bibr" rid="r280">280</xref>]. Albeit this data provides support for disrupted synaptogenesis, the lack of evidence limits any further conclusion concerning the importance of this phenomenon in MS progression. Altogether, future research should be conducted to understand better to what extent increased synaptic pruning or decreased synaptogenesis could influence MS development.</p>
<p>Despite the scarcity of data regarding the molecular mechanisms involved in spine loss in MS, it is well known that glutamatergic and GABAergic transmissions are altered in this disease, especially in the case of the first system, which is implicated in triggering excitotoxic neuronal damage [<xref ref-type="bibr" rid="r239">239</xref>, <xref ref-type="bibr" rid="r266">266</xref>, <xref ref-type="bibr" rid="r281">281</xref>-<xref ref-type="bibr" rid="r283">283</xref>]. Elevated TNF-α level is observed during MS progression, leading to substantial increase in spontaneous excitatory post-synaptic currents (sEPSCs) and subsequent neuronal damage due to augmented glutamate release [<xref ref-type="bibr" rid="r240">240</xref>]. This elevated level of glutamate seems to be largely due to increased TNF-α release by astrocytes and microglia, ultimately leading to impaired memory in EAE and increased neurotoxicity [<xref ref-type="bibr" rid="r283">283</xref>, <xref ref-type="bibr" rid="r284">284</xref>]. In addition, this cytokine also mediates increased synaptic turnover, even before microglial activation and lymphocyte infiltration in EAE mouse brains, suggesting that this proinflammatory molecule might also play an important role in modulating synapse density in MS [<xref ref-type="bibr" rid="r285">285</xref>]. Interestingly, treating EAE mice with the cannabinoid receptors 1 and 2 (CB1 and CB2, respectively) agonist WIN55,512-2 significantly ameliorates disease progression, even reducing cellular infiltrates in the spinal cord [<xref ref-type="bibr" rid="r286">286</xref>]. This effect is largely mediated by CB1, triggering subsequent downregulation of TNF-α levels, which, in turn, diminishes the glutamatergic excitotoxicity [<xref ref-type="bibr" rid="r286">286</xref>, <xref ref-type="bibr" rid="r287">287</xref>]. Similar results are observed when microglial cells are treated with either the gap junction blocker carbenoxolone or the glutaminase inhibitor 6-diazo-5-oxo-L-norleucine, with both drugs preventing the excessive glutamate release [<xref ref-type="bibr" rid="r288">288</xref>]. Thereby, therapeutic strategies aiming at reducing either TNF-α or released glutamate levels comprise an attractive approach to ameliorate MS progression.</p>
</sec>
</sec>
<sec id="sec2.3">
<label>2.3</label>
<title>Schizophrenia</title>
<p>SCZ is a neurodevelopmental disorder that is characterized by high level of synapse elimination. This disorder is estimated to affect approximately 1% of the entire world population and its symptoms begin to manifest at late adolescence and early adulthood [<xref ref-type="bibr" rid="r289">289</xref>-<xref ref-type="bibr" rid="r290">290</xref>]. SCZ symptoms are often divided into three categories: positive symptoms (hallucinations, delusions, thought disorder and psychosis), negative symptoms (avolition, depression, anhedonia and loss of social drive) and cognitive deficits (disorganized speech, thought and attention deficits) [<xref ref-type="bibr" rid="r290">290</xref>, <xref ref-type="bibr" rid="r291">291</xref>]. Anatomical studies using imaging techniques, such as magnetic resonance imaging (MRI), have identified several brain alterations in schizophrenic individuals. Thus, researchers have found substantial enlargements of the third and lateral ventricles, which are correlated with augmented cognitive deficits [<xref ref-type="bibr" rid="r292">292</xref>-<xref ref-type="bibr" rid="r295">295</xref>]. In addition, it is also perceived a 3% and 5.5-6.5% reduction in the whole cerebrum and hippocampal volume, respectively, as well as overall reduced cortical thickness [<xref ref-type="bibr" rid="r294">294</xref>-<xref ref-type="bibr" rid="r296">296</xref>]. Interestingly, this reduction in brain volume is not accompanied by the corresponding decrease in neuronal numbers. In fact, studies suggest that not only are neuronal numbers similar between schizophrenic and healthy individuals, but they might also be increased in the former group, especially in the pre-frontal cortex, a region implicated in SCZ [<xref ref-type="bibr" rid="r297">297</xref>-<xref ref-type="bibr" rid="r299">299</xref>].</p>
<p>Based on these findings, researchers hypothesize that SCZ brain volume and cortical thickness reductions are caused by altered morphological features in the neuropil [<xref ref-type="bibr" rid="r300">300</xref>]. <italic>Post-mortem</italic> tissue analyses have shown substantially decreased number of dendritic spines in several cortical structures, including the striatum, the subiculum and the temporal, auditory and pre-frontal cortices [<xref ref-type="bibr" rid="r300">300</xref>-<xref ref-type="bibr" rid="r305">305</xref>]. These evidences provide strong support for the hypothesis firstly proposed by Feinberg in 1983, that SCZ could arise from excessive synaptic pruning during adolescence. This phenomenon could lead to significant cortical connectivity alterations in the adulthood, and, ultimately, to the characteristic symptoms observed throughout disease progression [<xref ref-type="bibr" rid="r306">306</xref>]. Despite almost four decades after being proposed, the mechanisms whereby elevated synaptic elimination could account for the onset of SCZ are still poorly understood.</p>
<p>Even though schizophrenia etiology is still mostly unknown, several genetic and environmental risk factors are thought to trigger this neurodevelopmental disorder [<xref ref-type="bibr" rid="r289">289</xref>, <xref ref-type="bibr" rid="r307">307</xref>]. Notably, genetic studies have provided the majority of evidences linking SCZ and abnormal synaptic pruning. For instance, Sekar and colleagues [<xref ref-type="bibr" rid="r308">308</xref>] have demonstrated that schizophrenic individuals possess genetic structural variants favoring the greater expression of C4A mRNA, one of the C4 isoforms found in the human genome. C4 activates C3 in the classical complement cascade and these authors have demonstrated that mice lacking C4 show abnormal eye-specific segregation in the dLGN as well as reduced C3-puncta colocalization at synapses [<xref ref-type="bibr" rid="r308">308</xref>]. Corroborating C4 involvement in SCZ, Prasad <italic>et al</italic> [<xref ref-type="bibr" rid="r309">309</xref>] have identified that both C4 isoforms (C4A and C4B) expression correlates with neuropil contraction in SCZ patients. Furthermore, chronic schizophrenic patients display higher blood levels of C4, while those at high-risk of developing psychosis present increased levels of both C3 and C4 compared to healthy individuals [<xref ref-type="bibr" rid="r310">310</xref>]. On the other hand, SIRPα, the CD47 receptor, is downregulated in the dorsolateral pre-frontal cortex of schizophrenic individuals [<xref ref-type="bibr" rid="r311">311</xref>]. These findings are particularly remarkable, as C4 is a pruning-promoting molecule, while SIRPα takes part in the protective signaling preventing synaptic elimination. Additionally, if brain complement component levels are actually elevated in SCZ, it is possible to speculate the involvement of mGluR1 in this phenomenon, similarly to what has been observed in Alzheimer’s disease [<xref ref-type="bibr" rid="r207">207</xref>]. As such, augmented levels of mGluR1 has been observed in the pre-frontal cortex of SCZ patients [<xref ref-type="bibr" rid="r312">312</xref>], while non-synonymous mutations in the mGluR1 gene (<italic>GRM1</italic>) has been found in a cohort of schizophrenic individuals [<xref ref-type="bibr" rid="r313">313</xref>]. Moreover, the downstream target of mGluR1 activation, FMRP, is decreased in the blood of SCZ individuals [<xref ref-type="bibr" rid="r314">314</xref>]. Since C1q mRNA is repressed upon FMRP binding, these data might suggest a connection between mGluR1 activation, which could also lead to LTD induction, and increased complement-dependent synaptic pruning in SCZ. In remarkable contrast, other genetic studies, using distinct schizophrenic patient cohorts, failed to detect the association between the classical complement cascade and schizophrenia [<xref ref-type="bibr" rid="r315">315</xref>-<xref ref-type="bibr" rid="r317">317</xref>]. This contradiction might reflect the high heterogenicity found between schizophrenic patients and the polygenic nature of this disorder. Therefore, further functional studies, using novel strategies, should be carried out to elucidate the actual contribution of the complement cascade to SCZ development.</p>
<p>Bergon and colleagues [<xref ref-type="bibr" rid="r318">318</xref>] have performed a large meta-analysis based on gene expression alterations found in schizophrenic individuals compared to healthy ones in order to find other suitable candidates important for synaptic elimination. Intriguingly, it has been shown that CX3CR1 is downregulated in both the brain and blood in SCZ patients. Moreover, another study identified that the genetic variant coding for CX3CR1<sup>A55T</sup> is associated with SCZ [<xref ref-type="bibr" rid="r319">319</xref>]. The functional validation of this mutated CX3CR1 form <italic>in vitro</italic> indicated that it leads to impairments in downstream signaling upon CX3CL1 binding, which might affect the microglial phenotype in this disorder. Additionally, it is important to mention that common genetic variant analyses indicate that polymorphisms in the MHC locus are significantly associated with SCZ [<xref ref-type="bibr" rid="r320">320</xref>, <xref ref-type="bibr" rid="r321">321</xref>]. Another genetic study has identified progranulin genetic variants conferring higher risk for schizophrenia [<xref ref-type="bibr" rid="r322">322</xref>], whereas others found that glypicans, which are responsible for neuronal pentraxin release regulation [<xref ref-type="bibr" rid="r323">323</xref>], are also related to this disease [<xref ref-type="bibr" rid="r324">324</xref>].</p>
<p><italic>Post-mortem</italic> analyses and imaging techniques point to the activation of microglial cells in SCZ [<xref ref-type="bibr" rid="r324">324</xref>-<xref ref-type="bibr" rid="r326">326</xref>]. This microglial phenotype suggests the occurrence of neuroinflammation and enhanced levels of proinflammatory molecules in the brain of schizophrenic individuals [<xref ref-type="bibr" rid="r327">327</xref>-<xref ref-type="bibr" rid="r328">328</xref>]. For instance, evidences indicate elevated TNF-α and IL-6 in the brain, blood and CSF of SCZ patients [<xref ref-type="bibr" rid="r328">328</xref>-<xref ref-type="bibr" rid="r331">331</xref>]. On the other hand, increased IL-1β levels, a classic proinflammatory cytokine, have been implicated in SCZ, although these results are disputable [<xref ref-type="bibr" rid="r330">330</xref>-<xref ref-type="bibr" rid="r332">332</xref>]. Nonetheless, whether these cytokines contribute to promote microglia-mediated synaptic pruning in schizophrenia is still unknown. In an attempt to identify whether this is the case, studies using animals to model environmental factors have been used. Indeed, using the maternal immune activation model, which mimics pre-natal infection as a risk factor in SCZ [<xref ref-type="bibr" rid="r333">333</xref>], Mattei and colleagues [<xref ref-type="bibr" rid="r334">334</xref>] have verified that the microglia of the offspring display an activated phenotype with transcriptomic profile and cytokine expression partially matching those found in SCZ patients. Surprisingly, synaptic density in these animals is also reduced [<xref ref-type="bibr" rid="r335">335</xref>]. Unfortunately, the behavioral alterations observed in these animals recapitulate those associated with autism and not schizophrenia [<xref ref-type="bibr" rid="r336">336</xref>]. In addition, another major drawback of using this kind of model is the absence of the genetic component of SCZ, which does not allow the execution of studies aiming at analyzing the interaction between genetic and environmental risk factor.</p>
<p>The use of iPSCs derived from schizophrenic individuals could partially solve this issue, at least for studies attempting to investigate major changes at the molecular and cellular levels. Indeed, Brennand and colleagues [<xref ref-type="bibr" rid="r337">337</xref>] have found that iPSC-differentiated neurons derived from SCZ patients exhibit reduced neuronal connectivity and neurite numbers and decreased expression of PSD95 and glutamate ionotropic receptor kainate 1 expression. Additionally, Sellgren <italic>et al</italic> [<xref ref-type="bibr" rid="r338">338</xref>] have shown that microglial-like cells derived from schizophrenic individuals display a higher phagocytic index of synaptosomes obtained from hiPSC-derived neuronal preparations. These data indicate increased synaptic engulfment capacity by microglia in SCZ, which could underpin the elevated synapse loss observed in this condition. Interestingly, this higher phagocytic capacity of SCZ microglial-cells is inhibited by minocycline treatment, a drug recently suggested for schizophrenia treatment [<xref ref-type="bibr" rid="r338">338</xref>, <xref ref-type="bibr" rid="r339">339</xref>].</p>
</sec>
</sec>
<sec sec-type="conclusions">
<title>CONCLUSION</title>
<p>In recent years, several lines of evidence have indicated a prominent role of synaptic elimination as a key component in modulating neuroplasticity in the CNS. Nonetheless, disturbances in this process are likely underpinning the cognitive deficits often observed in many of the most relevant neurological disorders afflicting humankind. In this review, we summarized the most up-to-date information available in the scientific literature, regarding what is currently known about synaptic pruning in AD, MS and SCZ, three of the most relevant neurological disorders. Nevertheless, there  is still much to be learned about this process, especially  concerning the involvement of immune molecules and glial cells in mediating synapse maintenance/elimination in these disorders.</p>
</sec>
</body>
<back>
<ack>
<title>ACKNOWLEDGEMENTS</title>
<p>P.L.C., I.B.Q.L, E.M.A.M., N.C.S., T.D. and F.M.R. were responsible for the manuscript writing, proofreading and editing.</p>
</ack>
<sec>
<title>CONSENT FOR PUBLICATION</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>FUNDING</title>
<p>This work was supported by CNPq (grant number 429049/2018-8) and FAPEMIG (grant number PPM-00212-18) grants to F.M.R and by the grant from the Ministry of Education, Science, Research and Sport of the Slovak Republic to T.D., DB Biotech, Slovakia. P.L.C. and I.B.Q.L. are recipients of CAPES PhD and Masters scholarships,  respectively.</p>
</sec>
<sec sec-type="competing-interests">
<title>CONFLICT OF INTEREST</title>
<p>The authors declare no conflict of interest, financial or otherwise.</p>
</sec>
<ref-list>
<title>REFERENCES</title>
<ref id="r1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riccomagno</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Kolodkin</surname>
<given-names>A.L.</given-names>
</name>
</person-group>
<article-title>Sculpting neural circuits by axon and dendrite pruning.</article-title>
<source/>Annu. Rev. Cell Dev. Biol.
          <year>2015</year>
<volume>31</volume>
<fpage>779</fpage>
<lpage>805</lpage>
<comment>[http://dx.doi.org/10.1146/annurev-cellbio-100913-013038].</comment>
<pub-id pub-id-type="pmid">26436703</pub-id>
</element-citation>
</ref>
<ref id="r2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lichtman</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Colman</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Synapse elimination and indelible memory.</article-title>
<source/>Neuron
          <year>2000</year>
<volume>25</volume>
<issue>2</issue>
<fpage>269</fpage>
<lpage>278</lpage>
<comment>[http://dx.doi.org/10.1016/S0896-6273(00)80893-4]. [PMID: 10719884].</comment>
<pub-id pub-id-type="pmid">10719884</pub-id>
</element-citation>
</ref>
<ref id="r3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hashimoto</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Synapse elimination in the central nervous system.</article-title>
<source/>Curr. Opin. Neurobiol.
          <year>2009</year>
<volume>19</volume>
<issue>2</issue>
<fpage>154</fpage>
<lpage>161</lpage>
<comment>[http://dx.doi.org/10.1016/j.conb.2009.05.002]. [PMID: 19481442].</comment>
<pub-id pub-id-type="pmid">19481442</pub-id>
</element-citation>
</ref>
<ref id="r4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Gan</surname>
<given-names>W.B.</given-names>
</name>
</person-group>
<article-title>Stably maintained dendritic spines are associated with lifelong memories.</article-title>
<source/>Nature
          <year>2009</year>
<volume>462</volume>
<issue>7275</issue>
<fpage>920</fpage>
<lpage>924</lpage>
<comment>[http://dx.doi.org/10.1038/nature08577]. [PMID: 19946265].</comment>
<pub-id pub-id-type="pmid">19946265</pub-id>
</element-citation>
</ref>
<ref id="r5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukui</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bedi</surname>
<given-names>K.S.</given-names>
</name>
</person-group>
<article-title>Quantitative study of the development of neurons and synapses in rats reared in the dark during early postnatal life. 1. Superior colliculus.</article-title>
<source/>J. Anat.
          <year>1991</year>
<volume>174</volume>
<fpage>49</fpage>
<lpage>60</lpage>
<comment>[PMID: 2032942].</comment>
<pub-id pub-id-type="pmid">2032942</pub-id>
</element-citation>
</ref>
<ref id="r6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Regehr</surname>
<given-names>W.G.</given-names>
</name>
</person-group>
<article-title>Developmental remodeling of the retinogeniculate synapse.</article-title>
<source/>Neuron
          <year>2000</year>
<volume>28</volume>
<issue>3</issue>
<fpage>955</fpage>
<lpage>966</lpage>
<comment>[http://dx.doi.org/10.1016/S0896-6273(00)00166-5]. [PMID: 11163279].</comment>
<pub-id pub-id-type="pmid">11163279</pub-id>
</element-citation>
</ref>
<ref id="r7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cragg</surname>
<given-names>B.G.</given-names>
</name>
</person-group>
<article-title>The development of synapses in kitten visual cortex during visual deprivation.</article-title>
<source/>Exp. Neurol.
          <year>1975</year>
<volume>46</volume>
<issue>3</issue>
<fpage>445</fpage>
<lpage>451</lpage>
<comment>[http://dx.doi.org/10.1016/0014-4886(75)90118-1]. [PMID: 1112285].</comment>
<pub-id pub-id-type="pmid">1112285</pub-id>
</element-citation>
</ref>
<ref id="r8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shatz</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Stryker</surname>
<given-names>M.P.</given-names>
</name>
</person-group>
<article-title>Ocular dominance in layer IV of the cat’s visual cortex and the effects of monocular deprivation.</article-title>
<source/>J. Physiol.
          <year>1978</year>
<volume>281</volume>
<fpage>267</fpage>
<lpage>283</lpage>
<comment>[http://dx.doi.org/10.1113/jphysiol.1978.sp012421]. [PMID: 702379].</comment>
<pub-id pub-id-type="pmid">702379</pub-id>
</element-citation>
</ref>
<ref id="r9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shatz</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Stryker</surname>
<given-names>M.P.</given-names>
</name>
</person-group>
<article-title>Prenatal tetrodotoxin infusion blocks segregation of retinogeniculate afferents.</article-title>
<source/>Science
          <year>1988</year>
<volume>242</volume>
<issue>4875</issue>
<fpage>87</fpage>
<lpage>89</lpage>
<comment>[http://dx.doi.org/10.1126/science.3175636]. [PMID: 3175636].</comment>
<pub-id pub-id-type="pmid">3175636</pub-id>
</element-citation>
</ref>
<ref id="r10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huttenlocher</surname>
<given-names>P.R.</given-names>
</name>
<name>
<surname>Dabholkar</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>Regional differences in synaptogenesis in human cerebral cortex.</article-title>
<source/>J. Comp. Neurol.
          <year>1997</year>
<volume>387</volume>
<issue>2</issue>
<fpage>167</fpage>
<lpage>178</lpage>
<comment>[http://dx.doi.org/10.1002/(SICI)1096-9861(19971020)387:2&lt;167:AID-CNE1&gt;3.0.CO;2-Z]. [PMID: 9336221].</comment>
<pub-id pub-id-type="pmid">9336221</pub-id>
</element-citation>
</ref>
<ref id="r11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petanjek</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Judaš</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Šimic</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Rasin</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Uylings</surname>
<given-names>H.B.</given-names>
</name>
<name>
<surname>Rakic</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kostovic</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Extraordinary neoteny of synaptic spines in the human prefrontal cortex.</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2011</year>
<volume>108</volume>
<issue>32</issue>
<fpage>13281</fpage>
<lpage>13286</lpage>
<comment>[http://dx.doi.org/10.1073/pnas.1105108108]. [PMID: 21788513].</comment>
<pub-id pub-id-type="pmid">21788513</pub-id>
</element-citation>
</ref>
<ref id="r12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoshiko</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Arnoux</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Avignone</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Audinat</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Deficiency of the microglial receptor CX3CR1 impairs postnatal functional development of thalamocortical synapses in the barrel cortex.</article-title>
<source/>J. Neurosci.
          <year>2012</year>
<volume>32</volume>
<issue>43</issue>
<fpage>15106</fpage>
<lpage>15111</lpage>
<comment>[http://dx.doi.org/10.1523/JNEUROSCI.1167-12.2012]. [PMID: 23100431].</comment>
<pub-id pub-id-type="pmid">23100431</pub-id>
</element-citation>
</ref>
<ref id="r13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nägerl</surname>
<given-names>U.V.</given-names>
</name>
<name>
<surname>Eberhorn</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Cambridge</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Bonhoeffer</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Bidirectional activity-dependent morphological plasticity in hippocampal neurons.</article-title>
<source/>Neuron
          <year>2004</year>
<volume>44</volume>
<issue>5</issue>
<fpage>759</fpage>
<lpage>767</lpage>
<comment>[http://dx.doi.org/10.1016/j.neuron.2004.11.016]. [PMID: 15572108].</comment>
<pub-id pub-id-type="pmid">15572108</pub-id>
</element-citation>
</ref>
<ref id="r14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yildirim</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mapp</surname>
<given-names>O.M.</given-names>
</name>
<name>
<surname>Janssen</surname>
<given-names>W.G.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Morrison</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Gore</surname>
<given-names>A.C.</given-names>
</name>
</person-group>
<article-title>Postpubertal decrease in hippocampal dendritic spines of female rats.</article-title>
<source/>Exp. Neurol.
          <year>2008</year>
<volume>210</volume>
<issue>2</issue>
<fpage>339</fpage>
<lpage>348</lpage>
<comment>[http://dx.doi.org/10.1016/j.expneurol.2007.11.003]. [PMID: 18096161].</comment>
<pub-id pub-id-type="pmid">18096161</pub-id>
</element-citation>
</ref>
<ref id="r15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koss</surname>
<given-names>W.A.</given-names>
</name>
<name>
<surname>Belden</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Hristov</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Juraska</surname>
<given-names>J.M.</given-names>
</name>
</person-group>
<article-title>Dendritic remodeling in the adolescent medial prefrontal cortex and the basolateral amygdala of male and female rats.</article-title>
<source/>Synapse
          <year>2014</year>
<volume>68</volume>
<issue>2</issue>
<fpage>61</fpage>
<lpage>72</lpage>
<comment>[http://dx.doi.org/10.1002/syn.21716]. [PMID: 24105875].</comment>
<pub-id pub-id-type="pmid">24105875</pub-id>
</element-citation>
</ref>
<ref id="r16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huttenlocher</surname>
<given-names>P.R.</given-names>
</name>
</person-group>
<article-title>Synaptic density in human frontal cortex - developmental changes and effects of aging.</article-title>
<source/>Brain Res.
          <year>1979</year>
<volume>163</volume>
<issue>2</issue>
<fpage>195</fpage>
<lpage>205</lpage>
<comment>[http://dx.doi.org/10.1016/0006-8993(79)90349-4]. [PMID: 427544].</comment>
<pub-id pub-id-type="pmid">427544</pub-id>
</element-citation>
</ref>
<ref id="r17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hashimoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kano</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Synapse elimination in the devel-oping cerebellum. Cellular and molecular life sciences.</article-title>
<source/>Cell. Mol. Life Sci.
          <year>2013</year>
<volume>70</volume>
<issue>24</issue>
<fpage>4667</fpage>
<lpage>4680</lpage>
<comment>[http://dx.doi.org/10.1007/s00018-013-1405-2]. [PMID: 23811844].</comment>
<pub-id pub-id-type="pmid">23811844</pub-id>
</element-citation>
</ref>
<ref id="r18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elston</surname>
<given-names>G.N.</given-names>
</name>
<name>
<surname>Oga</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fujita</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Spinogenesis and pruning scales across functional hierarchies.</article-title>
<source/>J. Neurosci.
          <year>2009</year>
<volume>29</volume>
<issue>10</issue>
<fpage>3271</fpage>
<lpage>3275</lpage>
<comment>[http://dx.doi.org/10.1523/JNEUROSCI.5216-08.2009]. [PMID: 19279264].</comment>
<pub-id pub-id-type="pmid">19279264</pub-id>
</element-citation>
</ref>
<ref id="r19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stevens</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Vazquez</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Howell</surname>
<given-names>G.R.</given-names>
</name>
<name>
<surname>Christopherson</surname>
<given-names>K.S.</given-names>
</name>
<name>
<surname>Nouri</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Micheva</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Mehalow</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Huberman</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Stafford</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sher</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Litke</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Lambris</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>John</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>B.A.</given-names>
</name>
</person-group>
<article-title>The classical complement cascade mediates CNS synapse elimination.</article-title>
<source/>Cell
          <year>2007</year>
<volume>131</volume>
<issue>6</issue>
<fpage>1164</fpage>
<lpage>1178</lpage>
<comment>[http://dx.doi.org/10.1016/j.cell.2007.10.036]. [PMID: 18083105].</comment>
<pub-id pub-id-type="pmid">18083105</pub-id>
</element-citation>
</ref>
<ref id="r20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bialas</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>TGF-β signaling regulates neuronal C1q expression and developmental synaptic refinement.</article-title>
<source/>Nat. Neurosci.
          <year>2013</year>
<volume>16</volume>
<issue>12</issue>
<fpage>1773</fpage>
<lpage>1782</lpage>
<comment>[http://dx.doi.org/10.1038/nn.3560]. [PMID: 24162655].</comment>
<pub-id pub-id-type="pmid">24162655</pub-id>
</element-citation>
</ref>
<ref id="r21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tremblay</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Lowery</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Majewska</surname>
<given-names>A.K.</given-names>
</name>
</person-group>
<article-title>Microglial interactions with synapses are modulated by visual experience.</article-title>
<source/>PLoS Biol.
          <year>2010</year>
<volume>8</volume>
<issue>11</issue>
<elocation-id>e1000527</elocation-id>
<comment>[http://dx.doi.org/10.1371/journal.pbio.1000527]. [PMID: 21072242].</comment>
<pub-id pub-id-type="pmid">21072242</pub-id>
</element-citation>
</ref>
<ref id="r22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nimmerjahn</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kirchhoff</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Helmchen</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Resting microglial cells are highly dynamic surveillants of brain parenchyma <italic>in vivo.</italic></article-title>
<source/>Science
          <year>2005</year>
<volume>308</volume>
<issue>5726</issue>
<fpage>1314</fpage>
<lpage>1318</lpage>
<comment>[http://dx.doi.org/10.1126/science.1110647]. [PMID: 15831717].</comment>
<pub-id pub-id-type="pmid">15831717</pub-id>
</element-citation>
</ref>
<ref id="r23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coleman</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Nahmani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gavornik</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Haslinger</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Heynen</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Erisir</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bear</surname>
<given-names>M.F.</given-names>
</name>
</person-group>
<article-title>Rapid structural remodeling of thalamocortical synapses parallels experience-dependent functional plasticity in mouse primary visual cortex.</article-title>
<source/>J. Neurosci.
          <year>2010</year>
<volume>30</volume>
<issue>29</issue>
<fpage>9670</fpage>
<lpage>9682</lpage>
<comment>[http://dx.doi.org/10.1523/JNEUROSCI.1248-10.2010]. [PMID: 20660250].</comment>
<pub-id pub-id-type="pmid">20660250</pub-id>
</element-citation>
</ref>
<ref id="r24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Homma</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Poo</surname>
<given-names>M.M.</given-names>
</name>
</person-group>
<article-title>Shrinkage of dendritic spines associated with long-term depression of hippocampal synapses.</article-title>
<source/>Neuron
          <year>2004</year>
<volume>44</volume>
<issue>5</issue>
<fpage>749</fpage>
<lpage>757</lpage>
<comment>[http://dx.doi.org/10.1016/j.neuron.2004.11.011]. [PMID: 15572107].</comment>
<pub-id pub-id-type="pmid">15572107</pub-id>
</element-citation>
</ref>
<ref id="r25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Roo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Klauser</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Muller</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>LTP promotes a selective long-term stabilization and clustering of dendritic spines.</article-title>
<source/>PLoS Biol.
          <year>2008</year>
<volume>6</volume>
<issue>9</issue>
<elocation-id>e219</elocation-id>
<comment>[http://dx.doi.org/10.1371/journal.pbio.0060219]. [PMID: 18788894].</comment>
<pub-id pub-id-type="pmid">18788894</pub-id>
</element-citation>
</ref>
<ref id="r26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bastrikova</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gardner</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Reece</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Jeromin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dudek</surname>
<given-names>S.M.</given-names>
</name>
</person-group>
<article-title>Synapse elimination accompanies functional plasticity in hippocampal neurons.</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2008</year>
<volume>105</volume>
<issue>8</issue>
<fpage>3123</fpage>
<lpage>3127</lpage>
<comment>[http://dx.doi.org/10.1073/pnas.0800027105]. [PMID: 18287055].</comment>
<pub-id pub-id-type="pmid">18287055</pub-id>
</element-citation>
</ref>
<ref id="r27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Becker</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wierenga</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Fonseca</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bonhoeffer</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nägerl</surname>
<given-names>U.V.</given-names>
</name>
</person-group>
<article-title>LTD induction causes morphological changes of presynaptic boutons and reduces their contacts with spines.</article-title>
<source/>Neuron
          <year>2008</year>
<volume>60</volume>
<issue>4</issue>
<fpage>590</fpage>
<lpage>597</lpage>
<comment>[http://dx.doi.org/10.1016/j.neuron.2008.09.018]. [PMID: 19038217].</comment>
<pub-id pub-id-type="pmid">19038217</pub-id>
</element-citation>
</ref>
<ref id="r28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gladding</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Fitzjohn</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Molnár</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Metabotropic glutamate receptor-mediated long-term depression: molecular mechanisms.</article-title>
<source/>Pharmacol. Rev.
          <year>2009</year>
<volume>61</volume>
<issue>4</issue>
<fpage>395</fpage>
<lpage>412</lpage>
<comment>[http://dx.doi.org/10.1124/pr.109.001735]. [PMID: 19926678].</comment>
<pub-id pub-id-type="pmid">19926678</pub-id>
</element-citation>
</ref>
<ref id="r29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kanold</surname>
<given-names>P.O.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.K.</given-names>
</name>
</person-group>
<article-title>AMPA receptor subunit GluR1 (GluA1) serine-845 site is involved in synaptic depression but not in spine shrinkage associated with chemical long-term depression.</article-title>
<source/>J. Neurophysiol.
          <year>2011</year>
<volume>105</volume>
<issue>4</issue>
<fpage>1897</fpage>
<lpage>1907</lpage>
<comment>[http://dx.doi.org/10.1152/jn.00913.2010]. [PMID: 21307330].</comment>
<pub-id pub-id-type="pmid">21307330</pub-id>
</element-citation>
</ref>
<ref id="r30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brigman</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Talani</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Prasad-Mulcare</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jinde</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Seabold</surname>
<given-names>G.K.</given-names>
</name>
<name>
<surname>Mathur</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Bock</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gustin</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Colbran</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Alvarez</surname>
<given-names>V.A.</given-names>
</name>
<name>
<surname>Nakazawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Delpire</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lovinger</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Loss of GluN2B-containing NMDA receptors in CA1 hippocampus and cortex impairs long-term depression, reduces dendritic spine density, and disrupts learning.</article-title>
<source/>J. Neurosci.
          <year>2010</year>
<volume>30</volume>
<issue>13</issue>
<fpage>4590</fpage>
<lpage>4600</lpage>
<pub-id pub-id-type="pmid">20357110</pub-id>
</element-citation>
</ref>
<ref id="r31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X.B.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Independent expression of synaptic and morphological plasticity associated with long-term depression.</article-title>
<source/>J. Neurosci.
          <year>2007</year>
<volume>27</volume>
<issue>45</issue>
<fpage>12419</fpage>
<lpage>12429</lpage>
<comment>[http://dx.doi.org/10.1523/JNEUROSCI.2015-07.2007]. [PMID: 17989307].</comment>
<pub-id pub-id-type="pmid">17989307</pub-id>
</element-citation>
</ref>
<ref id="r32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henson</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Tucker</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dudek</surname>
<given-names>S.M.</given-names>
</name>
</person-group>
<article-title>Long-term depression-associated signaling is required for an <italic>in vitro</italic> model of NMDA receptor-dependent synapse pruning.</article-title>
<source/>Neurobiol. Learn. Mem.
          <year>2017</year>
<volume>138</volume>
<fpage>39</fpage>
<lpage>53</lpage>
<comment>[http://dx.doi.org/10.1016/j.nlm.2016.10.013]. [PMID: 27794462].</comment>
<pub-id pub-id-type="pmid">27794462</pub-id>
</element-citation>
</ref>
<ref id="r33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hashimoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kurihara</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Aiba</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tonegawa</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Persistent multiple climbing fiber innervation of cerebellar Purkinje cells in mice lacking mGluR1.</article-title>
<source/>Neuron
          <year>1997</year>
<volume>18</volume>
<issue>1</issue>
<fpage>71</fpage>
<lpage>79</lpage>
<comment>[http://dx.doi.org/10.1016/S0896-6273(01)80047-7]. [PMID: 9010206].</comment>
<pub-id pub-id-type="pmid">9010206</pub-id>
</element-citation>
</ref>
<ref id="r34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ichise</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hashimoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yanagihara</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Nakao</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shigemoto</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Katsuki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Aiba</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>mGluR1 in cerebellar Purkinje cells essential for long-term depression, synapse elimination, and motor coordination.</article-title>
<source/>Science
          <year>2000</year>
<volume>288</volume>
<issue>5472</issue>
<fpage>1832</fpage>
<lpage>1835</lpage>
<comment>[http://dx.doi.org/10.1126/science.288.5472.1832]. [PMID: 10846166].</comment>
<pub-id pub-id-type="pmid">10846166</pub-id>
</element-citation>
</ref>
<ref id="r35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huber</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Kayser</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Bear</surname>
<given-names>M.F.</given-names>
</name>
</person-group>
<article-title>Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression.</article-title>
<source/>Science
          <year>2000</year>
<volume>288</volume>
<issue>5469</issue>
<fpage>1254</fpage>
<lpage>1257</lpage>
<comment>[http://dx.doi.org/10.1126/science.288.5469.1254]. [PMID: 10818003].</comment>
<pub-id pub-id-type="pmid">10818003</pub-id>
</element-citation>
</ref>
<ref id="r36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Narushima</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Uchigashima</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yagasaki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Harada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nagumo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Uesaka</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hashimoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Aiba</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Miyata</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kano</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The Metabotropic glutamate receptor subtype 1 Mediates experience-dependent maintenance of mature synaptic connectivity in the visual thalamus.</article-title>
<source/>Neuron
          <year>2016</year>
<volume>91</volume>
<issue>5</issue>
<fpage>1097</fpage>
<lpage>1109</lpage>
<comment>[http://dx.doi.org/10.1016/j.neuron.2016.07.035]. [PMID: 27545713].</comment>
<pub-id pub-id-type="pmid">27545713</pub-id>
</element-citation>
</ref>
<ref id="r37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Brumberg</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>mGluR5 knockout mice display increased dendritic spine densities.</article-title>
<source/>Neurosci. Lett.
          <year>2012</year>
<volume>524</volume>
<issue>1</issue>
<fpage>65</fpage>
<lpage>68</lpage>
<comment>[http://dx.doi.org/10.1016/j.neulet.2012.07.014]. [PMID: 22819970].</comment>
<pub-id pub-id-type="pmid">22819970</pub-id>
</element-citation>
</ref>
<ref id="r38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shinoda</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tominaga-Yoshino</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ogura</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Persistent synapse loss induced by repetitive LTD in developing rat hippocampal neurons.</article-title>
<source/>PLoS One
          <year>2010</year>
<volume>5</volume>
<issue>4</issue>
<elocation-id>e10390</elocation-id>
<comment>[http://dx.doi.org/10.1371/journal.pone.0010390]. [PMID: 20436928].</comment>
<pub-id pub-id-type="pmid">20436928</pub-id>
</element-citation>
</ref>
<ref id="r39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shinoda</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kamikubo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Egashira</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tominaga-Yoshino</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ogura</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Repetition of mGluR-dependent LTD causes slowly developing persistent reduction in synaptic strength accompanied by synapse elimination.</article-title>
<source/>Brain Res.
          <year>2005</year>
<volume>1042</volume>
<issue>1</issue>
<fpage>99</fpage>
<lpage>107</lpage>
<comment>[http://dx.doi.org/10.1016/j.brainres.2005.02.028]. [PMID: 15823258].</comment>
<pub-id pub-id-type="pmid">15823258</pub-id>
</element-citation>
</ref>
<ref id="r40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiegert</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Oertner</surname>
<given-names>T.G.</given-names>
</name>
</person-group>
<article-title>Long-term depression triggers the selective elimination of weakly integrated synapses.</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2013</year>
<volume>110</volume>
<issue>47</issue>
<fpage>E4510</fpage>
<lpage>E4519</lpage>
<comment>[http://dx.doi.org/10.1073/pnas.1315926110]. [PMID: 24191047].</comment>
<pub-id pub-id-type="pmid">24191047</pub-id>
</element-citation>
</ref>
<ref id="r41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oh</surname>
<given-names>W.C.</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Zito</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Synapse-specific and size-dependent mechanisms of spine structural plasticity accompanying synaptic weakening.</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2013</year>
<volume>110</volume>
<issue>4</issue>
<fpage>E305</fpage>
<lpage>E312</lpage>
<comment>[http://dx.doi.org/10.1073/pnas.1214705110]. [PMID: 23269840].</comment>
<pub-id pub-id-type="pmid">23269840</pub-id>
</element-citation>
</ref>
<ref id="r42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uesaka</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Uchigashima</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mikuni</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nakazawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nakao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hirai</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Aiba</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kano</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Retrograde semaphorin signaling regulates synapse elimination in the developing mouse brain.</article-title>
<source/>Science
          <year>2014</year>
<volume>344</volume>
<issue>6187</issue>
<fpage>1020</fpage>
<lpage>1023</lpage>
<comment>[http://dx.doi.org/10.1126/science.1252514]. [PMID: 24831527].</comment>
<pub-id pub-id-type="pmid">24831527</pub-id>
</element-citation>
</ref>
<ref id="r43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Connor</surname>
<given-names>T.P.</given-names>
</name>
<name>
<surname>Cockburn</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Tapia</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Currie</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bamji</surname>
<given-names>S.X.</given-names>
</name>
</person-group>
<article-title>Semaphorin 5B mediates synapse elimination in hippocampal neurons.</article-title>
<source/>Neural Dev.
          <year>2009</year>
<volume>4</volume>
<fpage>18</fpage>
<comment>[http://dx.doi.org/10.1186/1749-8104-4-18]. [PMID: 19463192].</comment>
<pub-id pub-id-type="pmid">19463192</pub-id>
</element-citation>
</ref>
<ref id="r44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakayama</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Abe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Morimoto</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Iida</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Okabe</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sakimura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hashimoto</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Microglia permit climbing fiber elimination by promoting GABAergic inhibition in the developing cerebellum.</article-title>
<source/>Nat. Commun.
          <year>2018</year>
<volume>9</volume>
<issue>1</issue>
<fpage>2830</fpage>
<comment>[http://dx.doi.org/10.1038/s41467-018-05100-z]. [PMID: 30026565].</comment>
<pub-id pub-id-type="pmid">30026565</pub-id>
</element-citation>
</ref>
<ref id="r45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Afroz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Parato</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>S.S.</given-names>
</name>
</person-group>
<article-title>Synaptic pruning in the female hippocampus is triggered at puberty by extrasynaptic GABAA receptors on dendritic spines.</article-title>
<source/>eLife
          <year>2016</year>
<volume>5</volume>
<elocation-id>e15106</elocation-id>
<comment>[http://dx.doi.org/10.7554/eLife.15106]. [PMID: 27136678].</comment>
<pub-id pub-id-type="pmid">27136678</pub-id>
</element-citation>
</ref>
<ref id="r46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Díaz-Alonso</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nicoll</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>Postsynaptic δ1 glutamate receptor assembles and maintains hippocampal synapses <italic>via</italic> Cbln2 and neurexin.</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2018</year>
<volume>115</volume>
<issue>23</issue>
<fpage>E5373</fpage>
<lpage>E5381</lpage>
<comment>[http://dx.doi.org/10.1073/pnas.1802737115]. [PMID: 29784783].</comment>
<pub-id pub-id-type="pmid">29784783</pub-id>
</element-citation>
</ref>
<ref id="r47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uemura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Yasumura</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Takeuchi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ra</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Taguchi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sakimura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mishina</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Trans-synaptic interaction of GluRdelta2 and Neurexin through Cbln1 mediates synapse formation in the cerebellum.</article-title>
<source/>Cell
          <year>2010</year>
<volume>141</volume>
<issue>6</issue>
<fpage>1068</fpage>
<lpage>1079</lpage>
<comment>[http://dx.doi.org/10.1016/j.cell.2010.04.035]. [PMID: 20537373].</comment>
<pub-id pub-id-type="pmid">20537373</pub-id>
</element-citation>
</ref>
<ref id="r48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bian</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>W.Y.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>Coordinated spine pruning and maturation mediated by inter-spine competition for cadherin/catenin complexes.</article-title>
<source/>Cell
          <year>2015</year>
<volume>162</volume>
<issue>4</issue>
<fpage>808</fpage>
<lpage>822</lpage>
<pub-id pub-id-type="pmid">26255771</pub-id>
</element-citation>
</ref>
<ref id="r49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>W. Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Q. Z.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Taketo</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>A critical role of presynaptic cadherin/
catenin/p140Cap complexes in stabilizing spines and functional
synapses in the neocortex.</article-title>
<source/>Neuron
          <year>2017</year>
<volume>94</volume>
<issue>6</issue>
<fpage>1155</fpage>
<lpage>1172</lpage>
<comment>e8</comment>
<pub-id pub-id-type="pmid">28641114</pub-id>
</element-citation>
</ref>
<ref id="r50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huh</surname>
<given-names>G.S.</given-names>
</name>
<name>
<surname>Boulanger</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Riquelme</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Brotz</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Shatz</surname>
<given-names>C.J.</given-names>
</name>
</person-group>
<article-title>Functional requirement for class I MHC in CNS development and plasticity.</article-title>
<source/>Science
          <year>2000</year>
<volume>290</volume>
<issue>5499</issue>
<fpage>2155</fpage>
<lpage>2159</lpage>
<comment>[http://dx.doi.org/10.1126/science.290.5499.2155]. [PMID: 11118151].</comment>
<pub-id pub-id-type="pmid">11118151</pub-id>
</element-citation>
</ref>
<ref id="r51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goddard</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Butts</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Shatz</surname>
<given-names>C.J.</given-names>
</name>
</person-group>
<article-title>Regulation of CNS synapses by neuronal MHC class I.</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2007</year>
<volume>104</volume>
<issue>16</issue>
<fpage>6828</fpage>
<lpage>6833</lpage>
<comment>[http://dx.doi.org/10.1073/pnas.0702023104]. [PMID: 17420446].</comment>
<pub-id pub-id-type="pmid">17420446</pub-id>
</element-citation>
</ref>
<ref id="r52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Brott</surname>
<given-names>B.K.</given-names>
</name>
<name>
<surname>Kirkby</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Adelson</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Feller</surname>
<given-names>M.B.</given-names>
</name>
<name>
<surname>Datwani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Shatz</surname>
<given-names>C.J.</given-names>
</name>
</person-group>
<article-title>Synapse elimination and learning rules co-regulated by MHC class I H2-Db.</article-title>
<source/>Nature
          <year>2014</year>
<volume>509</volume>
<issue>7499</issue>
<fpage>195</fpage>
<lpage>200</lpage>
<comment>[http://dx.doi.org/10.1038/nature13154]. [PMID: 24695230].</comment>
<pub-id pub-id-type="pmid">24695230</pub-id>
</element-citation>
</ref>
<ref id="r53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adelson</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Sapp</surname>
<given-names>R.W.</given-names>
</name>
<name>
<surname>Brott</surname>
<given-names>B.K.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Miyamichi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Djurisic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shatz</surname>
<given-names>C.J.</given-names>
</name>
</person-group>
<article-title>Developmental sculpting of intracortical circuits by MHC class I H2-Db and H2-Kb.</article-title>
<source/>Cereb. Cortex
          <year>2016</year>
<volume>26</volume>
<issue>4</issue>
<fpage>1453</fpage>
<lpage>1463</lpage>
<comment>[http://dx.doi.org/10.1093/cercor/bhu243]. [PMID: 25316337].</comment>
<pub-id pub-id-type="pmid">25316337</pub-id>
</element-citation>
</ref>
<ref id="r54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Datwani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>McConnell</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Kanold</surname>
<given-names>P.O.</given-names>
</name>
<name>
<surname>Micheva</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Busse</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Shamloo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Shatz</surname>
<given-names>C.J.</given-names>
</name>
</person-group>
<article-title>Classical MHCI molecules regulate retinogeniculate refinement and limit ocular dominance plasticity.</article-title>
<source/>Neuron
          <year>2009</year>
<volume>64</volume>
<issue>4</issue>
<fpage>463</fpage>
<lpage>470</lpage>
<comment>[http://dx.doi.org/10.1016/j.neuron.2009.10.015]. [PMID: 19945389].</comment>
<pub-id pub-id-type="pmid">19945389</pub-id>
</element-citation>
</ref>
<ref id="r55">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vidal</surname>
<given-names>G. S.</given-names>
</name>
<name>
<surname>Djurisic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sapp</surname>
<given-names>R. W.</given-names>
</name>
<name>
<surname>Shatz</surname>
<given-names>C. J.</given-names>
</name>
</person-group>
<article-title>Developmental sculpting
of intracortical circuits by MHC class I H2-Db and H2-Kb</article-title>
<source/>Cereb. Cortex
          <volume>26</volume>
<issue>4</issue>
<fpage>1453</fpage>
<lpage>1463</lpage>
</element-citation>
</ref>
<ref id="r56">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Syken</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Grandpre</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kanold</surname>
<given-names>P.O.</given-names>
</name>
<name>
<surname>Shatz</surname>
<given-names>C.J.</given-names>
</name>
</person-group>
<article-title>PirB restricts ocular-dominance plasticity in visual cortex.</article-title>
<source/>Science
          <year>2006</year>
<volume>313</volume>
<issue>5794</issue>
<fpage>1795</fpage>
<lpage>1800</lpage>
<comment>[http://dx.doi.org/10.1126/science.1128232]. [PMID: 16917027].</comment>
<pub-id pub-id-type="pmid">16917027</pub-id>
</element-citation>
</ref>
<ref id="r57">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bochner</surname>
<given-names>D.N.</given-names>
</name>
<name>
<surname>Sapp</surname>
<given-names>R.W.</given-names>
</name>
<name>
<surname>Adelson</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Djurisic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Syken</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shatz</surname>
<given-names>C.J.</given-names>
</name>
</person-group>
<article-title>Blocking PirB up-regulates spines and functional synapses to unlock visual cortical plasticity and facilitate recovery from amblyopia.</article-title>
<source/>Sci. Transl. Med.
          <year>2014</year>
<volume>6</volume>
<issue>258</issue>
<elocation-id>258ra140</elocation-id>
<comment>[http://dx.doi.org/10.1126/scitranslmed.3010157]. [PMID: 25320232].</comment>
</element-citation>
</ref>
<ref id="r58">
<label>58</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Djurisic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brott</surname>
<given-names>B.K.</given-names>
</name>
<name>
<surname>Saw</surname>
<given-names>N.L.</given-names>
</name>
<name>
<surname>Shamloo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shatz</surname>
<given-names>C.J.</given-names>
</name>
</person-group>
<article-title>Activity-dependent modulation of hippocampal synaptic plasticity <italic>via</italic> PirB and endocannabinoids.</article-title>
<source/>Mol. Psychiatry
          <year>2018</year>
<volume>24</volume>
<issue>8</issue>
<fpage>1206</fpage>
<lpage>1219</lpage>
<comment>[PMID: 29670176].</comment>
<pub-id pub-id-type="pmid">29670176</pub-id>
</element-citation>
</ref>
<ref id="r59">
<label>59</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>VanGuilder Starkey</surname>
<given-names>H.D.</given-names>
</name>
<name>
<surname>Van Kirk</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Bixler</surname>
<given-names>G.V.</given-names>
</name>
<name>
<surname>Imperio</surname>
<given-names>C.G.</given-names>
</name>
<name>
<surname>Kale</surname>
<given-names>V.P.</given-names>
</name>
<name>
<surname>Serfass</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Farley</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Warrington</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mitschelen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sonntag</surname>
<given-names>W.E.</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>W.M.</given-names>
</name>
</person-group>
<article-title>Neuroglial expression of the MHCI pathway and PirB receptor is upregulated in the hippocampus with advanced aging.</article-title>
<source/>J. Mol. Neurosci.
          <year>2012</year>
<volume>48</volume>
<issue>1</issue>
<fpage>111</fpage>
<lpage>126</lpage>
<pub-id pub-id-type="pmid">22562814</pub-id>
</element-citation>
</ref>
<ref id="r60">
<label>60</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stephan</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Madison</surname>
<given-names>D.V.</given-names>
</name>
<name>
<surname>Mateos</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Lovelett</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Coutellier</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>H.H.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Rowitch</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Berns</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Tenner</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Shamloo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>B.A.</given-names>
</name>
</person-group>
<article-title>A dramatic increase of C1q protein in the CNS during normal aging.</article-title>
<source/>J. Neurosci.
          <year>2013</year>
<volume>33</volume>
<issue>33</issue>
<fpage>13460</fpage>
<lpage>13474</lpage>
<comment>[http://dx.doi.org/10.1523/JNEUROSCI.1333-13.2013]. [PMID: 23946404].</comment>
<pub-id pub-id-type="pmid">23946404</pub-id>
</element-citation>
</ref>
<ref id="r61">
<label>61</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schafer</surname>
<given-names>D.P.</given-names>
</name>
<name>
<surname>Lehrman</surname>
<given-names>E.K.</given-names>
</name>
<name>
<surname>Kautzman</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Koyama</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mardinly</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Yamasaki</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ransohoff</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner.</article-title>
<source/>Neuron
          <year>2012</year>
<volume>74</volume>
<issue>4</issue>
<fpage>691</fpage>
<lpage>705</lpage>
<comment>[http://dx.doi.org/10.1016/j.neuron.2012.03.026]. [PMID: 22632727].</comment>
<pub-id pub-id-type="pmid">22632727</pub-id>
</element-citation>
</ref>
<ref id="r62">
<label>62</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Malik</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>H.B.</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>R.W.</given-names>
</name>
<name>
<surname>Dissing-Olesen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>MacVicar</surname>
<given-names>B.A.</given-names>
</name>
</person-group>
<article-title>Microglial CR3 activation triggers long-term synaptic depression in the hippocampus <italic>via</italic> NADPH oxidase.</article-title>
<source/>Neuron
          <year>2014</year>
<volume>82</volume>
<issue>1</issue>
<fpage>195</fpage>
<lpage>207</lpage>
<comment>[http://dx.doi.org/10.1016/j.neuron.2014.01.043]. [PMID: 24631344].</comment>
<pub-id pub-id-type="pmid">24631344</pub-id>
</element-citation>
</ref>
<ref id="r63">
<label>63</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ertürk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Local pruning of dendrites and spines by caspase-3-dependent and proteasome-limited mechanisms.</article-title>
<source/>J. Neurosci.
          <year>2014</year>
<volume>34</volume>
<issue>5</issue>
<fpage>1672</fpage>
<lpage>1688</lpage>
<comment>[http://dx.doi.org/10.1523/JNEUROSCI.3121-13.2014]. [PMID: 24478350].</comment>
<pub-id pub-id-type="pmid">24478350</pub-id>
</element-citation>
</ref>
<ref id="r64">
<label>64</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Györffy</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Kun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Török</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bulyáki</surname>
<given-names>É.</given-names>
</name>
<name>
<surname>Borhegyi</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gulyássy</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kis</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Szocsics</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Micsonai</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Matkó</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Drahos</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Juhász</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kékesi</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Kardos</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Local apoptotic-like mechanisms underlie complement-mediated synaptic pruning.</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2018</year>
<volume>115</volume>
<issue>24</issue>
<fpage>6303</fpage>
<lpage>6308</lpage>
<comment>[http://dx.doi.org/10.1073/pnas.1722613115]. [PMID: 29844190].</comment>
<pub-id pub-id-type="pmid">29844190</pub-id>
</element-citation>
</ref>
<ref id="r65">
<label>65</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fraser</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Pisalyaput</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tenner</surname>
<given-names>A.J.</given-names>
</name>
</person-group>
<article-title>C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production.</article-title>
<source/>J. Neurochem.
          <year>2010</year>
<volume>112</volume>
<issue>3</issue>
<fpage>733</fpage>
<lpage>743</lpage>
<comment>[http://dx.doi.org/10.1111/j.1471-4159.2009.06494.x]. [PMID: 19919576].</comment>
<pub-id pub-id-type="pmid">19919576</pub-id>
</element-citation>
</ref>
<ref id="r66">
<label>66</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meng</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mulcahy</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Neubauer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>The cell death pathway regulates synapse elimination through cleavage of gelsolin in <italic>caenorhabditis elegans</italic> neurons.</article-title>
<source/>Cell Rep.
          <year>2015</year>
<volume>11</volume>
<issue>11</issue>
<fpage>1737</fpage>
<lpage>1748</lpage>
<comment>[http://dx.doi.org/10.1016/j.celrep.2015.05.031]. [PMID: 26074078].</comment>
<pub-id pub-id-type="pmid">26074078</pub-id>
</element-citation>
</ref>
<ref id="r67">
<label>67</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paolicelli</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Bolasco</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pagani</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Maggi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Scianni</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Panzanelli</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Giustetto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Guiducci</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Dumas</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ragozzino</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>C.T.</given-names>
</name>
</person-group>
<article-title>Synaptic pruning by microglia is necessary for normal brain development.</article-title>
<source/>Science
          <year>2011</year>
<volume>333</volume>
<issue>6048</issue>
<fpage>1456</fpage>
<lpage>1458</lpage>
<comment>[http://dx.doi.org/10.1126/science.1202529]. [PMID: 21778362].</comment>
<pub-id pub-id-type="pmid">21778362</pub-id>
</element-citation>
</ref>
<ref id="r68">
<label>68</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Paolicelli</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Sforazzini</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Weinhard</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bolasco</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pagani</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Vyssotski</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Bifone</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gozzi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ragozzino</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>C.T.</given-names>
</name>
</person-group>
<article-title>Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior.</article-title>
<source/>Nat. Neurosci.
          <year>2014</year>
<volume>17</volume>
<issue>3</issue>
<fpage>400</fpage>
<lpage>406</lpage>
<comment>[http://dx.doi.org/10.1038/nn.3641]. [PMID: 24487234].</comment>
<pub-id pub-id-type="pmid">24487234</pub-id>
</element-citation>
</ref>
<ref id="r69">
<label>69</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sokolowski</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Chabanon-Hicks</surname>
<given-names>C.N.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>C.Z.</given-names>
</name>
<name>
<surname>Heffron</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Mandell</surname>
<given-names>J.W.</given-names>
</name>
</person-group>
<article-title>Fractalkine is a “find-me” signal released by neurons undergoing ethanol-induced apoptosis.</article-title>
<source/>Front. Cell. Neurosci.
          <year>2014</year>
<volume>8</volume>
<fpage>360</fpage>
<comment>[http://dx.doi.org/10.3389/fncel.2014.00360]. [PMID: 25426022].</comment>
<pub-id pub-id-type="pmid">25426022</pub-id>
</element-citation>
</ref>
<ref id="r70">
<label>70</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lui</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Makinson</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Cahill</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Kelley</surname>
<given-names>K.W.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Shang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Oldham</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Martens</surname>
<given-names>L.H.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Coppola</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sloan</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Hsieh</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Bigio</surname>
<given-names>E.H.</given-names>
</name>
<name>
<surname>Weintraub</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mesulam</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Rademakers</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mackenzie</surname>
<given-names>I.R.</given-names>
</name>
<name>
<surname>Seeley</surname>
<given-names>W.W.</given-names>
</name>
<name>
<surname>Karydas</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Borroni</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ghidoni</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Farese</surname>
<given-names>R.V.</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Paz</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>E.J.</given-names>
</name>
</person-group>
<article-title>Progranulin deficiency promotes circuit-Specific synaptic pruning by microglia <italic>via</italic> complement activation.</article-title>
<source/>Cell
          <year>2016</year>
<volume>165</volume>
<issue>4</issue>
<fpage>921</fpage>
<lpage>935</lpage>
<comment>[http://dx.doi.org/10.1016/j.cell.2016.04.001]. [PMID: 27114033].</comment>
<pub-id pub-id-type="pmid">27114033</pub-id>
</element-citation>
</ref>
<ref id="r71">
<label>71</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Srinivasan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Suto</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Modrusan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>W.P.</given-names>
</name>
<name>
<surname>Kaminker</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>D.V.</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Progranulin deficiency causes impairment of autophagy and TDP-43 accumulation.</article-title>
<source/>J. Exp. Med.
          <year>2017</year>
<volume>214</volume>
<issue>9</issue>
<fpage>2611</fpage>
<lpage>2628</lpage>
<comment>[http://dx.doi.org/10.1084/jem.20160999]. [PMID: 28778989].</comment>
<pub-id pub-id-type="pmid">28778989</pub-id>
</element-citation>
</ref>
<ref id="r72">
<label>72</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.J.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>K.Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.S.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhuo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>M.G.</given-names>
</name>
</person-group>
<article-title>Elevated progranulin contributes to synaptic and learning deficit due to loss of fragile X mental retardation protein.</article-title>
<source/>Brain
          <year>2017</year>
<volume>140</volume>
<issue>12</issue>
<fpage>3215</fpage>
<lpage>3232</lpage>
<comment>[http://dx.doi.org/10.1093/brain/awx265]. [PMID: 29096020].</comment>
<pub-id pub-id-type="pmid">29096020</pub-id>
</element-citation>
</ref>
<ref id="r73">
<label>73</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Shim</surname>
<given-names>W.H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Jeon</surname>
<given-names>E.Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>S.Y.</given-names>
</name>
</person-group>
<article-title>Deficient autophagy in microglia impairs synaptic pruning and causes social behavioral defects.</article-title>
<source/>Mol. Psychiatry
          <year>2017</year>
<volume>22</volume>
<issue>11</issue>
<fpage>1576</fpage>
<lpage>1584</lpage>
<comment>[http://dx.doi.org/10.1038/mp.2016.103]. [PMID: 27400854].</comment>
<pub-id pub-id-type="pmid">27400854</pub-id>
</element-citation>
</ref>
<ref id="r74">
<label>74</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vainchtein</surname>
<given-names>I.D.</given-names>
</name>
<name>
<surname>Chin</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>F.S.</given-names>
</name>
<name>
<surname>Kelley</surname>
<given-names>K.W.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Chien</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Liddelow</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>P.T.</given-names>
</name>
<name>
<surname>Nakao-Inoue</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Dorman</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Akil</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Joshita</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Paz</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Molofsky</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Molofsky</surname>
<given-names>A.V.</given-names>
</name>
</person-group>
<article-title>Astrocyte-derived interleukin-33 promotes microglial synapse engulfment and neural circuit development.</article-title>
<source/>Science
          <year>2018</year>
<volume>359</volume>
<issue>6381</issue>
<fpage>1269</fpage>
<lpage>1273</lpage>
<comment>[http://dx.doi.org/10.1126/science.aal3589]. [PMID: 29420261].</comment>
<pub-id pub-id-type="pmid">29420261</pub-id>
</element-citation>
</ref>
<ref id="r75">
<label>75</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parkhurst</surname>
<given-names>C.N.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ninan</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Savas</surname>
<given-names>J.N.</given-names>
</name>
<name>
<surname>Yates</surname>
<given-names>J.R.</given-names>
<suffix>III</suffix>
</name>
<name>
<surname>Lafaille</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Hempstead</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Littman</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Gan</surname>
<given-names>W.B.</given-names>
</name>
</person-group>
<article-title>Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor.</article-title>
<source/>Cell
          <year>2013</year>
<volume>155</volume>
<issue>7</issue>
<fpage>1596</fpage>
<lpage>1609</lpage>
<comment>[http://dx.doi.org/10.1016/j.cell.2013.11.030]. [PMID: 24360280].</comment>
<pub-id pub-id-type="pmid">24360280</pub-id>
</element-citation>
</ref>
<ref id="r76">
<label>76</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lehrman</surname>
<given-names>E. K.</given-names>
</name>
<name>
<surname>Wilton</surname>
<given-names>D. K.</given-names>
</name>
<name>
<surname>Litvina</surname>
<given-names>E. Y.</given-names>
</name>
<name>
<surname>Welsh</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>S. T.</given-names>
</name>
<name>
<surname>Frouin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Heller</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Umemori</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>CD47 Protects Synapses from Excess
Microglia-Mediated Pruning during Develop-ment.</article-title>
<source/>Neuron,
          <volume>100</volume>
<issue>1</issue>
<fpage>120</fpage>
<lpage>134</lpage>
<year>2018</year>
<pub-id pub-id-type="pmid">30308165</pub-id>
</element-citation>
</ref>
<ref id="r77">
<label>77</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bjartmar</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Huberman</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Ullian</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Rentería</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Prezioso</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Susman</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Stellwagen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Stokes</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Worley</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Malenka</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Ball</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Peachey</surname>
<given-names>N.S.</given-names>
</name>
<name>
<surname>Copenhagen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Nakamoto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Perin</surname>
<given-names>M.S.</given-names>
</name>
</person-group>
<article-title>Neuronal pentraxins mediate synaptic refinement in the developing visual system.</article-title>
<source/>J. Neurosci.
          <year>2006</year>
<volume>26</volume>
<issue>23</issue>
<fpage>6269</fpage>
<lpage>6281</lpage>
<comment>[http://dx.doi.org/10.1523/JNEUROSCI.4212-05.2006]. [PMID: 16763034].</comment>
<pub-id pub-id-type="pmid">16763034</pub-id>
</element-citation>
</ref>
<ref id="r78">
<label>78</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koch</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Ullian</surname>
<given-names>E.M.</given-names>
</name>
</person-group>
<article-title>Neuronal pentraxins mediate silent synapse conversion in the developing visual system.</article-title>
<source/>J. Neurosci.
          <year>2010</year>
<volume>30</volume>
<issue>15</issue>
<fpage>5404</fpage>
<lpage>5414</lpage>
<comment>[http://dx.doi.org/10.1523/JNEUROSCI.4893-09.2010]. [PMID: 20392962].</comment>
<pub-id pub-id-type="pmid">20392962</pub-id>
</element-citation>
</ref>
<ref id="r79">
<label>79</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinelli</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Chew</surname>
<given-names>K.S.</given-names>
</name>
<name>
<surname>Rohlmann</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lum</surname>
<given-names>M.Y.</given-names>
</name>
<name>
<surname>Ressl</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hattar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Brunger</surname>
<given-names>A.T.</given-names>
</name>
<name>
<surname>Missler</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Südhof</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Expression of C1ql3 in discrete neuronal populations controls efferent synapse numbers and diverse behaviors.</article-title>
<source/>Neuron
          <year>2016</year>
<volume>91</volume>
<issue>5</issue>
<fpage>1034</fpage>
<lpage>1051</lpage>
<comment>[http://dx.doi.org/10.1016/j.neuron.2016.07.002]. [PMID: 27478018].</comment>
<pub-id pub-id-type="pmid">27478018</pub-id>
</element-citation>
</ref>
<ref id="r80">
<label>80</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bolliger</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Martinelli</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Südhof</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>The cell-adhesion G protein-coupled receptor BAI3 is a high-affinity receptor for C1q-like proteins.</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2011</year>
<volume>108</volume>
<issue>6</issue>
<fpage>2534</fpage>
<lpage>2539</lpage>
<comment>[http://dx.doi.org/10.1073/pnas.1019577108]. [PMID: 21262840].</comment>
<pub-id pub-id-type="pmid">21262840</pub-id>
</element-citation>
</ref>
<ref id="r81">
<label>81</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>P.B.</given-names>
</name>
<name>
<surname>Kawaguchi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Blum</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Achiro</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Coppola</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>O’Dell</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>K.C.</given-names>
</name>
</person-group>
<article-title>Mapping Gene Expression in Excitatory Neurons during Hippocampal Late-Phase Long-Term Potentiation.</article-title>
<source/>Front. Mol. Neurosci.
          <year>2017</year>
<volume>10</volume>
<fpage>39</fpage>
<comment>[http://dx.doi.org/10.3389/fnmol.2017.00039]. [PMID: 28275336].</comment>
<pub-id pub-id-type="pmid">28275336</pub-id>
</element-citation>
</ref>
<ref id="r82">
<label>82</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weinhard</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>di Bartolomei</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bolasco</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Machado</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Schieber</surname>
<given-names>N.L.</given-names>
</name>
<name>
<surname>Neniskyte</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Exiga</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vadisiute</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Raggioli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schertel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schwab</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>C.T.</given-names>
</name>
</person-group>
<article-title>Microglia remodel synapses by presynaptic trogocytosis and spine head filopodia induction.</article-title>
<source/>Nat. Commun.
          <year>2018</year>
<volume>9</volume>
<issue>1</issue>
<fpage>1228</fpage>
<comment>[http://dx.doi.org/10.1038/s41467-018-03566-5]. [PMID: 29581545].</comment>
<pub-id pub-id-type="pmid">29581545</pub-id>
</element-citation>
</ref>
<ref id="r83">
<label>83</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyamoto</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wake</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ishikawa</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>Eto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shibata</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Murakoshi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Koizumi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Moorhouse</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Yoshimura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nabekura</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Microglia contact induces synapse formation in developing somatosensory cortex.</article-title>
<source/>Nat. Commun.
          <year>2016</year>
<volume>7</volume>
<fpage>12540</fpage>
<comment>[http://dx.doi.org/10.1038/ncomms12540]. [PMID: 27558646].</comment>
<pub-id pub-id-type="pmid">27558646</pub-id>
</element-citation>
</ref>
<ref id="r84">
<label>84</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Colodner</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Matousek</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Merry</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kenison</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Frost</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Le</surname>
<given-names>K.X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dodart</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Caldarone</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lemere</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>Complement C3-Deficient mice fail to display age-related hippocampal decline.</article-title>
<source/>J. Neurosci.
          <year>2015</year>
<volume>35</volume>
<issue>38</issue>
<fpage>13029</fpage>
<lpage>13042</lpage>
<comment>[http://dx.doi.org/10.1523/JNEUROSCI.1698-15.2015]. [PMID: 26400934].</comment>
<pub-id pub-id-type="pmid">26400934</pub-id>
</element-citation>
</ref>
<ref id="r85">
<label>85</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chung</surname>
<given-names>W.S.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>G.X.</given-names>
</name>
<name>
<surname>Stafford</surname>
<given-names>B.K.</given-names>
</name>
<name>
<surname>Sher</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chakraborty</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Joung</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Foo</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>B.A.</given-names>
</name>
</person-group>
<article-title>Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways.</article-title>
<source/>Nature
          <year>2013</year>
<volume>504</volume>
<issue>7480</issue>
<fpage>394</fpage>
<lpage>400</lpage>
<comment>[http://dx.doi.org/10.1038/nature12776]. [PMID: 24270812].</comment>
<pub-id pub-id-type="pmid">24270812</pub-id>
</element-citation>
</ref>
<ref id="r86">
<label>86</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patterson</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>World Alzheimer Report 2018; Alzheimer's Disease
International (ADI): London, September. 2018,</article-title>
<year>2018</year>
<fpage>1</fpage>
<lpage>48</lpage>
</element-citation>
</ref>
<ref id="r87">
<label>87</label>
<element-citation publication-type="book">
<article-title>(WHO), W. H. O.</article-title>
<source/>Towards a dementia plan: a WHO guide
          <person-group person-group-type="editor">
<name>
<surname>S.</surname>
<given-names>Freel</given-names>
</name>
<name>
<surname>K.</surname>
<given-names>Seeher</given-names>
</name>
<name>
<surname>N.</surname>
<given-names>Chowdhary</given-names>
</name>
<name>
<surname>S.</surname>
<given-names>Sivananthan</given-names>
</name>
<name>
<surname>A. M.</surname>
<given-names>Pot</given-names>
</name>
</person-group>
<publisher-name>World Health Organization (WHO):</publisher-name>
<publisher-loc>Geneva</publisher-loc>
<year>2018</year>
<fpage>78</fpage>
<ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris/handle/10665/272642(accessedJanuary6th,2019)">http://apps.who.int/iris/handle/10665/272642(accessed January 6th, 2019)</ext-link>
</element-citation>
</ref>
<ref id="r88">
<label>88</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alzheimer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stelzmann</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Schnitzlein</surname>
<given-names>H.N.</given-names>
</name>
<name>
<surname>Murtagh</surname>
<given-names>F.R.</given-names>
</name>
</person-group>
<article-title>An English translation of Alzheimer’s 1907 paper, “Uber eine eigenartige Erkankung der Hirnrinde.</article-title>
<source/>Clin. Anat.
          <year>1995</year>
<volume>8</volume>
<issue>6</issue>
<fpage>429</fpage>
<lpage>431</lpage>
<pub-id pub-id-type="pmid">8713166</pub-id>
</element-citation>
</ref>
<ref id="r89">
<label>89</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colon</surname>
<given-names>E.J.</given-names>
</name>
</person-group>
<article-title>The cerebral cortex in presenile dementia. A quantitative analysis.</article-title>
<source/>Acta Neuropathol.
          <year>1973</year>
<volume>23</volume>
<issue>4</issue>
<fpage>281</fpage>
<lpage>290</lpage>
<comment>[http://dx.doi.org/10.1007/BF00687457]. [PMID: 4718195].</comment>
<pub-id pub-id-type="pmid">4718195</pub-id>
</element-citation>
</ref>
<ref id="r90">
<label>90</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shefer</surname>
<given-names>V.F.</given-names>
</name>
</person-group>
<article-title>Absolute number of neurons and thickness of the cerebral cortex during aging, senile and vascular dementia, and Pick’s and Alzheimer’s diseases.</article-title>
<source/>Neurosci. Behav. Physiol.
          <year>1973</year>
<volume>6</volume>
<issue>4</issue>
<fpage>319</fpage>
<lpage>324</lpage>
<comment>[http://dx.doi.org/10.1007/BF01182672]. [PMID: 4781784].</comment>
<pub-id pub-id-type="pmid">4781784</pub-id>
</element-citation>
</ref>
<ref id="r91">
<label>91</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Najlerahim</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bowen</surname>
<given-names>D.M.</given-names>
</name>
</person-group>
<article-title>Regional weight loss of the cerebral cortex and some subcortical nuclei in senile dementia of the Alzheimer type.</article-title>
<source/>Acta Neuropathol.
          <year>1988</year>
<volume>75</volume>
<issue>5</issue>
<fpage>509</fpage>
<lpage>512</lpage>
<comment>[http://dx.doi.org/10.1007/BF00687139]. [PMID: 3376753].</comment>
<pub-id pub-id-type="pmid">3376753</pub-id>
</element-citation>
</ref>
<ref id="r92">
<label>92</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mann</surname>
<given-names>D.M.</given-names>
</name>
</person-group>
<article-title>Alzheimer’s disease and Down’s syndrome.</article-title>
<source/>Histopathology
          <year>1988</year>
<volume>13</volume>
<issue>2</issue>
<fpage>125</fpage>
<lpage>137</lpage>
<comment>[http://dx.doi.org/10.1111/j.1365-2559.1988.tb02018.x]. [PMID: 2971602].</comment>
<pub-id pub-id-type="pmid">2971602</pub-id>
</element-citation>
</ref>
<ref id="r93">
<label>93</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hubbard</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>J.M.</given-names>
</name>
</person-group>
<article-title>A quantitative study of cerebral atrophy in old age and senile dementia.</article-title>
<source/>J. Neurol. Sci.
          <year>1981</year>
<volume>50</volume>
<issue>1</issue>
<fpage>135</fpage>
<lpage>145</lpage>
<comment>[http://dx.doi.org/10.1016/0022-510X(81)90048-4]. [PMID: 7229656].</comment>
<pub-id pub-id-type="pmid">7229656</pub-id>
</element-citation>
</ref>
<ref id="r94">
<label>94</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davies</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Sumpter</surname>
<given-names>P.Q.</given-names>
</name>
<name>
<surname>Yates</surname>
<given-names>P.O.</given-names>
</name>
</person-group>
<article-title>A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer’s disease.</article-title>
<source/>J. Neurol. Sci.
          <year>1987</year>
<volume>78</volume>
<issue>2</issue>
<fpage>151</fpage>
<lpage>164</lpage>
<comment>[http://dx.doi.org/10.1016/0022-510X(87)90057-8]. [PMID: 3572454].</comment>
<pub-id pub-id-type="pmid">3572454</pub-id>
</element-citation>
</ref>
<ref id="r95">
<label>95</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Whitwell</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Przybelski</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Weigand</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Knopman</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Boeve</surname>
<given-names>B.F.</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Jack</surname>
<given-names>C.R.</given-names>
</name>
</person-group>
<article-title>Jr 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer’s disease.</article-title>
<source/>Brain
          <year>2007</year>
<volume>130</volume>
<issue>Pt 7</issue>
<fpage>1777</fpage>
<lpage>1786</lpage>
<comment>[http://dx.doi.org/10.1093/brain/awm112]. [PMID: 17533169].</comment>
<pub-id pub-id-type="pmid">17533169</pub-id>
</element-citation>
</ref>
<ref id="r96">
<label>96</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spires</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>Meyer-Luehmann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Stern</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>McLean</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Skoch</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>P.T.</given-names>
</name>
<name>
<surname>Bacskai</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Hyman</surname>
<given-names>B.T.</given-names>
</name>
</person-group>
<article-title>Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy.</article-title>
<source/>J. Neurosci.
          <year>2005</year>
<volume>25</volume>
<issue>31</issue>
<fpage>7278</fpage>
<lpage>7287</lpage>
<comment>[http://dx.doi.org/10.1523/JNEUROSCI.1879-05.2005].</comment>
<pub-id pub-id-type="pmid">16079410</pub-id>
</element-citation>
</ref>
<ref id="r97">
<label>97</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glenner</surname>
<given-names>G.G.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>C.W.</given-names>
</name>
</person-group>
<article-title>Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <year>1984</year>
<volume>120</volume>
<issue>3</issue>
<fpage>885</fpage>
<lpage>890</lpage>
<comment>[http://dx.doi.org/10.1016/S0006-291X(84)80190-4]. [PMID: 6375662].</comment>
<pub-id pub-id-type="pmid">6375662</pub-id>
</element-citation>
</ref>
<ref id="r98">
<label>98</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Masters</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Multhaup</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Simms</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pottgiesser</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Martins</surname>
<given-names>R.N.</given-names>
</name>
<name>
<surname>Beyreuther</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer’s disease contain the same protein as the amyloid of plaque cores and blood vessels.</article-title>
<source/>EMBO J.
          <year>1985</year>
<volume>4</volume>
<issue>11</issue>
<fpage>2757</fpage>
<lpage>2763</lpage>
<comment>[http://dx.doi.org/10.1002/j.1460-2075.1985.tb04000.x]. [PMID: 4065091].</comment>
<pub-id pub-id-type="pmid">4065091</pub-id>
</element-citation>
</ref>
<ref id="r99">
<label>99</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Masters</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Simms</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Weinman</surname>
<given-names>N.A.</given-names>
</name>
<name>
<surname>Multhaup</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Beyreuther</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Amyloid plaque core protein in Alzheimer disease and Down syndrome.</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>1985</year>
<volume>82</volume>
<issue>12</issue>
<fpage>4245</fpage>
<lpage>4249</lpage>
<comment>[http://dx.doi.org/10.1073/pnas.82.12.4245]. [PMID: 3159021].</comment>
<pub-id pub-id-type="pmid">3159021</pub-id>
</element-citation>
</ref>
<ref id="r100">
<label>100</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knafo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Alonso-Nanclares</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gonzalez-Soriano</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Merino-Serrais</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Fernaud-Espinosa</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ferrer</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>DeFelipe</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Widespread changes in dendritic spines in a model of Alzheimer’s disease.</article-title>
<source/>Cereb. Cortex
          <year>2009</year>
<volume>19</volume>
<issue>3</issue>
<fpage>586</fpage>
<lpage>592</lpage>
<comment>[http://dx.doi.org/10.1093/cercor/bhn111]. [PMID: 18632740].</comment>
<pub-id pub-id-type="pmid">18632740</pub-id>
</element-citation>
</ref>
<ref id="r101">
<label>101</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshiyama</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Higuchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Iwata</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Saido</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Suhara</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Trojanowski</surname>
<given-names>J.Q.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>V.M.</given-names>
</name>
</person-group>
<article-title>Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model.</article-title>
<source/>Neuron
          <year>2007</year>
<volume>53</volume>
<issue>3</issue>
<fpage>337</fpage>
<lpage>351</lpage>
<comment>[http://dx.doi.org/10.1016/j.neuron.2007.01.010]. [PMID: 17270732].</comment>
<pub-id pub-id-type="pmid">17270732</pub-id>
</element-citation>
</ref>
<ref id="r102">
<label>102</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kandimalla</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Manczak</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Reddy</surname>
<given-names>P.H.</given-names>
</name>
</person-group>
<article-title>Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer’s disease.</article-title>
<source/>Hum. Mol. Genet.
          <year>2018</year>
<volume>27</volume>
<issue>1</issue>
<fpage>30</fpage>
<lpage>40</lpage>
<comment>[http://dx.doi.org/10.1093/hmg/ddx381]. [PMID: 29040533].</comment>
<pub-id pub-id-type="pmid">29040533</pub-id>
</element-citation>
</ref>
<ref id="r103">
<label>103</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamelin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lagarde</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dorothée</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Potier</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Corlier</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kuhnast</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Caillé</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Dubois</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Fillon</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chupin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bottlaender</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sarazin</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Distinct dynamic profiles of microglial activation are associated with progression of Alzheimer’s disease.</article-title>
<source/>Brain
          <year>2018</year>
<volume>141</volume>
<issue>6</issue>
<fpage>1855</fpage>
<lpage>1870</lpage>
<comment>[http://dx.doi.org/10.1093/brain/awy079]. [PMID: 29608645].</comment>
<pub-id pub-id-type="pmid">29608645</pub-id>
</element-citation>
</ref>
<ref id="r104">
<label>104</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wood</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mizoguchi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hinz</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Biju</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kuruvilla</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Edison</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Microglial activation correlates <italic>in vivo</italic> with both tau and amyloid in Alzheimer’s disease.</article-title>
<source/>Brain
          <year>2018</year>
<volume>141</volume>
<issue>9</issue>
<fpage>2740</fpage>
<lpage>2754</lpage>
<comment>[http://dx.doi.org/10.1093/brain/awy188]. [PMID: 30052812].</comment>
<pub-id pub-id-type="pmid">30052812</pub-id>
</element-citation>
</ref>
<ref id="r105">
<label>105</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Haroutunian</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Purohit</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pasinetti</surname>
<given-names>G.M.</given-names>
</name>
</person-group>
<article-title>Microglia activation in the brain as inflammatory biomarker of Alzheimer’s disease neuropathology and clinical dementia.</article-title>
<source/>Dis. Markers
          <year>2006</year>
<volume>22</volume>
<issue>1-2</issue>
<fpage>95</fpage>
<lpage>102</lpage>
<comment>[http://dx.doi.org/10.1155/2006/276239]. [PMID: 16410654].</comment>
<pub-id pub-id-type="pmid">16410654</pub-id>
</element-citation>
</ref>
<ref id="r106">
<label>106</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lemaire</surname>
<given-names>H.G.</given-names>
</name>
<name>
<surname>Unterbeck</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Salbaum</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Masters</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Grzeschik</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Multhaup</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Beyreuther</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Müller-Hill</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor.</article-title>
<source/>Nature
          <year>1987</year>
<volume>325</volume>
<issue>6106</issue>
<fpage>733</fpage>
<lpage>736</lpage>
<comment>[http://dx.doi.org/10.1038/325733a0]. [PMID: 2881207].</comment>
<pub-id pub-id-type="pmid">2881207</pub-id>
</element-citation>
</ref>
<ref id="r107">
<label>107</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shoji</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Golde</surname>
<given-names>T.E.</given-names>
</name>
<name>
<surname>Ghiso</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>T.T.</given-names>
</name>
<name>
<surname>Estus</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shaffer</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>X.D.</given-names>
</name>
<name>
<surname>McKay</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Tintner</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Frangione</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Production of the Alzheimer amyloid beta protein by normal proteolytic processing.</article-title>
<source/>Science
          <year>1992</year>
<volume>258</volume>
<issue>5079</issue>
<fpage>126</fpage>
<lpage>129</lpage>
<comment>[http://dx.doi.org/10.1126/science.1439760]. [PMID: 1439760].</comment>
<pub-id pub-id-type="pmid">1439760</pub-id>
</element-citation>
</ref>
<ref id="r108">
<label>108</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kimberly</surname>
<given-names>W.T.</given-names>
</name>
<name>
<surname>Esler</surname>
<given-names>W.P.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ostaszewski</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Diehl</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Selkoe</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Wolfe</surname>
<given-names>M.S.</given-names>
</name>
</person-group>
<article-title>Notch and the amyloid precursor protein are cleaved by similar gamma-secretase(s).</article-title>
<source/>Biochemistry
          <year>2003</year>
<volume>42</volume>
<issue>1</issue>
<fpage>137</fpage>
<lpage>144</lpage>
<comment>[http://dx.doi.org/10.1021/bi026888g]. [PMID: 12515548].</comment>
<pub-id pub-id-type="pmid">12515548</pub-id>
</element-citation>
</ref>
<ref id="r109">
<label>109</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kimberly</surname>
<given-names>W.T.</given-names>
</name>
<name>
<surname>Wolfe</surname>
<given-names>M.S.</given-names>
</name>
</person-group>
<article-title>Identity and function of gamma-secretase.</article-title>
<source/>J. Neurosci. Res.
          <year>2003</year>
<volume>74</volume>
<issue>3</issue>
<fpage>353</fpage>
<lpage>360</lpage>
<comment>[http://dx.doi.org/10.1002/jnr.10736]. [PMID: 14598311].</comment>
<pub-id pub-id-type="pmid">14598311</pub-id>
</element-citation>
</ref>
<ref id="r110">
<label>110</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vassar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>B.D.</given-names>
</name>
<name>
<surname>Babu-Khan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kahn</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mendiaz</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Denis</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Teplow</surname>
<given-names>D.B.</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Amarante</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Loeloff</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fuller</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Edenson</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lile</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jarosinski</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Biere</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Curran</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Burgess</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Louis</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Treanor</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Citron</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE.</article-title>
<source/>Science
          <year>1999</year>
<volume>286</volume>
<issue>5440</issue>
<fpage>735</fpage>
<lpage>741</lpage>
<comment>[http://dx.doi.org/10.1126/science.286.5440.735]. [PMID: 10531052].</comment>
<pub-id pub-id-type="pmid">10531052</pub-id>
</element-citation>
</ref>
<ref id="r111">
<label>111</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szaruga</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Veugelen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Benurwar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lismont</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sepulveda-Falla</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lleo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>N.S.</given-names>
</name>
<name>
<surname>Lashley</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>N.C.</given-names>
</name>
<name>
<surname>Murayama</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gijsen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>De Strooper</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Chávez-Gutiérrez</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Qualitative changes in human γ-secretase underlie familial Alzheimer’s disease.</article-title>
<source/>J. Exp. Med.
          <year>2015</year>
<volume>212</volume>
<issue>12</issue>
<fpage>2003</fpage>
<lpage>2013</lpage>
<comment>[http://dx.doi.org/10.1084/jem.20150892]. [PMID: 26481686].</comment>
<pub-id pub-id-type="pmid">26481686</pub-id>
</element-citation>
</ref>
<ref id="r112">
<label>112</label>
<element-citation id="r112a" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
</person-group>
</element-citation>
<element-citation id="r112b" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Comparison of neurotoxicity of different aggregated forms of Abeta40, Abeta42 and Abeta43 in cell cultures. Journal of peptide science.</article-title>
<source/>Eur. Peptide Soc.
          <year>2017</year>
<volume>23</volume>
<issue>3</issue>
<fpage>245</fpage>
<lpage>251</lpage>
</element-citation>
</ref>
<ref id="r113">
<label>113</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lue</surname>
<given-names>L.F.</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>Y.M.</given-names>
</name>
<name>
<surname>Roher</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Brachova</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sue</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Beach</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kurth</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Rydel</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer’s disease.</article-title>
<source/>Am. J. Pathol.
          <year>1999</year>
<volume>155</volume>
<issue>3</issue>
<fpage>853</fpage>
<lpage>862</lpage>
<comment>[http://dx.doi.org/10.1016/S0002-9440(10)65184-X]. [PMID: 10487842].</comment>
<pub-id pub-id-type="pmid">10487842</pub-id>
</element-citation>
</ref>
<ref id="r114">
<label>114</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tomiyama</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Matsuyama</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Iso</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Umeda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Takuma</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ohnishi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ishibashi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Teraoka</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sakama</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yamashita</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nishitsuji</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shimada</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lambert</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>W.L.</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss <italic>in vivo.</italic></article-title>
<source/>J. Neurosci.
          <year>2010</year>
<volume>30</volume>
<issue>14</issue>
<fpage>4845</fpage>
<lpage>4856</lpage>
<comment>[http://dx.doi.org/10.1523/JNEUROSCI.5825-09.2010]. [PMID: 20371804].</comment>
<pub-id pub-id-type="pmid">20371804</pub-id>
</element-citation>
</ref>
<ref id="r115">
<label>115</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lambert</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Barlow</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Chromy</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Freed</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Liosatos</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>T.E.</given-names>
</name>
<name>
<surname>Rozovsky</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Trommer</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Viola</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Wals</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Finch</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Krafft</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>W.L.</given-names>
</name>
</person-group>
<article-title>Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>1998</year>
<volume>95</volume>
<issue>11</issue>
<fpage>6448</fpage>
<lpage>6453</lpage>
<comment>[http://dx.doi.org/10.1073/pnas.95.11.6448]. [PMID: 9600986].</comment>
<pub-id pub-id-type="pmid">9600986</pub-id>
</element-citation>
</ref>
<ref id="r116">
<label>116</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shankar</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Bloodgood</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Townsend</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Selkoe</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Sabatini</surname>
<given-names>B.L.</given-names>
</name>
</person-group>
<article-title>Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway.</article-title>
<source/>J. Neurosci.
          <year>2007</year>
<volume>27</volume>
<issue>11</issue>
<fpage>2866</fpage>
<lpage>2875</lpage>
<comment>[http://dx.doi.org/10.1523/JNEUROSCI.4970-06.2007]. [PMID: 17360908].</comment>
<pub-id pub-id-type="pmid">17360908</pub-id>
</element-citation>
</ref>
<ref id="r117">
<label>117</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>L.N.</given-names>
</name>
<name>
<surname>Kessels</surname>
<given-names>H.W.</given-names>
</name>
<name>
<surname>Hagiwara</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sisodia</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Malinow</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Amyloid beta from axons and dendrites reduces local spine number and plasticity.</article-title>
<source/>Nat. Neurosci.
          <year>2010</year>
<volume>13</volume>
<issue>2</issue>
<fpage>190</fpage>
<lpage>196</lpage>
<comment>[http://dx.doi.org/10.1038/nn.2476]. [PMID: 20037574].</comment>
<pub-id pub-id-type="pmid">20037574</pub-id>
</element-citation>
</ref>
<ref id="r118">
<label>118</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stéphan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Laroche</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits.</article-title>
<source/>J. Neurosci.
          <year>2001</year>
<volume>21</volume>
<issue>15</issue>
<fpage>5703</fpage>
<lpage>5714</lpage>
<comment>[http://dx.doi.org/10.1523/JNEUROSCI.21-15-05703.2001]. [PMID: 11466442].</comment>
<pub-id pub-id-type="pmid">11466442</pub-id>
</element-citation>
</ref>
<ref id="r119">
<label>119</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H.W.</given-names>
</name>
<name>
<surname>Pasternak</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ristic</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lambert</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Chromy</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Viola</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>W.L.</given-names>
</name>
<name>
<surname>Stine</surname>
<given-names>W.B.</given-names>
</name>
<name>
<surname>Krafft</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Trommer</surname>
<given-names>B.L.</given-names>
</name>
</person-group>
<article-title>Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.</article-title>
<source/>Brain Res.
          <year>2002</year>
<volume>924</volume>
<issue>2</issue>
<fpage>133</fpage>
<lpage>140</lpage>
<comment>[http://dx.doi.org/10.1016/S0006-8993(01)03058-X]. [PMID: 11750898].</comment>
<pub-id pub-id-type="pmid">11750898</pub-id>
</element-citation>
</ref>
<ref id="r120">
<label>120</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shankar</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>Garcia-Munoz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Shepardson</surname>
<given-names>N.E.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Brett</surname>
<given-names>F.M.</given-names>
</name>
<name>
<surname>Farrell</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Rowan</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Lemere</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Regan</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Sabatini</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Selkoe</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>Amyloid-beta protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory.</article-title>
<source/>Nat. Med.
          <year>2008</year>
<volume>14</volume>
<issue>8</issue>
<fpage>837</fpage>
<lpage>842</lpage>
<comment>[http://dx.doi.org/10.1038/nm1782]. [PMID: 18568035].</comment>
<pub-id pub-id-type="pmid">18568035</pub-id>
</element-citation>
</ref>
<ref id="r121">
<label>121</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>W.M.</given-names>
</name>
<name>
<surname>Corbett</surname>
<given-names>G.T.</given-names>
</name>
<name>
<surname>Moreno</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Frosch</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Slutsky</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Young-Pearse</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>Spires-Jones</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>D.M.</given-names>
</name>
</person-group>
<article-title>Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.</article-title>
<source/>J. Neurosci.
          <year>2017</year>
<volume>37</volume>
<issue>49</issue>
<fpage>11947</fpage>
<lpage>11966</lpage>
<comment>[http://dx.doi.org/10.1523/JNEUROSCI.2009-17.2017]. [PMID: 29101243].</comment>
<pub-id pub-id-type="pmid">29101243</pub-id>
</element-citation>
</ref>
<ref id="r122">
<label>122</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Q.S.</given-names>
</name>
<name>
<surname>Kagan</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Hirakura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>C.W.</given-names>
</name>
</person-group>
<article-title>Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides.</article-title>
<source/>J. Neurosci. Res.
          <year>2000</year>
<volume>60</volume>
<issue>1</issue>
<fpage>65</fpage>
<lpage>72</lpage>
<comment>[http://dx.doi.org/10.1002/(SICI)10974547(20000401)60:1&lt;65:AID-JNR7&gt;3.0.CO;2-Q]. [PMID: 10723069].</comment>
<pub-id pub-id-type="pmid">10723069</pub-id>
</element-citation>
</ref>
<ref id="r123">
<label>123</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walsh</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Klyubin</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Fadeeva</surname>
<given-names>J.V.</given-names>
</name>
<name>
<surname>Cullen</surname>
<given-names>W.K.</given-names>
</name>
<name>
<surname>Anwyl</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wolfe</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Rowan</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Selkoe</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation <italic>in vivo.</italic></article-title>
<source/>Nature
          <year>2002</year>
<volume>416</volume>
<issue>6880</issue>
<fpage>535</fpage>
<lpage>539</lpage>
<comment>[http://dx.doi.org/10.1038/416535a]. [PMID: 11932745].</comment>
<pub-id pub-id-type="pmid">11932745</pub-id>
</element-citation>
</ref>
<ref id="r124">
<label>124</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shepardson</surname>
<given-names>N.E.</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Shankar</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Selkoe</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake.</article-title>
<source/>Neuron
          <year>2009</year>
<volume>62</volume>
<issue>6</issue>
<fpage>788</fpage>
<lpage>801</lpage>
<comment>[http://dx.doi.org/10.1016/j.neuron.2009.05.012]. [PMID: 19555648].</comment>
<pub-id pub-id-type="pmid">19555648</pub-id>
</element-citation>
</ref>
<ref id="r125">
<label>125</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsieh</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Boehm</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Iwatsubo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tomita</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sisodia</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Malinow</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss.</article-title>
<source/>Neuron
          <year>2006</year>
<volume>52</volume>
<issue>5</issue>
<fpage>831</fpage>
<lpage>843</lpage>
<comment>[http://dx.doi.org/10.1016/j.neuron.2006.10.035]. [PMID: 17145504].</comment>
<pub-id pub-id-type="pmid">17145504</pub-id>
</element-citation>
</ref>
<ref id="r126">
<label>126</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Talantova</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sanz-Blasco</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Akhtar</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dziewczapolski</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pratt</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>Y.J.</given-names>
</name>
<name>
<surname>Tu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Molokanova</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>McKercher</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Hires</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Sason</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Stouffer</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Buczynski</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Solomon</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Michael</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Powers</surname>
<given-names>E.T.</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Fang-Newmeyer</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Holland</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Nakanishi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H.S.</given-names>
</name>
<name>
<surname>Wolosker</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Parsons</surname>
<given-names>L.H.</given-names>
</name>
<name>
<surname>Ambasudhan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Masliah</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Heinemann</surname>
<given-names>S.F.</given-names>
</name>
<name>
<surname>Piña-Crespo</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Lipton</surname>
<given-names>S.A.</given-names>
</name>
</person-group>
<article-title>Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss.</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2013</year>
<volume>110</volume>
<issue>27</issue>
<fpage>E2518</fpage>
<lpage>E2527</lpage>
<comment>[http://dx.doi.org/10.1073/pnas.1306832110]. [PMID: 23776240].</comment>
<pub-id pub-id-type="pmid">23776240</pub-id>
</element-citation>
</ref>
<ref id="r127">
<label>127</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lei</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>O’Malley</surname>
<given-names>T.T.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Selkoe</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Soluble Aβ oligomers impair hippocampal LTP by disrupting glutamatergic/GABAergic balance.</article-title>
<source/>Neurobiol. Dis.
          <year>2016</year>
<volume>85</volume>
<fpage>111</fpage>
<lpage>121</lpage>
<comment>[http://dx.doi.org/10.1016/j.nbd.2015.10.019]. [PMID: 26525100].</comment>
<pub-id pub-id-type="pmid">26525100</pub-id>
</element-citation>
</ref>
<ref id="r128">
<label>128</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rajsombath</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Selkoe</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Soluble Abeta Oligomers Impair Dipolar Heterodendritic Plasticity
by Activation of mGluR in the Hippocampal CA1 Region</article-title>
<source/>iScience
          <year>2018</year>
<volume>6</volume>
<fpage>138</fpage>
<lpage>150</lpage>
<pub-id pub-id-type="pmid">30240608</pub-id>
</element-citation>
</ref>
<ref id="r129">
<label>129</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Molokanova</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Akhtar</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Sanz-Blasco</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Piña-Crespo</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>McKercher</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Lipton</surname>
<given-names>S.A.</given-names>
</name>
</person-group>
<article-title>Differential effects of synaptic and extrasynaptic NMDA receptors on Aβ-induced nitric oxide production in cerebrocortical neurons.</article-title>
<source/>J. Neurosci.
          <year>2014</year>
<volume>34</volume>
<issue>14</issue>
<fpage>5023</fpage>
<lpage>5028</lpage>
<comment>[http://dx.doi.org/10.1523/JNEUROSCI.2907-13.2014]. [PMID: 24695719].</comment>
<pub-id pub-id-type="pmid">24695719</pub-id>
</element-citation>
</ref>
<ref id="r130">
<label>130</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Holland</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>McKercher</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Lipton</surname>
<given-names>S.A.</given-names>
</name>
</person-group>
<article-title>S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide.</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2011</year>
<volume>108</volume>
<issue>34</issue>
<fpage>14330</fpage>
<lpage>14335</lpage>
<comment>[http://dx.doi.org/10.1073/pnas.1105172108]. [PMID: 21844361].</comment>
<pub-id pub-id-type="pmid">21844361</pub-id>
</element-citation>
</ref>
<ref id="r131">
<label>131</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cleary</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Hofmeister</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Shankar</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Kuskowski</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Selkoe</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Ashe</surname>
<given-names>K.H.</given-names>
</name>
</person-group>
<article-title>Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function.</article-title>
<source/>Nat. Neurosci.
          <year>2005</year>
<volume>8</volume>
<issue>1</issue>
<fpage>79</fpage>
<lpage>84</lpage>
<comment>[http://dx.doi.org/10.1038/nn1372]. [PMID: 15608634].</comment>
<pub-id pub-id-type="pmid">15608634</pub-id>
</element-citation>
</ref>
<ref id="r132">
<label>132</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Figueiredo</surname>
<given-names>C.P.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Ledo</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Ribeiro</surname>
<given-names>F.C.</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>C.V.</given-names>
</name>
<name>
<surname>Melo</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Mota-Sales</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Saraiva</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>W.L.</given-names>
</name>
<name>
<surname>Sebollela</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>De Felice</surname>
<given-names>F.G.</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>S.T.</given-names>
</name>
</person-group>
<article-title>Memantine rescues transient cognitive impairment caused by high-molecular-weight aβ oligomers but not the persistent impairment induced by low-molecular-weight oligomers.</article-title>
<source/>J. Neurosci.
          <year>2013</year>
<volume>33</volume>
<issue>23</issue>
<fpage>9626</fpage>
<lpage>9634</lpage>
<comment>[http://dx.doi.org/10.1523/JNEUROSCI.0482-13.2013]. [PMID: 23739959].</comment>
<pub-id pub-id-type="pmid">23739959</pub-id>
</element-citation>
</ref>
<ref id="r133">
<label>133</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ledo</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Azevedo</surname>
<given-names>E.P.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Ribeiro</surname>
<given-names>F.C.</given-names>
</name>
<name>
<surname>Figueiredo</surname>
<given-names>C.P.</given-names>
</name>
<name>
<surname>Foguel</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>De Felice</surname>
<given-names>F.G.</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>S.T.</given-names>
</name>
</person-group>
<article-title>Amyloid-β oligomers link depressive-like behavior and cognitive deficits in mice.</article-title>
<source/>Mol. Psychiatry
          <year>2013</year>
<volume>18</volume>
<issue>10</issue>
<fpage>1053</fpage>
<lpage>1054</lpage>
<comment>[http://dx.doi.org/10.1038/mp.2012.168]. [PMID: 23183490].</comment>
<pub-id pub-id-type="pmid">23183490</pub-id>
</element-citation>
</ref>
<ref id="r134">
<label>134</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morroni</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Sita</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tarozzi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rimondini</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hrelia</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Early effects of Aβ1-42 oligomers injection in mice: Involvement of PI3K/Akt/GSK3 and MAPK/ERK1/2 pathways.</article-title>
<source/>Behav. Brain Res.
          <year>2016</year>
<volume>314</volume>
<fpage>106</fpage>
<lpage>115</lpage>
<comment>[http://dx.doi.org/10.1016/j.bbr.2016.08.002]. [PMID: 27498145].</comment>
<pub-id pub-id-type="pmid">27498145</pub-id>
</element-citation>
</ref>
<ref id="r135">
<label>135</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>King</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jeon</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>George</surname>
<given-names>A.T.</given-names>
</name>
</person-group>
<article-title>Alzheimer’s Disease neuroimaging initiative. Fractal dimension analysis of the cortical ribbon in mild Alzheimer’s disease.</article-title>
<source/>Neuroimage
          <year>2010</year>
<volume>53</volume>
<issue>2</issue>
<fpage>471</fpage>
<lpage>479</lpage>
<comment>[http://dx.doi.org/10.1016/j.neuroimage.2010.06.050]. [PMID: 20600974].</comment>
<pub-id pub-id-type="pmid">20600974</pub-id>
</element-citation>
</ref>
<ref id="r136">
<label>136</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clare</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>King</surname>
<given-names>V.G.</given-names>
</name>
<name>
<surname>Wirenfeldt</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vinters</surname>
<given-names>H.V.</given-names>
</name>
</person-group>
<article-title>Synapse loss in dementias.</article-title>
<source/>J. Neurosci. Res.
          <year>2010</year>
<volume>88</volume>
<issue>10</issue>
<fpage>2083</fpage>
<lpage>2090</lpage>
<comment>[http://dx.doi.org/10.1002/jnr.22392]. [PMID: 20533377].</comment>
<pub-id pub-id-type="pmid">20533377</pub-id>
</element-citation>
</ref>
<ref id="r137">
<label>137</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scheff</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Schmitt</surname>
<given-names>F.A.</given-names>
</name>
<name>
<surname>Mufson</surname>
<given-names>E.J.</given-names>
</name>
</person-group>
<article-title>Hippocampal synaptic loss in early Alzheimer’s disease and mild cognitive impairment.</article-title>
<source/>Neurobiol. Aging
          <year>2006</year>
<volume>27</volume>
<issue>10</issue>
<fpage>1372</fpage>
<lpage>1384</lpage>
<comment>[http://dx.doi.org/10.1016/j.neurobiolaging.2005.09.012]. [PMID: 16289476].</comment>
<pub-id pub-id-type="pmid">16289476</pub-id>
</element-citation>
</ref>
<ref id="r138">
<label>138</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scheff</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Schmitt</surname>
<given-names>F.A.</given-names>
</name>
<name>
<surname>DeKosky</surname>
<given-names>S.T.</given-names>
</name>
<name>
<surname>Mufson</surname>
<given-names>E.J.</given-names>
</name>
</person-group>
<article-title>Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment.</article-title>
<source/>Neurology
          <year>2007</year>
<volume>68</volume>
<issue>18</issue>
<fpage>1501</fpage>
<lpage>1508</lpage>
<comment>[http://dx.doi.org/10.1212/01.wnl.0000260698.46517.8f]. [PMID: 17470753].</comment>
<pub-id pub-id-type="pmid">17470753</pub-id>
</element-citation>
</ref>
<ref id="r139">
<label>139</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scheff</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>Synapse loss in the temporal lobe in Alzheimer’s disease.</article-title>
<source/>Ann. Neurol.
          <year>1993</year>
<volume>33</volume>
<issue>2</issue>
<fpage>190</fpage>
<lpage>199</lpage>
<comment>[http://dx.doi.org/10.1002/ana.410330209]. [PMID: 8434881].</comment>
<pub-id pub-id-type="pmid">8434881</pub-id>
</element-citation>
</ref>
<ref id="r140">
<label>140</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scheff</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>DeKosky</surname>
<given-names>S.T.</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>Quantitative assessment of cortical synaptic density in Alzheimer’s disease.</article-title>
<source/>Neurobiol. Aging
          <year>1990</year>
<volume>11</volume>
<issue>1</issue>
<fpage>29</fpage>
<lpage>37</lpage>
<comment>[http://dx.doi.org/10.1016/0197-4580(90)90059-9]. [PMID: 2325814].</comment>
<pub-id pub-id-type="pmid">2325814</pub-id>
</element-citation>
</ref>
<ref id="r141">
<label>141</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reddy</surname>
<given-names>P.H.</given-names>
</name>
<name>
<surname>Mani</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Jacques</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Murdoch</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Whetsell</surname>
<given-names>W.</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Kaye</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Manczak</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Differential loss of synaptic proteins in Alzheimer’s disease: implications for synaptic dysfunction.</article-title>
<source/>J. Alzheimers Dis.
          <year>2005</year>
<volume>7</volume>
<issue>2</issue>
<fpage>103</fpage>
<lpage>117</lpage>
<comment>[http://dx.doi.org/10.3233/JAD-2005-7203]. [PMID: 15851848].</comment>
<pub-id pub-id-type="pmid">15851848</pub-id>
</element-citation>
</ref>
<ref id="r142">
<label>142</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scheff</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Schmitt</surname>
<given-names>F.A.</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>K.N.</given-names>
</name>
<name>
<surname>Ikonomovic</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Mufson</surname>
<given-names>E.J.</given-names>
</name>
</person-group>
<article-title>Synapse stability in the precuneus early in the progression of Alzheimer’s disease.</article-title>
<source/>J. Alzheimers Dis.
          <year>2013</year>
<volume>35</volume>
<issue>3</issue>
<fpage>599</fpage>
<lpage>609</lpage>
<comment>[http://dx.doi.org/10.3233/JAD-122353]. [PMID: 23478309].</comment>
<pub-id pub-id-type="pmid">23478309</pub-id>
</element-citation>
</ref>
<ref id="r143">
<label>143</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Honer</surname>
<given-names>W.G.</given-names>
</name>
</person-group>
<article-title>Pathology of presynaptic proteins in Alzheimer’s disease: more than simple loss of terminals.</article-title>
<source/>Neurobiol. Aging
          <year>2003</year>
<volume>24</volume>
<issue>8</issue>
<fpage>1047</fpage>
<lpage>1062</lpage>
<comment>[http://dx.doi.org/10.1016/j.neurobiolaging.2003.04.005]. [PMID: 14643376].</comment>
<pub-id pub-id-type="pmid">14643376</pub-id>
</element-citation>
</ref>
<ref id="r144">
<label>144</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Masliah</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mallory</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Alford</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>DeTeresa</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>McKeel</surname>
<given-names>D.W.</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Morris</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>Altered expression of synaptic proteins occurs early during progression of Alzheimer’s disease.</article-title>
<source/>Neurology
          <year>2001</year>
<volume>56</volume>
<issue>1</issue>
<fpage>127</fpage>
<lpage>129</lpage>
<comment>[http://dx.doi.org/10.1212/WNL.56.1.127]. [PMID: 11148253].</comment>
<pub-id pub-id-type="pmid">11148253</pub-id>
</element-citation>
</ref>
<ref id="r145">
<label>145</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wakabayashi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Honer</surname>
<given-names>W.G.</given-names>
</name>
<name>
<surname>Masliah</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Synapse alterations in the hippocampal-entorhinal formation in Alzheimer’s disease with and without Lewy body disease.</article-title>
<source/>Brain Res.
          <year>1994</year>
<volume>667</volume>
<issue>1</issue>
<fpage>24</fpage>
<lpage>32</lpage>
<comment>[http://dx.doi.org/10.1016/0006-8993(94)91709-4]. [PMID: 7895080].</comment>
<pub-id pub-id-type="pmid">7895080</pub-id>
</element-citation>
</ref>
<ref id="r146">
<label>146</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marksteiner</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kaufmann</surname>
<given-names>W.A.</given-names>
</name>
<name>
<surname>Gurka</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Humpel</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Synaptic proteins in Alzheimer’s disease.</article-title>
<source/>Journal of Molecular Neuroscience: MN
          <year>2002</year>
<volume>18</volume>
<issue>1-2</issue>
<fpage>53</fpage>
<lpage>63</lpage>
<comment>[http://dx.doi.org/10.1385/JMN:18:1-2:53].</comment>
<pub-id pub-id-type="pmid">11931350</pub-id>
</element-citation>
</ref>
<ref id="r147">
<label>147</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Almeida</surname>
<given-names>C.G.</given-names>
</name>
<name>
<surname>Tampellini</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>R.H.</given-names>
</name>
<name>
<surname>Greengard</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Snyder</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Gouras</surname>
<given-names>G.K.</given-names>
</name>
</person-group>
<article-title>Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses.</article-title>
<source/>Neurobiol. Dis.
          <year>2005</year>
<volume>20</volume>
<issue>2</issue>
<fpage>187</fpage>
<lpage>198</lpage>
<comment>[http://dx.doi.org/10.1016/j.nbd.2005.02.008]. [PMID: 16242627].</comment>
<pub-id pub-id-type="pmid">16242627</pub-id>
</element-citation>
</ref>
<ref id="r148">
<label>148</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Canas</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>Simoes</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Rodrigues</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Cunha</surname>
<given-names>R. A.</given-names>
</name>
</person-group>
<article-title>Predominant loss of glutamatergic terminal markers in a beta-amyloid peptide model of Alzheimer's disease.</article-title>
<source/>Neuropharmacology,
          <year>2014</year>
<volume>76</volume>
<issue>Pt A)</issue>
<fpage>51</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="pmid">24029236</pub-id>
</element-citation>
</ref>
<ref id="r149">
<label>149</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berchtold</surname>
<given-names>N.C.</given-names>
</name>
<name>
<surname>Coleman</surname>
<given-names>P.D.</given-names>
</name>
<name>
<surname>Cribbs</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gillen</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Cotman</surname>
<given-names>C.W.</given-names>
</name>
</person-group>
<article-title>Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer’s disease.</article-title>
<source/>Neurobiol. Aging
          <year>2013</year>
<volume>34</volume>
<issue>6</issue>
<fpage>1653</fpage>
<lpage>1661</lpage>
<comment>[http://dx.doi.org/10.1016/j.neurobiolaging.2012.11.024]. [PMID: 23273601].</comment>
<pub-id pub-id-type="pmid">23273601</pub-id>
</element-citation>
</ref>
<ref id="r150">
<label>150</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitew</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kirkcaldie</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Dickson</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Vickers</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>Altered synapses and gliotransmission in Alzheimer’s disease and AD model mice.</article-title>
<source/>Neurobiol. Aging
          <year>2013</year>
<volume>34</volume>
<issue>10</issue>
<fpage>2341</fpage>
<lpage>2351</lpage>
<comment>[http://dx.doi.org/10.1016/j.neurobiolaging.2013.04.010]. [PMID: 23643146].</comment>
<pub-id pub-id-type="pmid">23643146</pub-id>
</element-citation>
</ref>
<ref id="r151">
<label>151</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roselli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Tirard</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hutzler</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lamberti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Livrea</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Morabito</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Almeida</surname>
<given-names>O.F.</given-names>
</name>
</person-group>
<article-title>Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses.</article-title>
<source/>J. Neurosci.
          <year>2005</year>
<volume>25</volume>
<issue>48</issue>
<fpage>11061</fpage>
<lpage>11070</lpage>
<comment>[http://dx.doi.org/10.1523/JNEUROSCI.3034-05.2005]. [PMID: 16319306].</comment>
<pub-id pub-id-type="pmid">16319306</pub-id>
</element-citation>
</ref>
<ref id="r152">
<label>152</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sze</surname>
<given-names>C.I.</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kleinschmidt-DeMasters</surname>
<given-names>B.K.</given-names>
</name>
<name>
<surname>Filley</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>L.J.</given-names>
</name>
</person-group>
<article-title>Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer’s disease brains.</article-title>
<source/>J. Neurol. Sci.
          <year>2000</year>
<volume>175</volume>
<issue>2</issue>
<fpage>81</fpage>
<lpage>90</lpage>
<comment>[http://dx.doi.org/10.1016/S0022-510X(00)00285-9]. [PMID: 10831767].</comment>
<pub-id pub-id-type="pmid">10831767</pub-id>
</element-citation>
</ref>
<ref id="r153">
<label>153</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeKosky</surname>
<given-names>S.T.</given-names>
</name>
<name>
<surname>Scheff</surname>
<given-names>S.W.</given-names>
</name>
</person-group>
<article-title>Synapse loss in frontal cortex biopsies in Alzheimer’s disease: correlation with cognitive severity.</article-title>
<source/>Ann. Neurol.
          <year>1990</year>
<volume>27</volume>
<issue>5</issue>
<fpage>457</fpage>
<lpage>464</lpage>
<comment>[http://dx.doi.org/10.1002/ana.410270502]. [PMID: 2360787].</comment>
<pub-id pub-id-type="pmid">2360787</pub-id>
</element-citation>
</ref>
<ref id="r154">
<label>154</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Terry</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Masliah</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Salmon</surname>
<given-names>D.P.</given-names>
</name>
<name>
<surname>Butters</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>DeTeresa</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Katzman</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment.</article-title>
<source/>Ann. Neurol.
          <year>1991</year>
<volume>30</volume>
<issue>4</issue>
<fpage>572</fpage>
<lpage>580</lpage>
<comment>[http://dx.doi.org/10.1002/ana.410300410]. [PMID: 1789684].</comment>
<pub-id pub-id-type="pmid">1789684</pub-id>
</element-citation>
</ref>
<ref id="r155">
<label>155</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Mecca</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Naganawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Finnema</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Toyonaga</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S.F.</given-names>
</name>
<name>
<surname>Najafzadeh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ropchan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Michalak</surname>
<given-names>H.R.</given-names>
</name>
<name>
<surname>Nabulsi</surname>
<given-names>N.B.</given-names>
</name>
<name>
<surname>Arnsten</surname>
<given-names>A.F.T.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Carson</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>van Dyck</surname>
<given-names>C.H.</given-names>
</name>
</person-group>
<article-title>Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.</article-title>
<source/>JAMA Neurol.
          <year>2018</year>
<volume>75</volume>
<issue>10</issue>
<fpage>1215</fpage>
<lpage>1224</lpage>
<comment>[http://dx.doi.org/10.1001/jamaneurol.2018.1836]. [PMID: 30014145].</comment>
<pub-id pub-id-type="pmid">30014145</pub-id>
</element-citation>
</ref>
<ref id="r156">
<label>156</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jackson</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Rudinskiy</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Herrmann</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Croft</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Petrova</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Ramos-Rodriguez</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Pitstick</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wegmann</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Garcia-Alloza</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Carlson</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Hyman</surname>
<given-names>B.T.</given-names>
</name>
<name>
<surname>Spires-Jones</surname>
<given-names>T.L.</given-names>
</name>
</person-group>
<article-title>Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer’s disease.</article-title>
<source/>Eur. J. Neurosci.
          <year>2016</year>
<volume>44</volume>
<issue>12</issue>
<fpage>3056</fpage>
<lpage>3066</lpage>
<comment>[http://dx.doi.org/10.1111/ejn.13442]. [PMID: 27748574].</comment>
<pub-id pub-id-type="pmid">27748574</pub-id>
</element-citation>
</ref>
<ref id="r157">
<label>157</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Merino-Serrais</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Benavides-Piccione</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Blazquez-Llorca</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kastanauskaite</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rábano</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Avila</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>DeFelipe</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>The influence of phospho-τ on dendritic spines of cortical pyramidal neurons in patients with Alzheimer’s disease.</article-title>
<source/>Brain
          <year>2013</year>
<volume>136</volume>
<issue>Pt 6</issue>
<fpage>1913</fpage>
<lpage>1928</lpage>
<comment>[http://dx.doi.org/10.1093/brain/awt088]. [PMID: 23715095].</comment>
<pub-id pub-id-type="pmid">23715095</pub-id>
</element-citation>
</ref>
<ref id="r158">
<label>158</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fein</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Sokolow</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Vinters</surname>
<given-names>H.V.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Gylys</surname>
<given-names>K.H.</given-names>
</name>
</person-group>
<article-title>Co-localization of amyloid beta and tau pathology in Alzheimer’s disease synaptosomes.</article-title>
<source/>Am. J. Pathol.
          <year>2008</year>
<volume>172</volume>
<issue>6</issue>
<fpage>1683</fpage>
<lpage>1692</lpage>
<comment>[http://dx.doi.org/10.2353/ajpath.2008.070829]. [PMID: 18467692].</comment>
<pub-id pub-id-type="pmid">18467692</pub-id>
</element-citation>
</ref>
<ref id="r159">
<label>159</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoover</surname>
<given-names>B.R.</given-names>
</name>
<name>
<surname>Reed</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Penrod</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Kotilinek</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Pitstick</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Carlson</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Lanier</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>L.L.</given-names>
</name>
<name>
<surname>Ashe</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration.</article-title>
<source/>Neuron
          <year>2010</year>
<volume>68</volume>
<issue>6</issue>
<fpage>1067</fpage>
<lpage>1081</lpage>
<comment>[http://dx.doi.org/10.1016/j.neuron.2010.11.030]. [PMID: 21172610].</comment>
<pub-id pub-id-type="pmid">21172610</pub-id>
</element-citation>
</ref>
<ref id="r160">
<label>160</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takahashi</surname>
<given-names>R.H.</given-names>
</name>
<name>
<surname>Capetillo-Zarate</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Milner</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Gouras</surname>
<given-names>G.K.</given-names>
</name>
</person-group>
<article-title>Co-occurrence of Alzheimer’s disease ß-amyloid and τ pathologies at synapses.</article-title>
<source/>Neurobiol. Aging
          <year>2010</year>
<volume>31</volume>
<issue>7</issue>
<fpage>1145</fpage>
<lpage>1152</lpage>
<comment>[http://dx.doi.org/10.1016/j.neurobiolaging.2008.07.021]. [PMID: 18771816].</comment>
<pub-id pub-id-type="pmid">18771816</pub-id>
</element-citation>
</ref>
<ref id="r161">
<label>161</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ittner</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Ke</surname>
<given-names>Y.D.</given-names>
</name>
<name>
<surname>Delerue</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gladbach</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>van Eersel</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wölfing</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chieng</surname>
<given-names>B.C.</given-names>
</name>
<name>
<surname>Christie</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Napier</surname>
<given-names>I.A.</given-names>
</name>
<name>
<surname>Eckert</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Staufenbiel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hardeman</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Götz</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer’s disease mouse models.</article-title>
<source/>Cell
          <year>2010</year>
<volume>142</volume>
<issue>3</issue>
<fpage>387</fpage>
<lpage>397</lpage>
<comment>[http://dx.doi.org/10.1016/j.cell.2010.06.036]. [PMID: 20655099].</comment>
<pub-id pub-id-type="pmid">20655099</pub-id>
</element-citation>
</ref>
<ref id="r162">
<label>162</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lasagna-Reeves</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Castillo-Carranza</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Sengupta</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Clos</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>G.R.</given-names>
</name>
<name>
<surname>Kayed</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice.</article-title>
<source/>Mol. Neurodegener.
          <year>2011</year>
<volume>6</volume>
<fpage>39</fpage>
<comment>[http://dx.doi.org/10.1186/1750-1326-6-39]. [PMID: 21645391].</comment>
<pub-id pub-id-type="pmid">21645391</pub-id>
</element-citation>
</ref>
<ref id="r163">
<label>163</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shipton</surname>
<given-names>O.A.</given-names>
</name>
<name>
<surname>Leitz</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Dworzak</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Acton</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Tunbridge</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Denk</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Dawson</surname>
<given-names>H.N.</given-names>
</name>
<name>
<surname>Vitek</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Wade-Martins</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Paulsen</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Vargas-Caballero</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Tau protein is required for amyloid beta-induced impairment of hippocampal long-term potentiation.</article-title>
<source/>J. Neurosci.
          <year>2011</year>
<volume>31</volume>
<issue>5</issue>
<fpage>1688</fpage>
<lpage>1692</lpage>
<comment>[http://dx.doi.org/10.1523/JNEUROSCI.2610-10.2011]. [PMID: 21289177].</comment>
<pub-id pub-id-type="pmid">21289177</pub-id>
</element-citation>
</ref>
<ref id="r164">
<label>164</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roberson</surname>
<given-names>E.D.</given-names>
</name>
<name>
<surname>Scearce-Levie</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Palop</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>I.H.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gerstein</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>G.Q.</given-names>
</name>
<name>
<surname>Mucke</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer’s disease mouse model.</article-title>
<source/>Science
          <year>2007</year>
<volume>316</volume>
<issue>5825</issue>
<fpage>750</fpage>
<lpage>754</lpage>
<comment>[http://dx.doi.org/10.1126/science.1141736]. [PMID: 17478722].</comment>
<pub-id pub-id-type="pmid">17478722</pub-id>
</element-citation>
</ref>
<ref id="r165">
<label>165</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gatz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Fratiglioni</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Johansson</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Mortimer</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Berg</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fiske</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>N.L.</given-names>
</name>
</person-group>
<article-title>Role of genes and environments for explaining Alzheimer disease.</article-title>
<source/>Arch. Gen. Psychiatry
          <year>2006</year>
<volume>63</volume>
<issue>2</issue>
<fpage>168</fpage>
<lpage>174</lpage>
<comment>[http://dx.doi.org/10.1001/archpsyc.63.2.168]. [PMID: 16461860].</comment>
<pub-id pub-id-type="pmid">16461860</pub-id>
</element-citation>
</ref>
<ref id="r166">
<label>166</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Emahazion</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Feuk</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Jobs</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sawyer</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Fredman</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>St Clair</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Prince</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Brookes</surname>
<given-names>A.J.</given-names>
</name>
</person-group>
<article-title>SNP association studies in Alzheimer’s disease highlight problems for complex disease analysis.</article-title>
<source/>Trends Genet.
          <year>2001</year>
<volume>17</volume>
<issue>7</issue>
<fpage>407</fpage>
<lpage>413</lpage>
<comment>[http://dx.doi.org/10.1016/S0168-9525(01)02342-3]. [PMID: 11418222].</comment>
<pub-id pub-id-type="pmid">11418222</pub-id>
</element-citation>
</ref>
<ref id="r167">
<label>167</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>X.C.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.F.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>X.F.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J.T.</given-names>
</name>
</person-group>
<article-title>Rate of early onset Alzheimer’s disease: a systematic review and meta-analysis.</article-title>
<source/>Ann. Transl. Med.
          <year>2015</year>
<volume>3</volume>
<issue>3</issue>
<fpage>38</fpage>
<comment>[PMID: 25815299].</comment>
<pub-id pub-id-type="pmid">25815299</pub-id>
</element-citation>
</ref>
<ref id="r168">
<label>168</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goate</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chartier-Harlin</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Mullan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Fidani</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Giuffra</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Haynes</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Irving</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>James</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease.</article-title>
<source/>Nature
          <year>1991</year>
<volume>349</volume>
<issue>6311</issue>
<fpage>704</fpage>
<lpage>706</lpage>
<comment>[http://dx.doi.org/10.1038/349704a0]. [PMID: 1671712].</comment>
<pub-id pub-id-type="pmid">1671712</pub-id>
</element-citation>
</ref>
<ref id="r169">
<label>169</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jarrett</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Berger</surname>
<given-names>E.P.</given-names>
</name>
<name>
<surname>Lansbury</surname>
<given-names>P.T.</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer’s disease.</article-title>
<source/>Biochemistry
          <year>1993</year>
<volume>32</volume>
<issue>18</issue>
<fpage>4693</fpage>
<lpage>4697</lpage>
<comment>[http://dx.doi.org/10.1021/bi00069a001]. [PMID: 8490014].</comment>
<pub-id pub-id-type="pmid">8490014</pub-id>
</element-citation>
</ref>
<ref id="r170">
<label>170</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jarrett</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Berger</surname>
<given-names>E.P.</given-names>
</name>
<name>
<surname>Lansbury</surname>
<given-names>P.T.</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>The C-terminus of the beta protein is critical in amyloidogenesis.</article-title>
<source/>Ann. N. Y. Acad. Sci.
          <year>1993</year>
<volume>695</volume>
<fpage>144</fpage>
<lpage>148</lpage>
<comment>[http://dx.doi.org/10.1111/j.1749-6632.1993.tb23043.x]. [PMID: 8239273].</comment>
<pub-id pub-id-type="pmid">8239273</pub-id>
</element-citation>
</ref>
<ref id="r171">
<label>171</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>T.T.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>X.D.</given-names>
</name>
<name>
<surname>Odaka</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Otvos</surname>
<given-names>L.</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Eckman</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Golde</surname>
<given-names>T.E.</given-names>
</name>
<name>
<surname>Younkin</surname>
<given-names>S.G.</given-names>
</name>
</person-group>
<article-title>An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.</article-title>
<source/>Science
          <year>1994</year>
<volume>264</volume>
<issue>5163</issue>
<fpage>1336</fpage>
<lpage>1340</lpage>
<comment>[http://dx.doi.org/10.1126/science.8191290]. [PMID: 8191290].</comment>
<pub-id pub-id-type="pmid">8191290</pub-id>
</element-citation>
</ref>
<ref id="r172">
<label>172</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roher</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Lowenson</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Woods</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Cotter</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Gowing</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ball</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease.</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>1993</year>
<volume>90</volume>
<issue>22</issue>
<fpage>10836</fpage>
<lpage>10840</lpage>
<comment>[http://dx.doi.org/10.1073/pnas.90.22.10836]. [PMID: 8248178].</comment>
<pub-id pub-id-type="pmid">8248178</pub-id>
</element-citation>
</ref>
<ref id="r173">
<label>173</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Duijn</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>de Knijff</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cruts</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wehnert</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Havekes</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Hofman</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Van Broeckhoven</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer’s disease.</article-title>
<source/>Nat. Genet.
          <year>1994</year>
<volume>7</volume>
<issue>1</issue>
<fpage>74</fpage>
<lpage>78</lpage>
<comment>[http://dx.doi.org/10.1038/ng0594-74]. [PMID: 8075646].</comment>
<pub-id pub-id-type="pmid">8075646</pub-id>
</element-citation>
</ref>
<ref id="r174">
<label>174</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strittmatter</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Weisgraber</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>D.Y.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Salvesen</surname>
<given-names>G.S.</given-names>
</name>
<name>
<surname>Pericak-Vance</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schmechel</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Saunders</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Goldgaber</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Roses</surname>
<given-names>A.D.</given-names>
</name>
</person-group>
<article-title>Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>1993</year>
<volume>90</volume>
<issue>17</issue>
<fpage>8098</fpage>
<lpage>8102</lpage>
<comment>[http://dx.doi.org/10.1073/pnas.90.17.8098]. [PMID: 8367470].</comment>
<pub-id pub-id-type="pmid">8367470</pub-id>
</element-citation>
</ref>
<ref id="r175">
<label>175</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strittmatter</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Saunders</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Schmechel</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pericak-Vance</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Enghild</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Salvesen</surname>
<given-names>G.S.</given-names>
</name>
<name>
<surname>Roses</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Apolipoprotein</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>1993</year>
<volume>90</volume>
<issue>5</issue>
<fpage>1977</fpage>
<lpage>1981</lpage>
<comment>[http://dx.doi.org/10.1073/pnas.90.5.1977]. [PMID: 8446617].</comment>
<pub-id pub-id-type="pmid">8446617</pub-id>
</element-citation>
</ref>
<ref id="r176">
<label>176</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chartier-Harlin</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Parfitt</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Legrain</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pérez-Tur</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Brousseau</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Berr</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Vidal</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Roques</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gourlet</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer’s disease: analysis of the 19q13.2 chromosomal region.</article-title>
<source/>Hum. Mol. Genet.
          <year>1994</year>
<volume>3</volume>
<issue>4</issue>
<fpage>569</fpage>
<lpage>574</lpage>
<comment>[http://dx.doi.org/10.1093/hmg/3.4.569]. [PMID: 8069300].</comment>
<pub-id pub-id-type="pmid">8069300</pub-id>
</element-citation>
</ref>
<ref id="r177">
<label>177</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Talbot</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lendon</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Craddock</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Shears</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Goate</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Protection against Alzheimer’s disease with apoE epsilon 2.</article-title>
<source/>Lancet
          <year>1994</year>
<volume>343</volume>
<issue>8910</issue>
<fpage>1432</fpage>
<lpage>1433</lpage>
<comment>[http://dx.doi.org/10.1016/S0140-6736(94)92557-7]. [PMID: 7910910].</comment>
</element-citation>
</ref>
<ref id="r178">
<label>178</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corder</surname>
<given-names>E.H.</given-names>
</name>
<name>
<surname>Saunders</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Strittmatter</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Schmechel</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Gaskell</surname>
<given-names>P.C.</given-names>
</name>
<name>
<surname>Small</surname>
<given-names>G.W.</given-names>
</name>
<name>
<surname>Roses</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Haines</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Pericak-Vance</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families.</article-title>
<source/>Science
          <year>1993</year>
<volume>261</volume>
<issue>5123</issue>
<fpage>921</fpage>
<lpage>923</lpage>
<comment>[http://dx.doi.org/10.1126/science.8346443]. [PMID: 8346443].</comment>
<pub-id pub-id-type="pmid">8346443</pub-id>
</element-citation>
</ref>
<ref id="r179">
<label>179</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>Y.A.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wernig</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sudhof</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Abeta Secretion.</article-title>
<source/>Cell
          <volume>168</volume>
<issue>3</issue>
<fpage>427</fpage>
<lpage>441</lpage>
</element-citation>
</ref>
<ref id="r180">
<label>180</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hashimoto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Serrano-Pozo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hori</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>K.W.</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Banerji</surname>
<given-names>A.O.</given-names>
</name>
<name>
<surname>Mitani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Joyner</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Thyssen</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Bacskai</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Frosch</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Spires-Jones</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>Finn</surname>
<given-names>M.B.</given-names>
</name>
<name>
<surname>Holtzman</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Hyman</surname>
<given-names>B.T.</given-names>
</name>
<name>
<surname>Apolipoprotein</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.</article-title>
<source/>J. Neurosci.
          <year>2012</year>
<volume>32</volume>
<issue>43</issue>
<fpage>15181</fpage>
<lpage>15192</lpage>
<comment>[http://dx.doi.org/10.1523/JNEUROSCI.1542-12.2012]. [PMID: 23100439].</comment>
<pub-id pub-id-type="pmid">23100439</pub-id>
</element-citation>
</ref>
<ref id="r181">
<label>181</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dumanis</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Tesoriero</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Babus</surname>
<given-names>L.W.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Trotter</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Ladu</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Weeber</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Rebeck</surname>
<given-names>G.W.</given-names>
</name>
<name>
<surname>Hoe</surname>
<given-names>H.S.</given-names>
</name>
</person-group>
<article-title>ApoE4 decreases spine density and dendritic complexity in cortical neurons <italic>in vivo.</italic></article-title>
<source/>J. Neurosci.
          <year>2009</year>
<volume>29</volume>
<issue>48</issue>
<fpage>15317</fpage>
<lpage>15322</lpage>
<comment>[http://dx.doi.org/10.1523/JNEUROSCI.4026-09.2009]. [PMID: 19955384].</comment>
<pub-id pub-id-type="pmid">19955384</pub-id>
</element-citation>
</ref>
<ref id="r182">
<label>182</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klein</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Mace</surname>
<given-names>B.E.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>P.M.</given-names>
</name>
</person-group>
<article-title>Progressive loss of synaptic integrity in human apolipoprotein E4 targeted replacement mice and attenuation by apolipoprotein E2.</article-title>
<source/>Neuroscience
          <year>2010</year>
<volume>171</volume>
<issue>4</issue>
<fpage>1265</fpage>
<lpage>1272</lpage>
<comment>[http://dx.doi.org/10.1016/j.neuroscience.2010.10.027]. [PMID: 20951774].</comment>
<pub-id pub-id-type="pmid">20951774</pub-id>
</element-citation>
</ref>
<ref id="r183">
<label>183</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nwabuisi-Heath</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Rebeck</surname>
<given-names>G.W.</given-names>
</name>
<name>
<surname>Ladu</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>ApoE4 delays dendritic spine formation during neuron development and accelerates loss of mature spines <italic>in vitro.</italic></article-title>
<source/>ASN Neuro
          <year>2014</year>
<volume>6</volume>
<issue>1</issue>
<elocation-id>e00134</elocation-id>
<comment>[PMID: 24328732].</comment>
<pub-id pub-id-type="pmid">24328732</pub-id>
</element-citation>
</ref>
<ref id="r184">
<label>184</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nwabuisi-Heath</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Dumanis</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Tai</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rebeck</surname>
<given-names>G.W.</given-names>
</name>
<name>
<surname>LaDu</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>APOE genotype alters glial activation and loss of synaptic markers in mice.</article-title>
<source/>Glia
          <year>2012</year>
<volume>60</volume>
<issue>4</issue>
<fpage>559</fpage>
<lpage>569</lpage>
<comment>[http://dx.doi.org/10.1002/glia.22289]. [PMID: 22228589].</comment>
<pub-id pub-id-type="pmid">22228589</pub-id>
</element-citation>
</ref>
<ref id="r185">
<label>185</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andrews-Zwilling</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bien-Ly</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bernardo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>S.Y.</given-names>
</name>
<name>
<surname>Zwilling</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>T.X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Apolipoprotein E4 causes age- and Tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice.</article-title>
<source/>J. Neurosci.
          <year>2010</year>
<volume>30</volume>
<issue>41</issue>
<fpage>13707</fpage>
<lpage>13717</lpage>
<pub-id pub-id-type="pmid">20943911</pub-id>
</element-citation>
</ref>
<ref id="r186">
<label>186</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koffie</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Hashimoto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tai</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Kay</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Serrano-Pozo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Joyner</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kopeikina</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Frosch</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>V.M.</given-names>
</name>
<name>
<surname>Holtzman</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Hyman</surname>
<given-names>B.T.</given-names>
</name>
<name>
<surname>Spires-Jones</surname>
<given-names>T.L.</given-names>
</name>
</person-group>
<article-title>Apolipoprotein E4 effects in Alzheimer’s disease are mediated by synaptotoxic oligomeric amyloid-β.</article-title>
<source/>Brain
          <year>2012</year>
<volume>135</volume>
<issue>Pt 7</issue>
<fpage>2155</fpage>
<lpage>2168</lpage>
<comment>[http://dx.doi.org/10.1093/brain/aws127]. [PMID: 22637583].</comment>
<pub-id pub-id-type="pmid">22637583</pub-id>
</element-citation>
</ref>
<ref id="r187">
<label>187</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>Y.T.</given-names>
</name>
<name>
<surname>Seo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Feldman</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>H.L.</given-names>
</name>
<name>
<surname>Pen-ney</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cam</surname>
<given-names>H.P.</given-names>
</name>
<name>
<surname>Gjoneska</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Raja</surname>
<given-names>W.K.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rueda</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kritskiy</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Abdurrob</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Milo</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Elmsaouri</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dey</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yankner</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>L.H.</given-names>
</name>
</person-group>
<article-title>APOE4 Causes Widespread Molecular and Cellular Altera-tions Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types.</article-title>
<source/>Neuron
          <year>2018</year>
<volume>98</volume>
<issue>6</issue>
<fpage>1141</fpage>
<lpage>1154</lpage>
<pub-id pub-id-type="pmid">29861287</pub-id>
</element-citation>
</ref>
<ref id="r188">
<label>188</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chung</surname>
<given-names>W.S.</given-names>
</name>
<name>
<surname>Verghese</surname>
<given-names>P.B.</given-names>
</name>
<name>
<surname>Chakraborty</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Joung</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hyman</surname>
<given-names>B.T.</given-names>
</name>
<name>
<surname>Ulrich</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Holtzman</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>B.A.</given-names>
</name>
</person-group>
<article-title>Novel allele-dependent role for APOE in controlling the rate of synapse pruning by astrocytes.</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2016</year>
<volume>113</volume>
<issue>36</issue>
<fpage>10186</fpage>
<lpage>10191</lpage>
<comment>[http://dx.doi.org/10.1073/pnas.1609896113]. [PMID: 27559087].</comment>
<pub-id pub-id-type="pmid">27559087</pub-id>
</element-citation>
</ref>
<ref id="r189">
<label>189</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Egensperger</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kösel</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>von Eitzen</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Graeber</surname>
<given-names>M.B.</given-names>
</name>
</person-group>
<article-title>Microglial activation in Alzheimer disease: Association with APOE genotype.</article-title>
<source/>Brain Pathol.
          <year>1998</year>
<volume>8</volume>
<issue>3</issue>
<fpage>439</fpage>
<lpage>447</lpage>
<comment>[http://dx.doi.org/10.1111/j.1750-3639.1998.tb00166.x]. [PMID: 9669695].</comment>
<pub-id pub-id-type="pmid">9669695</pub-id>
</element-citation>
</ref>
<ref id="r190">
<label>190</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Currais</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Quehenberger</surname>
<given-names>O.A.</given-names>
</name>
</person-group>
<article-title>M. A.; Daugherty, D.; Ma-her, P.; Schubert, D. Amyloid proteotoxicity initiates an in-flammatory response blocked by cannabinoids.</article-title>
<source/>NPJ Aging Mech. Dis.
          <year>2016</year>
<volume>2</volume>
<fpage>16012</fpage>
<comment>[http://dx.doi.org/10.1038/npjamd.2016.12]. [PMID: 28721267].</comment>
<pub-id pub-id-type="pmid">28721267</pub-id>
</element-citation>
</ref>
<ref id="r191">
<label>191</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bornemann</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Wiederhold</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Pauli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ermini</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Stalder</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schnell</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sommer</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Jucker</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Staufenbiel</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice.</article-title>
<source/>Am. J. Pathol.
          <year>2001</year>
<volume>158</volume>
<issue>1</issue>
<fpage>63</fpage>
<lpage>73</lpage>
<comment>[http://dx.doi.org/10.1016/S0002-9440(10)63945-4]. [PMID: 11141480].</comment>
<pub-id pub-id-type="pmid">11141480</pub-id>
</element-citation>
</ref>
<ref id="r192">
<label>192</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lue</surname>
<given-names>L.F.</given-names>
</name>
<name>
<surname>Brachova</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Civin</surname>
<given-names>W.H.</given-names>
</name>
</person-group>
<article-title>Rogers, J. Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer’s disease neurodegeneration.</article-title>
<source/>J. Neuropathol. Exp. Neurol.
          <year>1996</year>
<volume>55</volume>
<issue>10</issue>
<fpage>1083</fpage>
<lpage>1088</lpage>
<comment>[http://dx.doi.org/10.1097/00005072-199655100-00008]. [PMID: 8858005].</comment>
<pub-id pub-id-type="pmid">8858005</pub-id>
</element-citation>
</ref>
<ref id="r193">
<label>193</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>L.B.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Meri</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Deficiency of complement defense protein CD59 may contribute to neurodegeneration in Alzheimer’s disease.</article-title>
<source/>J. Neurosci.
          <year>2000</year>
<volume>20</volume>
<issue>20</issue>
<fpage>7505</fpage>
<lpage>7509</lpage>
<comment>[http://dx.doi.org/10.1523/JNEUROSCI.20-20-07505.2000]. [PMID: 11027207].</comment>
<pub-id pub-id-type="pmid">11027207</pub-id>
</element-citation>
</ref>
<ref id="r194">
<label>194</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reichwald</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Danner</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wiederhold</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Staufenbiel</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Expression of complement system components during aging and amyloid deposition in APP transgenic mice.</article-title>
<source/>J. Neuroinflammation
          <year>2009</year>
<volume>6</volume>
<fpage>35</fpage>
<comment>[http://dx.doi.org/10.1186/1742-2094-6-35]. [PMID: 19917141].</comment>
<pub-id pub-id-type="pmid">19917141</pub-id>
</element-citation>
</ref>
<ref id="r195">
<label>195</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fonseca</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Botto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tenner</surname>
<given-names>A.J.</given-names>
</name>
</person-group>
<article-title>Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer’s disease.</article-title>
<source/>J. Neurosci.
          <year>2004</year>
<volume>24</volume>
<issue>29</issue>
<fpage>6457</fpage>
<lpage>6465</lpage>
<comment>[http://dx.doi.org/10.1523/JNEUROSCI.0901-04.2004]. [PMID: 15269255].</comment>
<pub-id pub-id-type="pmid">15269255</pub-id>
</element-citation>
</ref>
<ref id="r196">
<label>196</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Chowdhury</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Le</surname>
<given-names>K.X.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Caldarone</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lemere</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice.</article-title>
<source/>Sci. Transl. Med.
          <year>2017</year>
<volume>9</volume>
<issue>392</issue>
<elocation-id>eaaf6295</elocation-id>
<comment>[http://dx.doi.org/10.1126/scitranslmed.aaf6295]. [PMID: 28566429].</comment>
<pub-id pub-id-type="pmid">28566429</pub-id>
</element-citation>
</ref>
<ref id="r197">
<label>197</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Meri</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Yin and Yang: complement activation and regulation in Alzheimer’s disease.</article-title>
<source/>Prog. Neurobiol.
          <year>2003</year>
<volume>70</volume>
<issue>6</issue>
<fpage>463</fpage>
<lpage>472</lpage>
<comment>[http://dx.doi.org/10.1016/j.pneurobio.2003.08.001]. [PMID: 14568360].</comment>
<pub-id pub-id-type="pmid">14568360</pub-id>
</element-citation>
</ref>
<ref id="r198">
<label>198</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hong</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Beja-Glasser</surname>
<given-names>V.F.</given-names>
</name>
<name>
<surname>Nfonoyim</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Frouin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ramakrishnan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Merry</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Rosenthal</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Lemere</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Selkoe</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Complement and microglia mediate early synapse loss in Alzheimer mouse models.</article-title>
<source/>Science
          <year>2016</year>
<volume>352</volume>
<issue>6286</issue>
<fpage>712</fpage>
<lpage>716</lpage>
<comment>[http://dx.doi.org/10.1126/science.aad8373]. [PMID: 27033548].</comment>
<pub-id pub-id-type="pmid">27033548</pub-id>
</element-citation>
</ref>
<ref id="r199">
<label>199</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dejanovic</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Huntley</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>De Maziere</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Meilandt</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Srinivasan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gandham</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Ngu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Foreman</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Carano</surname>
<given-names>R.A.D.</given-names>
</name>
<name>
<surname>Chih</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Klumperman</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bakalarski</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies.</article-title>
<source/>Neuron
          <year>2018</year>
<volume>100</volume>
<issue>6</issue>
<fpage>1322</fpage>
<lpage>1336</lpage>
<comment>[http://dx.doi.org/10.1016/j.neuron.2018.10.014].</comment>
<pub-id pub-id-type="pmid">30392797</pub-id>
</element-citation>
</ref>
<ref id="r200">
<label>200</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Savas</surname>
<given-names>J.N.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.Z.</given-names>
</name>
<name>
<surname>DeNardo</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Martinez-Bartolome</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>McClatchy</surname>
<given-names>D.B.</given-names>
</name>
<name>
<surname>Hark</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Shanks</surname>
<given-names>N.F.</given-names>
</name>
<name>
<surname>Cozzolino</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Lavallée-Adam</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Smukowski</surname>
<given-names>S.N.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Koo</surname>
<given-names>E.H.</given-names>
</name>
<name>
<surname>Nakagawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Masliah</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yates</surname>
<given-names>J.R.</given-names>
</name>
</person-group>
<article-title>III Amyloid Accumulation Drives Proteome-wide Alterations in Mouse Models of Alzheimer’s Disease-like Pathology.</article-title>
<source/>Cell Rep.
          <year>2017</year>
<volume>21</volume>
<issue>9</issue>
<fpage>2614</fpage>
<lpage>2627</lpage>
<comment>[http://dx.doi.org/10.1016/j.celrep.2017.11.009]. [PMID: 29186695].</comment>
<pub-id pub-id-type="pmid">29186695</pub-id>
</element-citation>
</ref>
<ref id="r201">
<label>201</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seyfried</surname>
<given-names>N.T.</given-names>
</name>
<name>
<surname>Dammer</surname>
<given-names>E.B.</given-names>
</name>
<name>
<surname>Swarup</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Nandakumar</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Duong</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hales</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Wingo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Glass</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gearing</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Thambisetty</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Troncoso</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Lah</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Levey</surname>
<given-names>A.I.</given-names>
</name>
</person-group>
<article-title>A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s Disease.</article-title>
<source/>Cell Syst.
          <year>2017</year>
<volume>4</volume>
<issue>1</issue>
<fpage>60</fpage>
<lpage>72</lpage>
<comment>[http://dx.doi.org/10.1016/j.cels.2016.11.006].</comment>
<pub-id pub-id-type="pmid">27989508</pub-id>
</element-citation>
</ref>
<ref id="r202">
<label>202</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Litvinchuk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>Y.W.</given-names>
</name>
<name>
<surname>Swartzlander</surname>
<given-names>D.B.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Propson</surname>
<given-names>N.E.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer’s Disease.</article-title>
<source/>Neuron
          <year>2018</year>
<volume>100</volume>
<issue>6</issue>
<fpage>1337</fpage>
<lpage>1353</lpage>
<comment>[http://dx.doi.org/10.1016/j.neuron.2018.10.031].</comment>
<pub-id pub-id-type="pmid">30415998</pub-id>
</element-citation>
</ref>
<ref id="r203">
<label>203</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>What does complement do in Alzheimer’s disease? Old molecules with new insights.</article-title>
<source/>Transl. Neurodegener.
          <year>2013</year>
<volume>2</volume>
<issue>1</issue>
<fpage>21</fpage>
<comment>[http://dx.doi.org/10.1186/2047-9158-2-21]. [PMID: 24119446].</comment>
<pub-id pub-id-type="pmid">24119446</pub-id>
</element-citation>
</ref>
<ref id="r204">
<label>204</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keren-Shaul</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Spinrad</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Weiner</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Matcovitch-Natan</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Dvir-Szternfeld</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ulland</surname>
<given-names>T.K.</given-names>
</name>
<name>
<surname>David</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Baruch</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lara-Astaiso</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Toth</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Itzkovitz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Colonna</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Amit</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease.</article-title>
<source/>Cell
          <year>2017</year>
<volume>169</volume>
<issue>7</issue>
<fpage>1276</fpage>
<lpage>1290</lpage>
<comment>[http://dx.doi.org/10.1016/j.cell.2017.05.018].</comment>
<pub-id pub-id-type="pmid">28602351</pub-id>
</element-citation>
</ref>
<ref id="r205">
<label>205</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liddelow</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Guttenplan</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>F.C.</given-names>
</name>
<name>
<surname>Bohlen</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Schirmer</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Münch</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>W.S.</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Wilton</surname>
<given-names>D.K.</given-names>
</name>
<name>
<surname>Frouin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Napier</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Panicker</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Buckwalter</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Rowitch</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Dawson</surname>
<given-names>V.L.</given-names>
</name>
<name>
<surname>Dawson</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Barres</surname>
<given-names>B.A.</given-names>
</name>
</person-group>
<article-title>Neurotoxic reactive astrocytes are induced by activated microglia.</article-title>
<source/>Nature
          <year>2017</year>
<volume>541</volume>
<issue>7638</issue>
<fpage>481</fpage>
<lpage>487</lpage>
<comment>[http://dx.doi.org/10.1038/nature21029]. [PMID: 28099414].</comment>
<pub-id pub-id-type="pmid">28099414</pub-id>
</element-citation>
</ref>
<ref id="r206">
<label>206</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fonseca</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Hernandez</surname>
<given-names>M.X.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Modarresi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Selvan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>MacGregor</surname>
<given-names>G.R.</given-names>
</name>
<name>
<surname>Tenner</surname>
<given-names>A.J.</given-names>
</name>
</person-group>
<article-title>Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain.</article-title>
<source/>J. Neuroinflammation
          <year>2017</year>
<volume>14</volume>
<issue>1</issue>
<fpage>48</fpage>
<comment>[http://dx.doi.org/10.1186/s12974-017-0814-9]. [PMID: 28264694].</comment>
<pub-id pub-id-type="pmid">28264694</pub-id>
</element-citation>
</ref>
<ref id="r207">
<label>207</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bie</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Foss</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Naguib</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Activation of mGluR1 mediates C1q-dependent microglial phagocytosis of glutamatergic synapses in Alzheimer’s Rodent models.</article-title>
<source/>Mol. Neurobiol.
          <year>2019</year>
<volume>56</volume>
<issue>8</issue>
<fpage>5568</fpage>
<lpage>5585</lpage>
<comment>[http://dx.doi.org/10.1007/s12035-019-1467-8]. [PMID: 30652266].</comment>
<pub-id pub-id-type="pmid">30652266</pub-id>
</element-citation>
</ref>
<ref id="r208">
<label>208</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Louneva</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>L.Y.</given-names>
</name>
<name>
<surname>Talbot</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Trojanowski</surname>
<given-names>J.Q.</given-names>
</name>
<name>
<surname>Arnold</surname>
<given-names>S.E.</given-names>
</name>
</person-group>
<article-title>Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer’s disease.</article-title>
<source/>Am. J. Pathol.
          <year>2008</year>
<volume>173</volume>
<issue>5</issue>
<fpage>1488</fpage>
<lpage>1495</lpage>
<comment>[http://dx.doi.org/10.2353/ajpath.2008.080434]. [PMID: 18818379].</comment>
<pub-id pub-id-type="pmid">18818379</pub-id>
</element-citation>
</ref>
<ref id="r209">
<label>209</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>D’Amelio</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cavallucci</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Middei</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Marchetti</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pacioni</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ferri</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Diamantini</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>De Zio</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Carrara</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Battistini</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Moreno</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bacci</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ammassari-Teule</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Marie</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cecconi</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer’s disease.</article-title>
<source/>Nat. Neurosci.
          <year>2011</year>
<volume>14</volume>
<issue>1</issue>
<fpage>69</fpage>
<lpage>76</lpage>
<comment>[http://dx.doi.org/10.1038/nn.2709]. [PMID: 21151119].</comment>
<pub-id pub-id-type="pmid">21151119</pub-id>
</element-citation>
</ref>
<ref id="r210">
<label>210</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Vidal</surname>
<given-names>G.S.</given-names>
</name>
<name>
<surname>Djurisic</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>William</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Birnbaum</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>K.C.</given-names>
</name>
<name>
<surname>Hyman</surname>
<given-names>B.T.</given-names>
</name>
<name>
<surname>Shatz</surname>
<given-names>C.J.</given-names>
</name>
</person-group>
<article-title>Human LilrB2 is a β-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer’s model.</article-title>
<source/>Science
          <year>2013</year>
<volume>341</volume>
<issue>6152</issue>
<fpage>1399</fpage>
<lpage>1404</lpage>
<comment>[http://dx.doi.org/10.1126/science.1242077]. [PMID: 24052308].</comment>
<pub-id pub-id-type="pmid">24052308</pub-id>
</element-citation>
</ref>
<ref id="r211">
<label>211</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chapuis</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hot</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hansmannel</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kerdraon</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hubans</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Maurage</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Huot</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bensemain</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Laumet</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ayral</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Fievet</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hauw</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>DeKosky</surname>
<given-names>S.T.</given-names>
</name>
<name>
<surname>Lemoine</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Iwatsubo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wavrant-Devrièze</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Dartigues</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Tzourio</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Buée</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pasquier</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Berr</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lendon</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Alpérovitch</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kamboh</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Amouyel</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lambert</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer’s disease.</article-title>
<source/>Mol. Psychiatry
          <year>2009</year>
<volume>14</volume>
<issue>11</issue>
<fpage>1004</fpage>
<lpage>1016</lpage>
<comment>[http://dx.doi.org/10.1038/mp.2009.10]. [PMID: 19204726].</comment>
<pub-id pub-id-type="pmid">19204726</pub-id>
</element-citation>
</ref>
<ref id="r212">
<label>212</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>K.W.</given-names>
</name>
<name>
<surname>Yuen</surname>
<given-names>M.Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Mak</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>I.C.</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>W.Y.</given-names>
</name>
<name>
<surname>Liew</surname>
<given-names>F.Y.</given-names>
</name>
<name>
<surname>Ip</surname>
<given-names>N.Y.</given-names>
</name>
</person-group>
<article-title>IL-33 ameliorates Alzheimer’s disease-like pathology and cognitive decline.</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2016</year>
<volume>113</volume>
<issue>19</issue>
<fpage>E2705</fpage>
<lpage>E2713</lpage>
<comment>[http://dx.doi.org/10.1073/pnas.1604032113]. [PMID: 27091974].</comment>
<pub-id pub-id-type="pmid">27091974</pub-id>
</element-citation>
</ref>
<ref id="r213">
<label>213</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>Q.L.</given-names>
</name>
<name>
<surname>Teng</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Zuo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Teter</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>E.Y.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bilousova</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gylys</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Apostolova</surname>
<given-names>L.G.</given-names>
</name>
<name>
<surname>LaDu</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Hossain</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Frautschy</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>G.M.</given-names>
</name>
</person-group>
<article-title>Neuronal pentraxin 1: A synaptic-derived plasma biomarker in Alzheimer’s disease.</article-title>
<source/>Neurobiol. Dis.
          <year>2018</year>
<volume>114</volume>
<fpage>120</fpage>
<lpage>128</lpage>
<comment>[http://dx.doi.org/10.1016/j.nbd.2018.02.014]. [PMID: 29501530].</comment>
<pub-id pub-id-type="pmid">29501530</pub-id>
</element-citation>
</ref>
<ref id="r214">
<label>214</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abad</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Enguita</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>DeGregorio-Rocasolano</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ferrer</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Trullas</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Neuronal pentraxin 1 contributes to the neuronal damage evoked by amyloid-beta and is overexpressed in dystrophic neurites in Alzheimer’s brain.</article-title>
<source/>J. Neurosci.
          <year>2006</year>
<volume>26</volume>
<issue>49</issue>
<fpage>12735</fpage>
<lpage>12747</lpage>
<comment>[http://dx.doi.org/10.1523/JNEUROSCI.0575-06.2006]. [PMID: 17151277].</comment>
<pub-id pub-id-type="pmid">17151277</pub-id>
</element-citation>
</ref>
<ref id="r215">
<label>215</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suarez-Calvet</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Capell</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Araque Caballero</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Morenas-Rodriguez</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Fellerer</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Franzmeier</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Klein-berger</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Eren</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Deming</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Piccio</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Karch</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Cruchaga</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Paumier</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bateman</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Fagan</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Mor-ris</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Levin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Danek</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jucker</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Masters</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Rossor</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Ringman</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Trojanowski</surname>
<given-names>J.Q.</given-names>
</name>
<name>
<surname>Weiner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ewers</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Haass</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dominantly Inherited Alzheimer</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Alzheimer’s Disease Neuroimaging, I., CSF progranulin increases in the course of Alzheimer’s disease and is associated with sTREM2, neurodegeneration and cog-nitive decline.</article-title>
<source/>EMBO Mol. Med.
          <year>2018</year>
<volume>10</volume>
<issue>12</issue>
<comment>[http://dx.doi.org/10.15252/emmm.201809712]. [PMID: 30482868].</comment>
</element-citation>
</ref>
<ref id="r216">
<label>216</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cooper</surname>
<given-names>Y.A.</given-names>
</name>
<name>
<surname>Nachun</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dokuru</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Karydas</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Serrero</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Yue</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Alzheimer’s Disease Neuroimag-ing, I.; Boxer, A. L.; Miller, B. L.; Coppola, G., Progranulin levels in blood in Alzheimer’s disease and mild cognitive im-pairment.</article-title>
<source/>Ann. Clin. Transl. Neurol.
          <year>2018</year>
<volume>5</volume>
<issue>5</issue>
<fpage>616</fpage>
<lpage>629</lpage>
<comment>[http://dx.doi.org/10.1002/acn3.560]. [PMID: 29761124].</comment>
<pub-id pub-id-type="pmid">29761124</pub-id>
</element-citation>
</ref>
<ref id="r217">
<label>217</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Minami</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Krabbe</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Asgarov</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Martens</surname>
<given-names>L.H.</given-names>
</name>
<name>
<surname>Elia</surname>
<given-names>L.P.</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Mucke</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Farese</surname>
<given-names>R.V.</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Gan</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Progranulin protects against amyloid β deposition and toxicity in Alzheimer’s disease mouse models.</article-title>
<source/>Nat. Med.
          <year>2014</year>
<volume>20</volume>
<issue>10</issue>
<fpage>1157</fpage>
<lpage>1164</lpage>
<comment>[http://dx.doi.org/10.1038/nm.3672]. [PMID: 25261995].</comment>
<pub-id pub-id-type="pmid">25261995</pub-id>
</element-citation>
</ref>
<ref id="r218">
<label>218</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takahashi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>Z.A.</given-names>
</name>
<name>
<surname>Bhagat</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Kaufman</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Kostylev</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Ikezu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Strittmatter</surname>
<given-names>S.M.</given-names>
</name>
</person-group>
<article-title>Alzheimer’s Disease Neuroimaging, I. Opposing effects of progranulin de-ficiency on amyloid and tau pathologies <italic>via</italic> microglial TYROBP network.</article-title>
<source/>Acta Neuropathol.
          <year>2017</year>
<volume>133</volume>
<issue>5</issue>
<fpage>785</fpage>
<lpage>807</lpage>
<comment>[http://dx.doi.org/10.1007/s00401-017-1668-z]. [PMID: 28070672].</comment>
<pub-id pub-id-type="pmid">28070672</pub-id>
</element-citation>
</ref>
<ref id="r219">
<label>219</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perea</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Lleó</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Alcolea</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Fortea</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ávila</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bolós</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Decreased CX3CL1 levels in the Cerebrospinal fluid of patients With Alzheimer’s Disease.</article-title>
<source/>Front. Neurosci.
          <year>2018</year>
<volume>12</volume>
<fpage>609</fpage>
<comment>[http://dx.doi.org/10.3389/fnins.2018.00609]. [PMID: 30245615].</comment>
<pub-id pub-id-type="pmid">30245615</pub-id>
</element-citation>
</ref>
<ref id="r220">
<label>220</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cho</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kauppinen</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Halabisky</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wes</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ransohoff</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Gan</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease.</article-title>
<source/>J. Biol. Chem.
          <year>2011</year>
<volume>286</volume>
<issue>37</issue>
<fpage>32713</fpage>
<lpage>32722</lpage>
<comment>[http://dx.doi.org/10.1074/jbc.M111.254268]. [PMID: 21771791].</comment>
<pub-id pub-id-type="pmid">21771791</pub-id>
</element-citation>
</ref>
<ref id="r221">
<label>221</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Jay</surname>
<given-names>T.R.</given-names>
</name>
<name>
<surname>Bhatta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K.W.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Landreth</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>Ransohoff</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Lamb</surname>
<given-names>B.T.</given-names>
</name>
</person-group>
<article-title>Opposing effects of membrane-anchored CX3CL1 on amyloid and tau pathologies <italic>via</italic> the p38 MAPK pathway.</article-title>
<source/>J. Neurosci.
          <year>2014</year>
<volume>34</volume>
<issue>37</issue>
<fpage>12538</fpage>
<lpage>12546</lpage>
<comment>[http://dx.doi.org/10.1523/JNEUROSCI.0853-14.2014]. [PMID: 25209291].</comment>
<pub-id pub-id-type="pmid">25209291</pub-id>
</element-citation>
</ref>
<ref id="r222">
<label>222</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Varvel</surname>
<given-names>N.H.</given-names>
</name>
<name>
<surname>Konerth</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cardona</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Ransohoff</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Lamb</surname>
<given-names>B.T.</given-names>
</name>
</person-group>
<article-title>CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer’s disease mouse models.</article-title>
<source/>Am. J. Pathol.
          <year>2010</year>
<volume>177</volume>
<issue>5</issue>
<fpage>2549</fpage>
<lpage>2562</lpage>
<comment>[http://dx.doi.org/10.2353/ajpath.2010.100265]. [PMID: 20864679].</comment>
<pub-id pub-id-type="pmid">20864679</pub-id>
</element-citation>
</ref>
<ref id="r223">
<label>223</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Na</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Activation of CaMKIV by soluble amyloid-β<sub>1-42</sub> impedes trafficking of axonal vesicles and impairs activity-dependent synaptogenesis.</article-title>
<source/>Sci. Signal.
          <year>2017</year>
<volume>10</volume>
<issue>487</issue>
<elocation-id>eaam8661</elocation-id>
<comment>[PMID: 28698220].</comment>
<pub-id pub-id-type="pmid">28698220</pub-id>
</element-citation>
</ref>
<ref id="r224">
<label>224</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levi</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Jongen-Relo</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Feldon</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Roses</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Michaelson</surname>
<given-names>D.M.</given-names>
</name>
</person-group>
<article-title>ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory.</article-title>
<source/>Neurobiol. Dis.
          <year>2003</year>
<volume>13</volume>
<issue>3</issue>
<fpage>273</fpage>
<lpage>282</lpage>
<comment>[http://dx.doi.org/10.1016/S0969-9961(03)00045-7]. [PMID: 12901842].</comment>
<pub-id pub-id-type="pmid">12901842</pub-id>
</element-citation>
</ref>
<ref id="r225">
<label>225</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Kampen</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Kay</surname>
<given-names>D.G.</given-names>
</name>
</person-group>
<article-title>Progranulin gene delivery reduces plaque burden and synaptic atrophy in a mouse model of Alzheimer’s disease.</article-title>
<source/>PLoS One
          <year>2017</year>
<volume>12</volume>
<issue>8</issue>
<elocation-id>e0182896</elocation-id>
<comment>[http://dx.doi.org/10.1371/journal.pone.0182896]. [PMID: 28837568].</comment>
<pub-id pub-id-type="pmid">28837568</pub-id>
</element-citation>
</ref>
<ref id="r226">
<label>226</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sakata</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L.Q.</given-names>
</name>
<name>
<surname>Heldt</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>F.F.</given-names>
</name>
</person-group>
<article-title>Hsp90 chaperone inhibitor 17-AAG attenuates Abeta-induced synaptic toxicity and memory impairment.</article-title>
<source/>J. Neurosci.
          <year>2014</year>
<volume>34</volume>
<issue>7</issue>
<fpage>2464</fpage>
<lpage>2470</lpage>
<pub-id pub-id-type="pmid">24523537</pub-id>
</element-citation>
</ref>
<ref id="r227">
<label>227</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Resveratrol ameliorates spatial learning memory impairment induced by Aβ<sub>1-42</sub> in rats.</article-title>
<source/>Neuroscience
          <year>2017</year>
<volume>344</volume>
<fpage>39</fpage>
<lpage>47</lpage>
<comment>[http://dx.doi.org/10.1016/j.neuroscience.2016.08.051]. [PMID: 27600946].</comment>
<pub-id pub-id-type="pmid">27600946</pub-id>
</element-citation>
</ref>
<ref id="r228">
<label>228</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kodali</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Parihar</surname>
<given-names>V.K.</given-names>
</name>
<name>
<surname>Hattiangady</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Mishra</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Shuai</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Shetty</surname>
<given-names>A.K.</given-names>
</name>
</person-group>
<article-title>Resveratrol prevents age-related memory and mood dysfunction with increased hippocampal neurogenesis and microvasculature, and reduced glial activation.</article-title>
<source/>Sci. Rep.
          <year>2015</year>
<volume>5</volume>
<fpage>8075</fpage>
<comment>[http://dx.doi.org/10.1038/srep08075]. [PMID: 25627672].</comment>
<pub-id pub-id-type="pmid">25627672</pub-id>
</element-citation>
</ref>
<ref id="r229">
<label>229</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Inhibitive Effect of Resveratrol on the Inflammation in Cultured Astrocytes and Microglia Induced by Aβ<sub>1-42</sub>.</article-title>
<source/>Neuroscience
          <year>2018</year>
<volume>379</volume>
<fpage>390</fpage>
<lpage>404</lpage>
<comment>[http://dx.doi.org/10.1016/j.neuroscience.2018.03.047]. [PMID: 29627302].</comment>
<pub-id pub-id-type="pmid">29627302</pub-id>
</element-citation>
</ref>
<ref id="r230">
<label>230</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Craft</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>L.D.</given-names>
</name>
<name>
<surname>Montine</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Minoshima</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>G.S.</given-names>
</name>
<name>
<surname>Claxton</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Arbuckle</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Callaghan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Plymate</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>P.S.</given-names>
</name>
<name>
<surname>Leverenz</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cross</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gerton</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.</article-title>
<source/>Arch. Neurol.
          <year>2012</year>
<volume>69</volume>
<issue>1</issue>
<fpage>29</fpage>
<lpage>38</lpage>
<comment>[http://dx.doi.org/10.1001/archneurol.2011.233]. [PMID: 21911655].</comment>
<pub-id pub-id-type="pmid">21911655</pub-id>
</element-citation>
</ref>
<ref id="r231">
<label>231</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Felice</surname>
<given-names>F.G.</given-names>
</name>
<name>
<surname>Vieira</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Bomfim</surname>
<given-names>T.R.</given-names>
</name>
<name>
<surname>Decker</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Velasco</surname>
<given-names>P.T.</given-names>
</name>
<name>
<surname>Lambert</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Viola</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W.Q.</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>S.T.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>W.L.</given-names>
</name>
</person-group>
<article-title>Protection of synapses against Alzheimer’s-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers.</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2009</year>
<volume>106</volume>
<issue>6</issue>
<fpage>1971</fpage>
<lpage>1976</lpage>
<comment>[http://dx.doi.org/10.1073/pnas.0809158106]. [PMID: 19188609].</comment>
<pub-id pub-id-type="pmid">19188609</pub-id>
</element-citation>
</ref>
<ref id="r232">
<label>232</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Baranzini</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Geurts</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hemmer</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ciccarelli</surname>
<given-names>O.</given-names>
</name>
</person-group>
<article-title>Multiple sclerosis.</article-title>
<source/>Lancet
          <year>2018</year>
<volume>391</volume>
<issue>10130</issue>
<fpage>1622</fpage>
<lpage>1636</lpage>
<comment>[http://dx.doi.org/10.1016/S0140-6736(18)30481-1]. [PMID: 29576504].</comment>
<pub-id pub-id-type="pmid">29576504</pub-id>
</element-citation>
</ref>
<ref id="r233">
<label>233</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reich</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Lucchinetti</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Calabresi</surname>
<given-names>P.A.</given-names>
</name>
</person-group>
<article-title>Multiple Sclerosis.</article-title>
<source/>N. Engl. J. Med.
          <year>2018</year>
<volume>378</volume>
<issue>2</issue>
<fpage>169</fpage>
<lpage>180</lpage>
<comment>[http://dx.doi.org/10.1056/NEJMra1401483]. [PMID: 29320652].</comment>
<pub-id pub-id-type="pmid">29320652</pub-id>
</element-citation>
</ref>
<ref id="r234">
<label>234</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Filippo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>de Iure</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Durante</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Gaetani</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mancini</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sarchielli</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Calabresi</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Synaptic plasticity and experimental autoimmune encephalomyelitis: implications for multiple sclerosis.</article-title>
<source/>Brain Res.
          <year>2015</year>
<volume>1621</volume>
<fpage>205</fpage>
<lpage>213</lpage>
<comment>[http://dx.doi.org/10.1016/j.brainres.2014.12.004]. [PMID: 25498984].</comment>
<pub-id pub-id-type="pmid">25498984</pub-id>
</element-citation>
</ref>
<ref id="r235">
<label>235</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mandolesi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gentile</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Musella</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fresegna</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>De Vito</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bullitta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sepman</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Marfia</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Centonze</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis.</article-title>
<source/>Nat. Rev. Neurol.
          <year>2015</year>
<volume>11</volume>
<issue>12</issue>
<fpage>711</fpage>
<lpage>724</lpage>
<comment>[http://dx.doi.org/10.1038/nrneurol.2015.222]. [PMID: 26585978].</comment>
<pub-id pub-id-type="pmid">26585978</pub-id>
</element-citation>
</ref>
<ref id="r236">
<label>236</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruano</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Portaccio</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Goretti</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Niccolai</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Severo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Patti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cilia</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gallo</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Grossi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ghezzi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Roscio</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mattioli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Stampatori</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Trojano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Viterbo</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Amato</surname>
<given-names>M.P.</given-names>
</name>
</person-group>
<article-title>Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes.</article-title>
<source/>Mult. Scler.
          <year>2017</year>
<volume>23</volume>
<issue>9</issue>
<fpage>1258</fpage>
<lpage>1267</lpage>
<comment>[http://dx.doi.org/10.1177/1352458516674367]. [PMID: 27738090].</comment>
<pub-id pub-id-type="pmid">27738090</pub-id>
</element-citation>
</ref>
<ref id="r237">
<label>237</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Achiron</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Polliack</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Barak</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lavie</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Appelboim</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Harel</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves.</article-title>
<source/>J. Neurol. Neurosurg. Psychiatry
          <year>2005</year>
<volume>76</volume>
<issue>5</issue>
<fpage>744</fpage>
<lpage>749</lpage>
<comment>[http://dx.doi.org/10.1136/jnnp.2004.045518]. [PMID: 15834042].</comment>
<pub-id pub-id-type="pmid">15834042</pub-id>
</element-citation>
</ref>
<ref id="r238">
<label>238</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Centonze</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Muzio</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cavasinni</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>De Chiara</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Bergami</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Musella</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>D’Amelio</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cavallucci</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Martorana</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bergamaschi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cencioni</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Diamantini</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Butti</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Comi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bernardi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cecconi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Battistini</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Furlan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Martino</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis.</article-title>
<source/>J. Neurosci.
          <year>2009</year>
<volume>29</volume>
<issue>11</issue>
<fpage>3442</fpage>
<lpage>3452</lpage>
<comment>[http://dx.doi.org/10.1523/JNEUROSCI.5804-08.2009]. [PMID: 19295150].</comment>
<pub-id pub-id-type="pmid">19295150</pub-id>
</element-citation>
</ref>
<ref id="r239">
<label>239</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Motta</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Studer</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Barbieri</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Buttari</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bergami</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sancesario</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bernardini</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>De Angelis</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Martino</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Furlan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Centonze</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration.</article-title>
<source/>Mult. Scler.
          <year>2014</year>
<volume>20</volume>
<issue>3</issue>
<fpage>304</fpage>
<lpage>312</lpage>
<comment>[http://dx.doi.org/10.1177/1352458513498128]. [PMID: 23886826].</comment>
<pub-id pub-id-type="pmid">23886826</pub-id>
</element-citation>
</ref>
<ref id="r240">
<label>240</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>D.Y.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>F.D.</given-names>
</name>
<name>
<surname>Rho</surname>
<given-names>J.M.</given-names>
</name>
</person-group>
<article-title>Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis.</article-title>
<source/>PLoS One
          <year>2012</year>
<volume>7</volume>
<issue>5</issue>
<elocation-id>e35476</elocation-id>
<comment>[http://dx.doi.org/10.1371/journal.pone.0035476]. [PMID: 22567104].</comment>
<pub-id pub-id-type="pmid">22567104</pub-id>
</element-citation>
</ref>
<ref id="r241">
<label>241</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeLuca</surname>
<given-names>G.C.</given-names>
</name>
<name>
<surname>Yates</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Beale</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Morrow</surname>
<given-names>S.A.</given-names>
</name>
</person-group>
<article-title>Cognitive impairment in multiple sclerosis: clinical, radiologic and pathologic insights.</article-title>
<source/>Brain Pathol.
          <year>2015</year>
<volume>25</volume>
<issue>1</issue>
<fpage>79</fpage>
<lpage>98</lpage>
<comment>[http://dx.doi.org/10.1111/bpa.12220]. [PMID: 25521179].</comment>
<pub-id pub-id-type="pmid">25521179</pub-id>
</element-citation>
</ref>
<ref id="r242">
<label>242</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pitt</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Werner</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Raine</surname>
<given-names>C.S.</given-names>
</name>
</person-group>
<article-title>Glutamate excitotoxicity in a model of multiple sclerosis.</article-title>
<source/>Nat. Med.
          <year>2000</year>
<volume>6</volume>
<issue>1</issue>
<fpage>67</fpage>
<lpage>70</lpage>
<comment>[http://dx.doi.org/10.1038/71555]. [PMID: 10613826].</comment>
<pub-id pub-id-type="pmid">10613826</pub-id>
</element-citation>
</ref>
<ref id="r243">
<label>243</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calabrese</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Agosta</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Rinaldi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mattisi</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Grossi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Favaretto</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Atzori</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bernardi</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Barachino</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rinaldi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Perini</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gallo</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Filippi</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.</article-title>
<source/>Arch. Neurol.
          <year>2009</year>
<volume>66</volume>
<issue>9</issue>
<fpage>1144</fpage>
<lpage>1150</lpage>
<comment>[http://dx.doi.org/10.1001/archneurol.2009.174]. [PMID: 19752305].</comment>
<pub-id pub-id-type="pmid">19752305</pub-id>
</element-citation>
</ref>
<ref id="r244">
<label>244</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Batista</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zivadinov</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hoogs</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bergsland</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Heininen-Brown</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dwyer</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Weinstock-Guttman</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Benedict</surname>
<given-names>R.H.</given-names>
</name>
</person-group>
<article-title>Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis.</article-title>
<source/>J. Neurol.
          <year>2012</year>
<volume>259</volume>
<issue>1</issue>
<fpage>139</fpage>
<lpage>146</lpage>
<comment>[http://dx.doi.org/10.1007/s00415-011-6147-1]. [PMID: 21720932].</comment>
<pub-id pub-id-type="pmid">21720932</pub-id>
</element-citation>
</ref>
<ref id="r245">
<label>245</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergsland</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Zivadinov</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dwyer</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Weinstock-Guttman</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Benedict</surname>
<given-names>R.H.</given-names>
</name>
</person-group>
<article-title>Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients.</article-title>
<source/>Mult. Scler.
          <year>2016</year>
<volume>22</volume>
<issue>10</issue>
<fpage>1327</fpage>
<lpage>1336</lpage>
<comment>[http://dx.doi.org/10.1177/1352458515616204]. [PMID: 26541795].</comment>
<pub-id pub-id-type="pmid">26541795</pub-id>
</element-citation>
</ref>
<ref id="r246">
<label>246</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steenwijk</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Geurts</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Daams</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tijms</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Wink</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Balk</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Tewarie</surname>
<given-names>P.K.</given-names>
</name>
<name>
<surname>Uitdehaag</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Barkhof</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Vrenken</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Pouwels</surname>
<given-names>P.J.</given-names>
</name>
</person-group>
<article-title>Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.</article-title>
<source/>Brain
          <year>2016</year>
<volume>139</volume>
<issue>Pt 1</issue>
<fpage>115</fpage>
<lpage>126</lpage>
<comment>[http://dx.doi.org/10.1093/brain/awv337]. [PMID: 26637488].</comment>
<pub-id pub-id-type="pmid">26637488</pub-id>
</element-citation>
</ref>
<ref id="r247">
<label>247</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cocozza</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Petracca</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mormina</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Buyukturkoglu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Podranski</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Heinig</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Pontillo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Russo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tedeschi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Russo</surname>
<given-names>C.V.</given-names>
</name>
<name>
<surname>Costabile</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lanzillo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Harel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Klineova</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Brunetti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Morra</surname>
<given-names>V.B.</given-names>
</name>
<name>
<surname>Lublin</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Inglese</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Cerebellar lobule atrophy and disability in progressive MS.</article-title>
<source/>J. Neurol. Neurosurg. Psychiatry
          <year>2017</year>
<volume>88</volume>
<issue>12</issue>
<fpage>1065</fpage>
<lpage>1072</lpage>
<comment>[http://dx.doi.org/10.1136/jnnp-2017-316448]. [PMID: 28844067].</comment>
<pub-id pub-id-type="pmid">28844067</pub-id>
</element-citation>
</ref>
<ref id="r248">
<label>248</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Batista</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>d’Almeida</surname>
<given-names>O.C.</given-names>
</name>
<name>
<surname>Afonso</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Freitas</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Macário</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sousa</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Castelo-Branco</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Santana</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Cunha</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Impairment of social cognition in multiple sclerosis: Amygdala atrophy is the main predictor.</article-title>
<source/>Mult. Scler.
          <year>2017</year>
<volume>23</volume>
<issue>10</issue>
<fpage>1358</fpage>
<lpage>1366</lpage>
<comment>[http://dx.doi.org/10.1177/1352458516680750]. [PMID: 28273767].</comment>
<pub-id pub-id-type="pmid">28273767</pub-id>
</element-citation>
</ref>
<ref id="r249">
<label>249</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sicotte</surname>
<given-names>N.L.</given-names>
</name>
<name>
<surname>Kern</surname>
<given-names>K.C.</given-names>
</name>
<name>
<surname>Giesser</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Arshanapalli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schultz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Montag</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bookheimer</surname>
<given-names>S.Y.</given-names>
</name>
</person-group>
<article-title>Regional hippocampal atrophy in multiple sclerosis.</article-title>
<source/>Brain
          <year>2008</year>
<volume>131</volume>
<issue>Pt 4</issue>
<fpage>1134</fpage>
<lpage>1141</lpage>
<comment>[http://dx.doi.org/10.1093/brain/awn030]. [PMID: 18375977].</comment>
<pub-id pub-id-type="pmid">18375977</pub-id>
</element-citation>
</ref>
<ref id="r250">
<label>250</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ziehn</surname>
<given-names>M.O.</given-names>
</name>
<name>
<surname>Avedisian</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Tiwari-Woodruff</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Voskuhl</surname>
<given-names>R.R.</given-names>
</name>
</person-group>
<article-title>Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE.</article-title>
<source/>Lab. Invest.
          <year>2010</year>
<volume>90</volume>
<issue>5</issue>
<fpage>774</fpage>
<lpage>786</lpage>
<comment>[http://dx.doi.org/10.1038/labinvest.2010.6]. [PMID: 20157291].</comment>
<pub-id pub-id-type="pmid">20157291</pub-id>
</element-citation>
</ref>
<ref id="r251">
<label>251</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wegner</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Esiri</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Chance</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Palace</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Matthews</surname>
<given-names>P.M.</given-names>
</name>
</person-group>
<article-title>Neocortical neuronal, synaptic, and glial loss in multiple sclerosis.</article-title>
<source/>Neurology
          <year>2006</year>
<volume>67</volume>
<issue>6</issue>
<fpage>960</fpage>
<lpage>967</lpage>
<comment>[http://dx.doi.org/10.1212/01.wnl.0000237551.26858.39]. [PMID: 17000961].</comment>
<pub-id pub-id-type="pmid">17000961</pub-id>
</element-citation>
</ref>
<ref id="r252">
<label>252</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Magliozzi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Howell</surname>
<given-names>O.W.</given-names>
</name>
<name>
<surname>Reeves</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Roncaroli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Nicholas</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Serafini</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Aloisi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis.</article-title>
<source/>Ann. Neurol.
          <year>2010</year>
<volume>68</volume>
<issue>4</issue>
<fpage>477</fpage>
<lpage>493</lpage>
<comment>[http://dx.doi.org/10.1002/ana.22230]. [PMID: 20976767].</comment>
<pub-id pub-id-type="pmid">20976767</pub-id>
</element-citation>
</ref>
<ref id="r253">
<label>253</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peterson</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Bö</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mörk</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Trapp</surname>
<given-names>B.D.</given-names>
</name>
</person-group>
<article-title>Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.</article-title>
<source/>Ann. Neurol.
          <year>2001</year>
<volume>50</volume>
<issue>3</issue>
<fpage>389</fpage>
<lpage>400</lpage>
<comment>[http://dx.doi.org/10.1002/ana.1123]. [PMID: 11558796].</comment>
<pub-id pub-id-type="pmid">11558796</pub-id>
</element-citation>
</ref>
<ref id="r254">
<label>254</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jurewicz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Matysiak</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tybor</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kilianek</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Raine</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Selmaj</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Tumour necrosis factor-induced death of adult human oligodendrocytes is mediated by apoptosis inducing factor.</article-title>
<source/>Brain
          <year>2005</year>
<volume>128</volume>
<issue>Pt 11</issue>
<fpage>2675</fpage>
<lpage>2688</lpage>
<comment>[http://dx.doi.org/10.1093/brain/awh627]. [PMID: 16219674].</comment>
<pub-id pub-id-type="pmid">16219674</pub-id>
</element-citation>
</ref>
<ref id="r255">
<label>255</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vartanian</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Stefansson</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis.</article-title>
<source/>Mol. Med.
          <year>1995</year>
<volume>1</volume>
<issue>7</issue>
<fpage>732</fpage>
<lpage>743</lpage>
<comment>[http://dx.doi.org/10.1007/BF03401888]. [PMID: 8612196].</comment>
<pub-id pub-id-type="pmid">8612196</pub-id>
</element-citation>
</ref>
<ref id="r256">
<label>256</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takeuchi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kawanokuchi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mitsuma</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Mizuno</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Suzumura</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Interferon-gamma induces microglial-activation-induced cell death: a hypothetical mechanism of relapse and remission in multiple sclerosis.</article-title>
<source/>Neurobiol. Dis.
          <year>2006</year>
<volume>22</volume>
<issue>1</issue>
<fpage>33</fpage>
<lpage>39</lpage>
<comment>[http://dx.doi.org/10.1016/j.nbd.2005.09.014]. [PMID: 16386911].</comment>
<pub-id pub-id-type="pmid">16386911</pub-id>
</element-citation>
</ref>
<ref id="r257">
<label>257</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Motta</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Studer</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Macchiarulo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Volpe</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Barbieri</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ruocco</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Buttari</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Finardi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mancino</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Battistini</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Martino</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Furlan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Drulovic</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Centonze</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53.</article-title>
<source/>Mol. Neurodegener.
          <year>2014</year>
<volume>9</volume>
<fpage>56</fpage>
<comment>[http://dx.doi.org/10.1186/1750-1326-9-56]. [PMID: 25495224].</comment>
<pub-id pub-id-type="pmid">25495224</pub-id>
</element-citation>
</ref>
<ref id="r258">
<label>258</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilgun-Sherki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Melamed</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Offen</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy.</article-title>
<source/>J. Neurol.
          <year>2004</year>
<volume>251</volume>
<issue>3</issue>
<fpage>261</fpage>
<lpage>268</lpage>
<comment>[http://dx.doi.org/10.1007/s00415-004-0348-9]. [PMID: 15015004].</comment>
<pub-id pub-id-type="pmid">15015004</pub-id>
</element-citation>
</ref>
<ref id="r259">
<label>259</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nataf</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Carroll</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Wetsel</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Szalai</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Barnum</surname>
<given-names>S.R.</given-names>
</name>
</person-group>
<article-title>Attenuation of experimental autoimmune demyelination in complement-deficient mice.</article-title>
<source/>J. Immunol.
          <year>2000</year>
<volume>165</volume>
<issue>10</issue>
<fpage>5867</fpage>
<lpage>5873</lpage>
<comment>[http://dx.doi.org/10.4049/jimmunol.165.10.5867]. [PMID: 11067947].</comment>
<pub-id pub-id-type="pmid">11067947</pub-id>
</element-citation>
</ref>
<ref id="r260">
<label>260</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szalai</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Barnum</surname>
<given-names>S.R.</given-names>
</name>
</person-group>
<article-title>Complement in experimental autoimmune encephalomyelitis revisited: C3 is required for development of maximal disease.</article-title>
<source/>Mol. Immunol.
          <year>2007</year>
<volume>44</volume>
<issue>12</issue>
<fpage>3132</fpage>
<lpage>3136</lpage>
<comment>[http://dx.doi.org/10.1016/j.molimm.2007.02.002]. [PMID: 17353050].</comment>
<pub-id pub-id-type="pmid">17353050</pub-id>
</element-citation>
</ref>
<ref id="r261">
<label>261</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roostaei</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sadaghiani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mashhadi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Falahatian</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mohamadi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Javadian</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nazeri</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Doosti</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Naser Moghadasi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Owji</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hashemi Taheri</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Shakouri Rad</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Azimi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Voineskos</surname>
<given-names>A.N.</given-names>
</name>
<name>
<surname>Nazeri</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sahraian</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Convergent effects of a functional C3 variant on brain atrophy, demyelination, and cognitive impairment in multiple sclerosis.</article-title>
<source/>Mult. Scler.
          <year>2018</year>
<elocation-id>1352458518760715</elocation-id>
<comment>[PMID: 29485352].</comment>
</element-citation>
</ref>
<ref id="r262">
<label>262</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niculescu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Weerth</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Niculescu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cudrici</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rus</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Raine</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Rus</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Effects of complement C5 on apoptosis in experimental autoimmune encephalomyelitis.</article-title>
<source/>J. Immunol.
          <year>2004</year>
<volume>172</volume>
<issue>9</issue>
<fpage>5702</fpage>
<lpage>5706</lpage>
<comment>[http://dx.doi.org/10.4049/jimmunol.172.9.5702]. [PMID: 15100315].</comment>
<pub-id pub-id-type="pmid">15100315</pub-id>
</element-citation>
</ref>
<ref id="r263">
<label>263</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watkins</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Neal</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Loveless</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Michailidou</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ramaglia</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Rees</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>N.P.</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>B.P.</given-names>
</name>
<name>
<surname>Howell</surname>
<given-names>O.W.</given-names>
</name>
</person-group>
<article-title>Complement is activated in progressive multiple sclerosis cortical grey matter lesions.</article-title>
<source/>J. Neuroinflammation
          <year>2016</year>
<volume>13</volume>
<issue>1</issue>
<fpage>161</fpage>
<comment>[http://dx.doi.org/10.1186/s12974-016-0611-x]. [PMID: 27333900].</comment>
<pub-id pub-id-type="pmid">27333900</pub-id>
</element-citation>
</ref>
<ref id="r264">
<label>264</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papadopoulos</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dukes</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nicholas</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Vora</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Substantial archaeocortical atrophy and neuronal loss in multiple sclerosis.</article-title>
<source/>Brain Pathol.
          <year>2009</year>
<volume>19</volume>
<issue>2</issue>
<fpage>238</fpage>
<lpage>253</lpage>
<comment>[http://dx.doi.org/10.1111/j.1750-3639.2008.00177.x]. [PMID: 18492094].</comment>
<pub-id pub-id-type="pmid">18492094</pub-id>
</element-citation>
</ref>
<ref id="r265">
<label>265</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jürgens</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jafari</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kreutzfeldt</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bahn</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Brück</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kerschensteiner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Merkler</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis.</article-title>
<source/>Brain
          <year>2016</year>
<volume>139</volume>
<issue>Pt 1</issue>
<fpage>39</fpage>
<lpage>46</lpage>
<comment>[http://dx.doi.org/10.1093/brain/awv353]. [PMID: 26667278].</comment>
<pub-id pub-id-type="pmid">26667278</pub-id>
</element-citation>
</ref>
<ref id="r266">
<label>266</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dutta</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Doud</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Kidd</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Ribaudo</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Staugaitis</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Trapp</surname>
<given-names>B.D.</given-names>
</name>
</person-group>
<article-title>Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients.</article-title>
<source/>Ann. Neurol.
          <year>2011</year>
<volume>69</volume>
<issue>3</issue>
<fpage>445</fpage>
<lpage>454</lpage>
<comment>[http://dx.doi.org/10.1002/ana.22337]. [PMID: 21446020].</comment>
<pub-id pub-id-type="pmid">21446020</pub-id>
</element-citation>
</ref>
<ref id="r267">
<label>267</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>G.R.</given-names>
</name>
<name>
<surname>Paty</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Cynader</surname>
<given-names>M.S.</given-names>
</name>
</person-group>
<article-title>Dendritic and synaptic pathology in experimental autoimmune encephalomyelitis.</article-title>
<source/>Am. J. Pathol.
          <year>2003</year>
<volume>162</volume>
<issue>5</issue>
<fpage>1639</fpage>
<lpage>1650</lpage>
<comment>[http://dx.doi.org/10.1016/S0002-9440(10)64298-8]. [PMID: 12707048].</comment>
<pub-id pub-id-type="pmid">12707048</pub-id>
</element-citation>
</ref>
<ref id="r268">
<label>268</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michailidou</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Willems</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Kooi</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>van Eden</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gold</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Geurts</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Baas</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Huitinga</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ramaglia</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus.</article-title>
<source/>Ann. Neurol.
          <year>2015</year>
<volume>77</volume>
<issue>6</issue>
<fpage>1007</fpage>
<lpage>1026</lpage>
<comment>[http://dx.doi.org/10.1002/ana.24398]. [PMID: 25727254].</comment>
<pub-id pub-id-type="pmid">25727254</pub-id>
</element-citation>
</ref>
<ref id="r269">
<label>269</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koning</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bö</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hoek</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Huitinga</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions.</article-title>
<source/>Ann. Neurol.
          <year>2007</year>
<volume>62</volume>
<issue>5</issue>
<fpage>504</fpage>
<lpage>514</lpage>
<comment>[http://dx.doi.org/10.1002/ana.21220]. [PMID: 17879969].</comment>
<pub-id pub-id-type="pmid">17879969</pub-id>
</element-citation>
</ref>
<ref id="r270">
<label>270</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Lundgren</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Jaiswal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Garris</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Axtell</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>P.P.</given-names>
</name>
<name>
<surname>Lock</surname>
<given-names>C.B.</given-names>
</name>
<name>
<surname>Woodard</surname>
<given-names>J.I.</given-names>
</name>
<name>
<surname>Brownell</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Zoudilova</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hunt</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Baranzini</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Butcher</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Raine</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Sobel</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>D.K.</given-names>
</name>
<name>
<surname>Weissman</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Steinman</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice.</article-title>
<source/>J. Exp. Med.
          <year>2012</year>
<volume>209</volume>
<issue>7</issue>
<fpage>1325</fpage>
<lpage>1334</lpage>
<comment>[http://dx.doi.org/10.1084/jem.20101974]. [PMID: 22734047].</comment>
<pub-id pub-id-type="pmid">22734047</pub-id>
</element-citation>
</ref>
<ref id="r271">
<label>271</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freria</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Zanon</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>A.L.</given-names>
</name>
</person-group>
<article-title>Major histocompatibility complex class I expression and glial reaction influence spinal motoneuron synaptic plasticity during the course of experimental autoimmune encephalomyelitis.</article-title>
<source/>J. Comp. Neurol.
          <year>2010</year>
<volume>518</volume>
<issue>7</issue>
<fpage>990</fpage>
<lpage>1007</lpage>
<comment>[http://dx.doi.org/10.1002/cne.22259]. [PMID: 20127802].</comment>
<pub-id pub-id-type="pmid">20127802</pub-id>
</element-citation>
</ref>
<ref id="r272">
<label>272</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vercellino</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fenoglio</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Galimberti</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mattioda</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chiavazza</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Binello</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Pinessi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Giobbe</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Scarpini</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Cavalla</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Progranulin genetic polymorphisms influence progression of disability and relapse recovery in multiple sclerosis.</article-title>
<source/>Mult. Scler.
          <year>2016</year>
<volume>22</volume>
<issue>8</issue>
<fpage>1007</fpage>
<lpage>1012</lpage>
<comment>[http://dx.doi.org/10.1177/1352458515610646]. [PMID: 26447062].</comment>
<pub-id pub-id-type="pmid">26447062</pub-id>
</element-citation>
</ref>
<ref id="r273">
<label>273</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vercellino</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Grifoni</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Romagnolo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Masera</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mattioda</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Trebini</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chiavazza</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Caligiana</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Capello</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mancardi</surname>
<given-names>G.L.</given-names>
</name>
<name>
<surname>Giobbe</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mutani</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Giordana</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Cavalla</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Progranulin expression in brain tissue and cerebrospinal fluid levels in multiple sclerosis.</article-title>
<source/>Mult. Scler.
          <year>2011</year>
<volume>17</volume>
<issue>10</issue>
<fpage>1194</fpage>
<lpage>1201</lpage>
<comment>[http://dx.doi.org/10.1177/1352458511406164]. [PMID: 21613335].</comment>
<pub-id pub-id-type="pmid">21613335</pub-id>
</element-citation>
</ref>
<ref id="r274">
<label>274</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Riz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Galimberti</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Fenoglio</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Piccio</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Scalabrini</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Venturelli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Pietroboni</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Piola</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Naismith</surname>
<given-names>R.T.</given-names>
</name>
<name>
<surname>Parks</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Fumagalli</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bresolin</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Cross</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Scarpini</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Cerebrospinal fluid progranulin levels in patients with different multiple sclerosis subtypes.</article-title>
<source/>Neurosci. Lett.
          <year>2010</year>
<volume>469</volume>
<issue>2</issue>
<fpage>234</fpage>
<lpage>236</lpage>
<comment>[http://dx.doi.org/10.1016/j.neulet.2009.12.002]. [PMID: 19963041].</comment>
<pub-id pub-id-type="pmid">19963041</pub-id>
</element-citation>
</ref>
<ref id="r275">
<label>275</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kastenbauer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Koedel</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Wick</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kieseier</surname>
<given-names>B.C.</given-names>
</name>
<name>
<surname>Hartung</surname>
<given-names>H.P.</given-names>
</name>
<name>
<surname>Pfister</surname>
<given-names>H.W.</given-names>
</name>
</person-group>
<article-title>CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system.</article-title>
<source/>J. Neuroimmunol.
          <year>2003</year>
<volume>137</volume>
<issue>1-2</issue>
<fpage>210</fpage>
<lpage>217</lpage>
<comment>[http://dx.doi.org/10.1016/S0165-5728(03)00085-7]. [PMID: 12667665].</comment>
<pub-id pub-id-type="pmid">12667665</pub-id>
</element-citation>
</ref>
<ref id="r276">
<label>276</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mills</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Alabanza</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Mahamed</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Bynoe</surname>
<given-names>M.S.</given-names>
</name>
</person-group>
<article-title>Extracellular adenosine signaling induces CX3CL1 expression in the brain to promote experimental autoimmune encephalomyelitis.</article-title>
<source/>J. Neuroinflammation
          <year>2012</year>
<volume>9</volume>
<fpage>193</fpage>
<comment>[http://dx.doi.org/10.1186/1742-2094-9-193]. [PMID: 22883932].</comment>
<pub-id pub-id-type="pmid">22883932</pub-id>
</element-citation>
</ref>
<ref id="r277">
<label>277</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hulshof</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>van Haastert</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Kuipers</surname>
<given-names>H.F.</given-names>
</name>
<name>
<surname>van den Elsen</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>De Groot</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>van der Valk</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ravid</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Biber</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>CX3CL1 and CX3CR1 expression in human brain tissue: noninflammatory control versus multiple sclerosis.</article-title>
<source/>J. Neuropathol. Exp. Neurol.
          <year>2003</year>
<volume>62</volume>
<issue>9</issue>
<fpage>899</fpage>
<lpage>907</lpage>
<comment>[http://dx.doi.org/10.1093/jnen/62.9.899]. [PMID: 14533779].</comment>
<pub-id pub-id-type="pmid">14533779</pub-id>
</element-citation>
</ref>
<ref id="r278">
<label>278</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>F.D.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pien</surname>
<given-names>G.C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Salazar-Mather</surname>
<given-names>T.P.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>T.T.</given-names>
</name>
<name>
<surname>Weaver</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Ljunggren</surname>
<given-names>H.G.</given-names>
</name>
<name>
<surname>Biron</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Littman</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Ransohoff</surname>
<given-names>R.M.</given-names>
</name>
</person-group>
<article-title>The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system.</article-title>
<source/>FASEB J.
          <year>2006</year>
<volume>20</volume>
<issue>7</issue>
<fpage>896</fpage>
<lpage>905</lpage>
<comment>[http://dx.doi.org/10.1096/fj.05-5465com]. [PMID: 16675847].</comment>
<pub-id pub-id-type="pmid">16675847</pub-id>
</element-citation>
</ref>
<ref id="r279">
<label>279</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kroksveen</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Guldbrandsen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vedeler</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Myhr</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Opsahl</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Berven</surname>
<given-names>F.S.</given-names>
</name>
</person-group>
<article-title>Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls.</article-title>
<source/>Acta Neurol. Scand. Suppl.
          <year>2012</year>
<issue>195</issue>
<fpage>90</fpage>
<lpage>96</lpage>
<comment>[http://dx.doi.org/10.1111/ane.12029]. [PMID: 23278663].</comment>
<pub-id pub-id-type="pmid">23278663</pub-id>
</element-citation>
</ref>
<ref id="r280">
<label>280</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blakely</surname>
<given-names>P.K.</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Carlin</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Irani</surname>
<given-names>D.N.</given-names>
</name>
</person-group>
<article-title>Astrocyte matricellular proteins that control excitatory synaptogenesis are regulated by inflammatory cytokines and correlate with paralysis severity during experimental autoimmune encephalomyelitis.</article-title>
<source/>Front. Neurosci.
          <year>2015</year>
<volume>9</volume>
<fpage>344</fpage>
<comment>[http://dx.doi.org/10.3389/fnins.2015.00344]. [PMID: 26500475].</comment>
<pub-id pub-id-type="pmid">26500475</pub-id>
</element-citation>
</ref>
<ref id="r281">
<label>281</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vercellino</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Merola</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Piacentino</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Votta</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Capello</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mancardi</surname>
<given-names>G.L.</given-names>
</name>
<name>
<surname>Mutani</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Giordana</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Cavalla</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: Correlation with microglia infiltration, demyelination, and neuronal and synaptic damage.</article-title>
<source/>J. Neuropathol. Exp. Neurol.
          <year>2007</year>
<volume>66</volume>
<issue>8</issue>
<fpage>732</fpage>
<lpage>739</lpage>
<comment>[http://dx.doi.org/10.1097/nen.0b013e31812571b0]. [PMID: 17882017].</comment>
<pub-id pub-id-type="pmid">17882017</pub-id>
</element-citation>
</ref>
<ref id="r282">
<label>282</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Muzio</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>De Chiara</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Grasselli</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Musella</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Musumeci</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Mandolesi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>De Ceglia</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Maida</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Biffi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Pedrocchi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Menegon</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bernardi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Furlan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Martino</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Centonze</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis.</article-title>
<source/>Brain Behav. Immun.
          <year>2011</year>
<volume>25</volume>
<issue>5</issue>
<fpage>947</fpage>
<lpage>956</lpage>
<comment>[http://dx.doi.org/10.1016/j.bbi.2010.10.004]. [PMID: 20940040].</comment>
<pub-id pub-id-type="pmid">20940040</pub-id>
</element-citation>
</ref>
<ref id="r283">
<label>283</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Habbas</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Santello</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Stubbe</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zappia</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Liaudet</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Klaus</surname>
<given-names>F.R.</given-names>
</name>
<name>
<surname>Kollias</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Fontana</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pryce</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Suter</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Volterra</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Neuroinflammatory TNFα Impairs Memory <italic>via</italic> Astrocyte Signaling.</article-title>
<source/>Cell
          <year>2015</year>
<volume>163</volume>
<issue>7</issue>
<fpage>1730</fpage>
<lpage>1741</lpage>
<comment>[http://dx.doi.org/10.1016/j.cell.2015.11.023]. [PMID: 26686654].</comment>
<pub-id pub-id-type="pmid">26686654</pub-id>
</element-citation>
</ref>
<ref id="r284">
<label>284</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takeuchi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kawanokuchi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kuno</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sonobe</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mizuno</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Suzumura</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Tumor necrosis factor-alpha induces neurotoxicity <italic>via</italic> glutamate release from hemichannels of activated microglia in an autocrine manner.</article-title>
<source/>J. Biol. Chem.
          <year>2006</year>
<volume>281</volume>
<issue>30</issue>
<fpage>21362</fpage>
<lpage>21368</lpage>
<comment>[http://dx.doi.org/10.1074/jbc.M600504200]. [PMID: 16720574].</comment>
<pub-id pub-id-type="pmid">16720574</pub-id>
</element-citation>
</ref>
<ref id="r285">
<label>285</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Parkhurst</surname>
<given-names>C.N.</given-names>
</name>
<name>
<surname>Hayes</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gan</surname>
<given-names>W.B.</given-names>
</name>
</person-group>
<article-title>Peripheral elevation of TNF-α leads to early synaptic abnormalities in the mouse somatosensory cortex in experimental autoimmune encephalomyelitis.</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2013</year>
<volume>110</volume>
<issue>25</issue>
<fpage>10306</fpage>
<lpage>10311</lpage>
<comment>[http://dx.doi.org/10.1073/pnas.1222895110]. [PMID: 23733958].</comment>
<pub-id pub-id-type="pmid">23733958</pub-id>
</element-citation>
</ref>
<ref id="r286">
<label>286</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Lago</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Moreno-Martet</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cabranes</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ramos</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Fernández-Ruiz</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects.</article-title>
<source/>Neuropharmacology
          <year>2012</year>
<volume>62</volume>
<issue>7</issue>
<fpage>2299</fpage>
<lpage>2308</lpage>
<comment>[http://dx.doi.org/10.1016/j.neuropharm.2012.01.030]. [PMID: 22342378].</comment>
<pub-id pub-id-type="pmid">22342378</pub-id>
</element-citation>
</ref>
<ref id="r287">
<label>287</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Furlan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>De Chiara</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Muzio</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Musella</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Motta</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Studer</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Cavasinni</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bernardi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Martino</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cravatt</surname>
<given-names>B.F.</given-names>
</name>
<name>
<surname>Lutz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Maccarrone</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Centonze</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis.</article-title>
<source/>Brain Behav. Immun.
          <year>2011</year>
<volume>25</volume>
<issue>6</issue>
<fpage>1242</fpage>
<lpage>1248</lpage>
<comment>[http://dx.doi.org/10.1016/j.bbi.2011.03.017]. [PMID: 21473912].</comment>
<pub-id pub-id-type="pmid">21473912</pub-id>
</element-citation>
</ref>
<ref id="r288">
<label>288</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shijie</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Takeuchi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yawata</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Harada</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sonobe</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Doi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hua</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yasuoka</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Noda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kawanokuchi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mizuno</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Suzumura</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Blockade of glutamate release from microglia attenuates experimental autoimmune encephalomyelitis in mice.</article-title>
<source/>Tohoku J. Exp. Med.
          <year>2009</year>
<volume>217</volume>
<issue>2</issue>
<fpage>87</fpage>
<lpage>92</lpage>
<comment>[http://dx.doi.org/10.1620/tjem.217.87]. [PMID: 19212100].</comment>
<pub-id pub-id-type="pmid">19212100</pub-id>
</element-citation>
</ref>
<ref id="r289">
<label>289</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stilo</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>R.M.</given-names>
</name>
</person-group>
<article-title>The epidemiology of schizophrenia: replacing dogma with knowledge.</article-title>
<source/>Dialogues Clin. Neurosci.
          <year>2010</year>
<volume>12</volume>
<issue>3</issue>
<fpage>305</fpage>
<lpage>315</lpage>
<comment>[PMID: 20954427].</comment>
<pub-id pub-id-type="pmid">20954427</pub-id>
</element-citation>
</ref>
<ref id="r290">
<label>290</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patel</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Cherian</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gohil</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Atkinson</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Schizophrenia: overview and treatment options.</article-title>
<source/>P&amp;T
          <year>2014</year>
<volume>39</volume>
<issue>9</issue>
<fpage>638</fpage>
<lpage>345</lpage>
<pub-id pub-id-type="pmid">25210417</pub-id>
</element-citation>
</ref>
<ref id="r291">
<label>291</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Picchioni</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>R.M.</given-names>
</name>
</person-group>
<article-title>Schizophrenia.</article-title>
<source/>BMJ
          <year>2007</year>
<volume>335</volume>
<issue>7610</issue>
<fpage>91</fpage>
<lpage>95</lpage>
<comment>[http://dx.doi.org/10.1136/bmj.39227.616447.BE]. [PMID: 17626963].</comment>
<pub-id pub-id-type="pmid">17626963</pub-id>
</element-citation>
</ref>
<ref id="r292">
<label>292</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnstone</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Crow</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Frith</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Husband</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kreel</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Cerebral ventricular size and cognitive impairment in chronic schizophrenia.</article-title>
<source/>Lancet
          <year>1976</year>
<volume>2</volume>
<issue>7992</issue>
<fpage>924</fpage>
<lpage>926</lpage>
<comment>[http://dx.doi.org/10.1016/S0140-6736(76)90890-4]. [PMID: 62160].</comment>
<pub-id pub-id-type="pmid">62160</pub-id>
</element-citation>
</ref>
<ref id="r293">
<label>293</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keilp</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Sweeney</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Jacobsen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Solomon</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>St Louis</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Deck</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Frances</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>J.J.</given-names>
</name>
</person-group>
<article-title>Cognitive impairment in schizophrenia: specific relations to ventricular size and negative symptomatology.</article-title>
<source/>Biol. Psychiatry
          <year>1988</year>
<volume>24</volume>
<issue>1</issue>
<fpage>47</fpage>
<lpage>55</lpage>
<comment>[http://dx.doi.org/10.1016/0006-3223(88)90120-5]. [PMID: 3370277].</comment>
<pub-id pub-id-type="pmid">3370277</pub-id>
</element-citation>
</ref>
<ref id="r294">
<label>294</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vita</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>De Peri</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Silenzi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dieci</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies.</article-title>
<source/>Schizophr. Res.
          <year>2006</year>
<volume>82</volume>
<issue>1</issue>
<fpage>75</fpage>
<lpage>88</lpage>
<comment>[http://dx.doi.org/10.1016/j.schres.2005.11.004]. [PMID: 16377156].</comment>
<pub-id pub-id-type="pmid">16377156</pub-id>
</element-citation>
</ref>
<ref id="r295">
<label>295</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lawrie</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Abukmeil</surname>
<given-names>S.S.</given-names>
</name>
</person-group>
<article-title>Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies.</article-title>
<source/>Br. J. Psychiatry
          <year>1998</year>
<volume>172</volume>
<fpage>110</fpage>
<lpage>120</lpage>
<comment>[http://dx.doi.org/10.1192/bjp.172.2.110]. [PMID: 9519062].</comment>
<pub-id pub-id-type="pmid">9519062</pub-id>
</element-citation>
</ref>
<ref id="r296">
<label>296</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldman</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Pezawas</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mattay</surname>
<given-names>V.S.</given-names>
</name>
<name>
<surname>Fischl</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Verchinski</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Weinberger</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Meyer-Lindenberg</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Widespread reductions of cortical thickness in schizophrenia and spectrum disorders and evidence of heritability.</article-title>
<source/>Arch. Gen. Psychiatry
          <year>2009</year>
<volume>66</volume>
<issue>5</issue>
<fpage>467</fpage>
<lpage>477</lpage>
<comment>[http://dx.doi.org/10.1001/archgenpsychiatry.2009.24]. [PMID: 19414706].</comment>
<pub-id pub-id-type="pmid">19414706</pub-id>
</element-citation>
</ref>
<ref id="r297">
<label>297</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thune</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Uylings</surname>
<given-names>H.B.</given-names>
</name>
<name>
<surname>Pakkenberg</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>No deficit in total number of neurons in the prefrontal cortex in schizophrenics.</article-title>
<source/>J. Psychiatr. Res.
          <year>2001</year>
<volume>35</volume>
<issue>1</issue>
<fpage>15</fpage>
<lpage>21</lpage>
<comment>[http://dx.doi.org/10.1016/S0022-3956(00)00043-1]. [PMID: 11287052].</comment>
<pub-id pub-id-type="pmid">11287052</pub-id>
</element-citation>
</ref>
<ref id="r298">
<label>298</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Selemon</surname>
<given-names>L.D.</given-names>
</name>
<name>
<surname>Rajkowska</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Goldman-Rakic</surname>
<given-names>P.S.</given-names>
</name>
</person-group>
<article-title>Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17.</article-title>
<source/>Arch. Gen. Psychiatry
          <year>1995</year>
<volume>52</volume>
<issue>10</issue>
<fpage>805</fpage>
<lpage>818</lpage>
<comment>[http://dx.doi.org/10.1001/archpsyc.1995.03950220015005]. [PMID: 7575100].</comment>
<pub-id pub-id-type="pmid">7575100</pub-id>
</element-citation>
</ref>
<ref id="r299">
<label>299</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Selemon</surname>
<given-names>L.D.</given-names>
</name>
<name>
<surname>Rajkowska</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Goldman-Rakic</surname>
<given-names>P.S.</given-names>
</name>
</person-group>
<article-title>Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method.</article-title>
<source/>J. Comp. Neurol.
          <year>1998</year>
<volume>392</volume>
<issue>3</issue>
<fpage>402</fpage>
<lpage>412</lpage>
<comment>[http://dx.doi.org/10.1002/(SICI)1096-9861(19980316)392:3&lt;402:AID-CNE9&gt;3.0.CO;2-5]. [PMID: 9511926].</comment>
<pub-id pub-id-type="pmid">9511926</pub-id>
</element-citation>
</ref>
<ref id="r300">
<label>300</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roberts</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Conley</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kung</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Peretti</surname>
<given-names>F.J.</given-names>
</name>
<name>
<surname>Chute</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>Reduced striatal spine size in schizophrenia: a postmortem ultrastructural study.</article-title>
<source/>Neuroreport
          <year>1996</year>
<volume>7</volume>
<issue>6</issue>
<fpage>1214</fpage>
<lpage>1218</lpage>
<comment>[http://dx.doi.org/10.1097/00001756-199604260-00024]. [PMID: 8817535].</comment>
<pub-id pub-id-type="pmid">8817535</pub-id>
</element-citation>
</ref>
<ref id="r301">
<label>301</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosoklija</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Toomayan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Keilp</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Latov</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hays</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Dwork</surname>
<given-names>A.J.</given-names>
</name>
</person-group>
<article-title>Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings.</article-title>
<source/>Arch. Gen. Psychiatry
          <year>2000</year>
<volume>57</volume>
<issue>4</issue>
<fpage>349</fpage>
<lpage>356</lpage>
<comment>[http://dx.doi.org/10.1001/archpsyc.57.4.349]. [PMID: 10768696].</comment>
<pub-id pub-id-type="pmid">10768696</pub-id>
</element-citation>
</ref>
<ref id="r302">
<label>302</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garey</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Ong</surname>
<given-names>W.Y.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>T.S.</given-names>
</name>
<name>
<surname>Kanani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mortimer</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>T.R.</given-names>
</name>
<name>
<surname>Hirsch</surname>
<given-names>S.R.</given-names>
</name>
</person-group>
<article-title>Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia.</article-title>
<source/>J. Neurol. Neurosurg. Psychiatry
          <year>1998</year>
<volume>65</volume>
<issue>4</issue>
<fpage>446</fpage>
<lpage>453</lpage>
<comment>[http://dx.doi.org/10.1136/jnnp.65.4.446]. [PMID: 9771764].</comment>
<pub-id pub-id-type="pmid">9771764</pub-id>
</element-citation>
</ref>
<ref id="r303">
<label>303</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sweet</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Henteleff</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Sampson</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>D. A.</given-names>
</name>
</person-group>
<article-title>Reduced dendritic spine density in auditory cor-tex of subjects
with schizophrenia.</article-title>
<source/>Neuropsychopharmacology: official publication
of the American College of Neuropsychopharmacology
          <year>2009</year>
<volume>34</volume>
<issue>4</issue>
<fpage>374</fpage>
<lpage>389</lpage>
<pub-id pub-id-type="pmid">18463626</pub-id>
</element-citation>
</ref>
<ref id="r304">
<label>304</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glantz</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia.</article-title>
<source/>Arch. Gen. Psychiatry
          <year>2000</year>
<volume>57</volume>
<issue>1</issue>
<fpage>65</fpage>
<lpage>73</lpage>
<comment>[http://dx.doi.org/10.1001/archpsyc.57.1.65]. [PMID: 10632234].</comment>
<pub-id pub-id-type="pmid">10632234</pub-id>
</element-citation>
</ref>
<ref id="r305">
<label>305</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Konopaske</surname>
<given-names>G.T.</given-names>
</name>
<name>
<surname>Lange</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Coyle</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Benes</surname>
<given-names>F.M.</given-names>
</name>
</person-group>
<article-title>Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder.</article-title>
<source/>JAMA Psychiatry
          <year>2014</year>
<volume>71</volume>
<issue>12</issue>
<fpage>1323</fpage>
<lpage>1331</lpage>
<comment>[http://dx.doi.org/10.1001/jamapsychiatry.2014.1582]. [PMID: 25271938].</comment>
<pub-id pub-id-type="pmid">25271938</pub-id>
</element-citation>
</ref>
<ref id="r306">
<label>306</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feinberg</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?</article-title>
<source/>J. Psychiatr. Res.
          <year>1982-1983</year>
<volume>17</volume>
<issue>4</issue>
<fpage>319</fpage>
<lpage>334</lpage>
<comment>[http://dx.doi.org/10.1016/0022-3956(82) 90038-3]. [PMID: 7187776].</comment>
</element-citation>
</ref>
<ref id="r307">
<label>307</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davis</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Eyre</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jacka</surname>
<given-names>F.N.</given-names>
</name>
<name>
<surname>Dodd</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dean</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>McEwen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Debnath</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>McGrath</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Maes</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Amminger</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>McGorry</surname>
<given-names>P.D.</given-names>
</name>
<name>
<surname>Pantelis</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Berk</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis.</article-title>
<source/>Neurosci. Biobehav. Rev.
          <year>2016</year>
<volume>65</volume>
<fpage>185</fpage>
<lpage>194</lpage>
<comment>[http://dx.doi.org/10.1016/j.neubiorev. 2016.03.017]. [PMID: 27073049].</comment>
<pub-id pub-id-type="pmid">27073049</pub-id>
</element-citation>
</ref>
<ref id="r308">
<label>308</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sekar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bialas</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>de Rivera</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hammond</surname>
<given-names>T.R.</given-names>
</name>
<name>
<surname>Kamitaki</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Tooley</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Presumey</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Baum</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Van Doren</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Genovese</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Handsaker</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Daly</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Carroll</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>McCarroll</surname>
<given-names>S.A.</given-names>
</name>
</person-group>
<collab>Schizophrenia Working Group of the Psychiatric Genomics Consortium</collab>
<article-title>Schizophrenia risk from complex variation of complement component 4.</article-title>
<source/>Nature
          <year>2016</year>
<volume>530</volume>
<issue>7589</issue>
<fpage>177</fpage>
<lpage>183</lpage>
<comment>[http://dx.doi.org/10.1038/nature16549]. [PMID: 26814963].</comment>
<pub-id pub-id-type="pmid">26814963</pub-id>
</element-citation>
</ref>
<ref id="r309">
<label>309</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prasad</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Chowdari</surname>
<given-names>K.V.</given-names>
</name>
<name>
<surname>D’Aiuto</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Iyengar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Stanley</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Nimgaonkar</surname>
<given-names>V.L.</given-names>
</name>
</person-group>
<article-title>Neuropil contraction in relation to Complement C4 gene copy numbers in independent cohorts of adolescent-onset and young adult-onset schizophrenia patients-a pilot study.</article-title>
<source/>Transl. Psychiatry
          <year>2018</year>
<volume>8</volume>
<issue>1</issue>
<fpage>134</fpage>
<comment>[http://dx.doi.org/10.1038/s41398-018-0181-z]. [PMID: 30026462].</comment>
<pub-id pub-id-type="pmid">30026462</pub-id>
</element-citation>
</ref>
<ref id="r310">
<label>310</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laskaris</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zalesky</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Weickert</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Di Biase</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Chana</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Baune</surname>
<given-names>B.T.</given-names>
</name>
<name>
<surname>Bousman</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>McGorry</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Everall</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Pantelis</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cropley</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Investigation of pe-ripheral complement factors across stages of psychosis.</article-title>
<source/>Schizophr. Res.
          <year>2018</year>
<volume>204</volume>
<fpage>30</fpage>
<lpage>37</lpage>
<comment>[PMID: 30527272].</comment>
<pub-id pub-id-type="pmid">30527272</pub-id>
</element-citation>
</ref>
<ref id="r311">
<label>311</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martins-de-Souza</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gattaz</surname>
<given-names>W.F.</given-names>
</name>
<name>
<surname>Schmitt</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rewerts</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Maccarrone</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Dias-Neto</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Turck</surname>
<given-names>C.W.</given-names>
</name>
</person-group>
<article-title>Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia.</article-title>
<source/>Eur. Arch. Psychiatry Clin. Neurosci.
          <year>2009</year>
<volume>259</volume>
<issue>3</issue>
<fpage>151</fpage>
<lpage>163</lpage>
<comment>[http://dx.doi.org/10.1007/s00406-008-0847-2]. [PMID: 19165527].</comment>
<pub-id pub-id-type="pmid">19165527</pub-id>
</element-citation>
</ref>
<ref id="r312">
<label>312</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>McCullumsmith</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Beneyto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Haroutunian</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Meador-Woodruff</surname>
<given-names>J.H.</given-names>
</name>
</person-group>
<article-title>Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia.</article-title>
<source/>Synapse
          <year>2005</year>
<volume>57</volume>
<issue>3</issue>
<fpage>123</fpage>
<lpage>131</lpage>
<comment>[http://dx.doi.org/10.1002/syn.20164]. [PMID: 15945063].</comment>
<pub-id pub-id-type="pmid">15945063</pub-id>
</element-citation>
</ref>
<ref id="r313">
<label>313</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ayoub</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Angelicheva</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Vile</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chandler</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Morar</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cavanaugh</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Visscher</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Jablensky</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pfleger</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Kalaydjieva</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Deleterious GRM1 mutations in schizophrenia.</article-title>
<source/>PLoS One
          <year>2012</year>
<volume>7</volume>
<issue>3</issue>
<elocation-id>e32849</elocation-id>
<comment>[http://dx.doi.org/10.1371/journal.pone.0032849]. [PMID: 22448230].</comment>
<pub-id pub-id-type="pmid">22448230</pub-id>
</element-citation>
</ref>
<ref id="r314">
<label>314</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kovács</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kelemen</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Kéri</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Decreased fragile X mental retardation protein (FMRP) is associated with lower IQ and earlier illness onset in patients with schizophrenia.</article-title>
<source/>Psychiatry Res.
          <year>2013</year>
<volume>210</volume>
<issue>3</issue>
<fpage>690</fpage>
<lpage>693</lpage>
<comment>[http://dx.doi.org/10.1016/j.psychres.2012.12.022]. [PMID: 23333116].</comment>
<pub-id pub-id-type="pmid">23333116</pub-id>
</element-citation>
</ref>
<ref id="r315">
<label>315</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pouget</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Goncalves</surname>
<given-names>V.F.</given-names>
</name>
</person-group>
<article-title>Schizophrenia Working Group of the Psychiatric Genomics, C.; Spain, S. L.; Finucane, H. K.; Raychaudhuri, S.; Kennedy, J. L.; Knight, J., Genome-Wide Association Studies Suggest Limited Immune Gene Enrich-ment in Schizophrenia Compared to 5 Autoimmune Diseases.</article-title>
<source/>Schizophr. Bull.
          <year>2016</year>
<volume>42</volume>
<issue>5</issue>
<fpage>1176</fpage>
<lpage>1184</lpage>
<comment>[http://dx.doi.org/10.1093/schbul/sbw059]. [PMID: 27242348].</comment>
<pub-id pub-id-type="pmid">27242348</pub-id>
</element-citation>
</ref>
<ref id="r316">
<label>316</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajarajan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Borrman</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Schrode</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Flaherty</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Casiño</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yashaswini</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>LaMarca</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Kassim</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Javidfar</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Espeso-Gil</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Won</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>MacDonald</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hoffman</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>Roussos</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hahn</surname>
<given-names>C.G.</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Brennand</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Akbarian</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Neuron-specific signatures in the chromosomal connectome associated with schizophrenia risk.</article-title>
<source/>Science
          <year>2018</year>
<volume>362</volume>
<issue>6420</issue>
<elocation-id>eaat4311</elocation-id>
<comment>[http://dx.doi.org/10.1126/science.aat4311]. [PMID: 30545851].</comment>
<pub-id pub-id-type="pmid">30545851</pub-id>
</element-citation>
</ref>
<ref id="r317">
<label>317</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwarz</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Izmailov</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Liò</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Meyer-Lindenberg</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Protein Interaction Networks Link Schizophrenia Risk Loci to Synaptic Function.</article-title>
<source/>Schizophr. Bull.
          <year>2016</year>
<volume>42</volume>
<issue>6</issue>
<fpage>1334</fpage>
<lpage>1342</lpage>
<comment>[http://dx.doi.org/10.1093/schbul/sbw035]. [PMID: 27056717].</comment>
<pub-id pub-id-type="pmid">27056717</pub-id>
</element-citation>
</ref>
<ref id="r318">
<label>318</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergon</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Belzeaux</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Comte</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pelletier</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hervé</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gardiner</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Beveridge</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Carr</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cairns</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Kumarasinghe</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Schall</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Blin</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Boucraut</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tooney</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Fakra</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ibrahim</surname>
<given-names>E.C.</given-names>
</name>
</person-group>
<article-title>CX3CR1 is dysregulated in blood and brain from schizophrenia patients.</article-title>
<source/>Schizophr. Res.
          <year>2015</year>
<volume>168</volume>
<issue>1-2</issue>
<fpage>434</fpage>
<lpage>443</lpage>
<comment>[http://dx.doi.org/10.1016/j.schres.2015.08.010]. [PMID: 26285829].</comment>
<pub-id pub-id-type="pmid">26285829</pub-id>
</element-citation>
</ref>
<ref id="r319">
<label>319</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishizuka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fujita</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kawabata</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Iwayama</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Inada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Okahisa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Egawa</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Usami</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kushima</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Uno</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Okada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Aleksic</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Someya</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yoshikawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Iwata</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yamashita</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ozaki</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Rare genetic variants in CX3CR1 and their contribution to the increased risk of schizophrenia and autism spectrum disorders.</article-title>
<source/>Transl. Psychiatry
          <year>2017</year>
<volume>7</volume>
<issue>8</issue>
<elocation-id>e1184</elocation-id>
<comment>[http://dx.doi.org/10.1038/tp.2017.173]. [PMID: 28763059].</comment>
<pub-id pub-id-type="pmid">28763059</pub-id>
</element-citation>
</ref>
<ref id="r320">
<label>320</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stefansson</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ophoff</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Steinberg</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Andreassen</surname>
<given-names>O.A.</given-names>
</name>
<name>
<surname>Cichon</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rujescu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Werge</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Pietilainen</surname>
<given-names>O.P.</given-names>
</name>
<name>
<surname>Mors</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Mortensen</surname>
<given-names>P.B.</given-names>
</name>
<name>
<surname>Sigurdsson</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gustafsson</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Nyegaard</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tuulio-Henriksson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ingason</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Suvisaari</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lonnqvist</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Paunio</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Borglum</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Hartmann</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fink-Jensen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nordentoft</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hougaard</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Norgaard-Pedersen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bottcher</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Olesen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Breuer</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Moller</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Giegling</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Rasmussen</surname>
<given-names>H.B.</given-names>
</name>
<name>
<surname>Timm</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mat-theisen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bitter</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Rethelyi</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Magnusdottir</surname>
<given-names>B.B.</given-names>
</name>
<name>
<surname>Sigmundsson</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Olason</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Masson</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gulcher</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Har-aldsson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fossdal</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Thorgeirsson</surname>
<given-names>T.E.</given-names>
</name>
<name>
<surname>Thorsteinsdot-tir</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Ruggeri</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tosato</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Franke</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Strengman</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kiemeney</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Genetic</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Outcome in, P.; Melle, I.; Dju-rovic, S.; Abramova, L.; Kaleda, V.; Sanjuan, J.; de Frutos, R.; Bramon, E.; Vassos, E.; Fraser, G.; Ettinger, U.; Picchioni, M.; Walker, N.; Toulopoulou, T.; Need, A. C.; Ge, D.; Yoon, J. L.; Shianna, K. V.; Freimer, N. B.; Cantor, R. M.; Murray, R.; Kong, A.; Golimbet, V.; Carracedo, A.; Arango, C.; Costas, J.; Jonsson, E. G.; Terenius, L.; Agartz, I.; Petursson, H.; Nothen, M. M.; Rietschel, M.; Matthews, P. M.; Muglia, P.; Peltonen, L.; St Clair, D.; Goldstein, D. B.; Stefansson, K.; Collier, D. A. Common variants conferring risk of schizo-phrenia.</article-title>
<source/>Nature
          <year>2009</year>
<volume>460</volume>
<issue>7256</issue>
<fpage>744</fpage>
<lpage>747</lpage>
<comment>[http://dx.doi.org/10.1038/nature08186]. [PMID: 19571808].</comment>
<pub-id pub-id-type="pmid">19571808</pub-id>
</element-citation>
</ref>
<ref id="r321">
<label>321</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Purcell</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Wray</surname>
<given-names>N.R.</given-names>
</name>
<name>
<surname>Stone</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Visscher</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>O’Donovan</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>P.F.</given-names>
</name>
<name>
<surname>Sklar</surname>
<given-names>P.</given-names>
</name>
</person-group>
<collab>International Schizophrenia Consortium</collab>
<article-title>Common polygenic variation contributes to risk of schizophrenia and bipolar disorder.</article-title>
<source/>Nature
          <year>2009</year>
<volume>460</volume>
<issue>7256</issue>
<fpage>748</fpage>
<lpage>752</lpage>
<comment>[http://dx.doi.org/10.1038/nature08185]. [PMID: 19571811].</comment>
<pub-id pub-id-type="pmid">19571811</pub-id>
</element-citation>
</ref>
<ref id="r322">
<label>322</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galimberti</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dell’Osso</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Fenoglio</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Villa</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cortini</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Serpente</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kittel-Schneider</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Weigl</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Neuner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Volkert</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Leonhard</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Olmes</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Kopf</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cantoni</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ridolfi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Palazzo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ghezzi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bresolin</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Altamura</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Scarpini</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Reif</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia.</article-title>
<source/>PLoS One
          <year>2012</year>
<volume>7</volume>
<issue>4</issue>
<elocation-id>e32164</elocation-id>
<comment>[http://dx.doi.org/10.1371/journal.pone.0032164]. [PMID: 22505994].</comment>
<pub-id pub-id-type="pmid">22505994</pub-id>
</element-citation>
</ref>
<ref id="r323">
<label>323</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farhy-Tselnicker</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>van Casteren</surname>
<given-names>A.C.M.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>V.T.</given-names>
</name>
<name>
<surname>Aricescu</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>N.J.</given-names>
</name>
</person-group>
<article-title>Astrocyte-Secreted Glypican 4 Regulates Release of Neuronal Pentraxin 1 from Axons to Induce Functional Synapse Formation.</article-title>
<source/>Neuron
          <year>2017</year>
<volume>96</volume>
<issue>2</issue>
<fpage>428</fpage>
<lpage>445</lpage>
<pub-id pub-id-type="pmid">29024665</pub-id>
</element-citation>
</ref>
<ref id="r324">
<label>324</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Potkin</surname>
<given-names>S.G.</given-names>
</name>
<name>
<surname>Macciardi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Guffanti</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Fallon</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Lakatos</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Miles</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Lander</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vawter</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>Identifying gene regulatory networks in schizophrenia.</article-title>
<source/>Neuroimage
          <year>2010</year>
<volume>53</volume>
<issue>3</issue>
<fpage>839</fpage>
<lpage>847</lpage>
<comment>[http://dx.doi.org/10.1016/j.neuroimage.2010.06.036]. [PMID: 20600988].</comment>
<pub-id pub-id-type="pmid">20600988</pub-id>
</element-citation>
</ref>
<ref id="r325">
<label>325</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laskaris</surname>
<given-names>L.E.</given-names>
</name>
<name>
<surname>Di Biase</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Everall</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Chana</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Christopoulos</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Skafidas</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Cropley</surname>
<given-names>V.L.</given-names>
</name>
<name>
<surname>Pantelis</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Microglial activation and progressive brain changes in schizophrenia.</article-title>
<source/>Br. J. Pharmacol.
          <year>2016</year>
<volume>173</volume>
<issue>4</issue>
<fpage>666</fpage>
<lpage>680</lpage>
<comment>[http://dx.doi.org/10.1111/bph.13364]. [PMID: 26455353].</comment>
<pub-id pub-id-type="pmid">26455353</pub-id>
</element-citation>
</ref>
<ref id="r326">
<label>326</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trépanier</surname>
<given-names>M.O.</given-names>
</name>
<name>
<surname>Hopperton</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Mizrahi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mechawar</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bazinet</surname>
<given-names>R.P.</given-names>
</name>
</person-group>
<article-title>Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review.</article-title>
<source/>Mol. Psychiatry
          <year>2016</year>
<volume>21</volume>
<issue>8</issue>
<fpage>1009</fpage>
<lpage>1026</lpage>
<comment>[http://dx.doi.org/10.1038/mp.2016.90]. [PMID: 27271499].</comment>
<pub-id pub-id-type="pmid">27271499</pub-id>
</element-citation>
</ref>
<ref id="r327">
<label>327</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pasternak</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Kubicki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shenton</surname>
<given-names>M.E.</given-names>
</name>
</person-group>
<article-title><italic>In vivo</italic> imaging of neuroinflammation in schizophrenia.</article-title>
<source/>Schizophr. Res.
          <year>2016</year>
<volume>173</volume>
<issue>3</issue>
<fpage>200</fpage>
<lpage>212</lpage>
<comment>[http://dx.doi.org/10.1016/j.schres.2015.05.034]. [PMID: 26048294].</comment>
<pub-id pub-id-type="pmid">26048294</pub-id>
</element-citation>
</ref>
<ref id="r328">
<label>328</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Kesteren</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Gremmels</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>de Witte</surname>
<given-names>L.D.</given-names>
</name>
<name>
<surname>Hol</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Van Gool</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Falkai</surname>
<given-names>P.G.</given-names>
</name>
<name>
<surname>Kahn</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Sommer</surname>
<given-names>I.E.</given-names>
</name>
</person-group>
<article-title>Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies.</article-title>
<source/>Transl. Psychiatry
          <year>2017</year>
<volume>7</volume>
<issue>3</issue>
<elocation-id>e1075</elocation-id>
<comment>[http://dx.doi.org/10.1038/tp.2017.4]. [PMID: 28350400].</comment>
<pub-id pub-id-type="pmid">28350400</pub-id>
</element-citation>
</ref>
<ref id="r329">
<label>329</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quidé</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bortolasci</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Spolding</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kidnapillai</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Watkeys</surname>
<given-names>O.J.</given-names>
</name>
<name>
<surname>Cohen-Woods</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Berk</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Carr</surname>
<given-names>V.J.</given-names>
</name>
<name>
<surname>Walder</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>Association between childhood trauma exposure and pro-inflammatory cytokines in schizophrenia and bipolar-I disorder.</article-title>
<source/>Psychol. Med.
          <year>2018</year>
<fpage>1</fpage>
<lpage>9</lpage>
<comment>[http://dx.doi.org/10.1017/S0033291718003690]. [PMID: 30560764].</comment>
</element-citation>
</ref>
<ref id="r330">
<label>330</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gallego</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Blanco</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Husain-Krautter</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Madeline Fagen</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Moreno-Merino</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Del Ojo-Jiménez</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rothstein</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>Lencz</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Malhotra</surname>
<given-names>A.K.</given-names>
</name>
</person-group>
<article-title>Cytokines in cerebrospinal fluid of patients with schizophrenia spectrum disorders: New data and an updated meta-analysis.</article-title>
<source/>Schizophr. Res.
          <year>2018</year>
<volume>202</volume>
<fpage>64</fpage>
<lpage>71</lpage>
<comment>[http://dx.doi.org/10.1016/j.schres.2018.07.019]. [PMID: 30025760].</comment>
<pub-id pub-id-type="pmid">30025760</pub-id>
</element-citation>
</ref>
<ref id="r331">
<label>331</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldsmith</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Rapaport</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>B.J.</given-names>
</name>
</person-group>
<article-title>A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.</article-title>
<source/>Mol. Psychiatry
          <year>2016</year>
<volume>21</volume>
<issue>12</issue>
<fpage>1696</fpage>
<lpage>1709</lpage>
<comment>[http://dx.doi.org/10.1038/mp.2016.3]. [PMID: 26903267].</comment>
<pub-id pub-id-type="pmid">26903267</pub-id>
</element-citation>
</ref>
<ref id="r332">
<label>332</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Buckley</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Seabolt</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Mellor</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kirkpatrick</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Meta-analysis of cytokine alterations in schizophrenia: Clinical status and antipsychotic effects.</article-title>
<source/>Biol. Psychiatry
          <year>2011</year>
<volume>70</volume>
<issue>7</issue>
<fpage>663</fpage>
<lpage>671</lpage>
<comment>[http://dx.doi.org/10.1016/j.biopsych.2011.04.013]. [PMID: 21641581].</comment>
<pub-id pub-id-type="pmid">21641581</pub-id>
</element-citation>
</ref>
<ref id="r333">
<label>333</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>A.S.</given-names>
</name>
</person-group>
<article-title>Prenatal infection as a risk factor for schizophrenia.</article-title>
<source/>Schizophr. Bull.
          <year>2006</year>
<volume>32</volume>
<issue>2</issue>
<fpage>200</fpage>
<lpage>202</lpage>
<comment>[http://dx.doi.org/10.1093/schbul/sbj052]. [PMID: 16469941].</comment>
<pub-id pub-id-type="pmid">16469941</pub-id>
</element-citation>
</ref>
<ref id="r334">
<label>334</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mattei</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ivanov</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ferrai</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jordan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Guneykaya</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Buonfiglioli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schaafsma</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Przanowski</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Deuther-Conrad</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Brust</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hesse</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Patt</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sabri</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>T.L.</given-names>
</name>
<name>
<surname>Eggen</surname>
<given-names>B.J.L.</given-names>
</name>
<name>
<surname>Boddeke</surname>
<given-names>E.W.G.M.</given-names>
</name>
<name>
<surname>Kaminska</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Beule</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pombo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kettenmann</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>S.A.</given-names>
</name>
</person-group>
<article-title>Maternal immune activation results in complex microglial transcriptome signature in the adult offspring that is reversed by minocycline treatment.</article-title>
<source/>Transl. Psychiatry
          <year>2017</year>
<volume>7</volume>
<issue>5</issue>
<elocation-id>e1120</elocation-id>
<comment>[http://dx.doi.org/10.1038/tp.2017.80]. [PMID: 28485733].</comment>
<pub-id pub-id-type="pmid">28485733</pub-id>
</element-citation>
</ref>
<ref id="r335">
<label>335</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coiro</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Padmashri</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Suresh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Spartz</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Pendyala</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Meays</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gautam</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Alnouti</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dunaevsky</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Impaired synaptic development in a maternal immune activation mouse model of neurodevelopmental disorders.</article-title>
<source/>Brain Behav. Immun.
          <year>2015</year>
<volume>50</volume>
<fpage>249</fpage>
<lpage>258</lpage>
<comment>[http://dx.doi.org/10.1016/j.bbi.2015.07.022]. [PMID: 26218293].</comment>
<pub-id pub-id-type="pmid">26218293</pub-id>
</element-citation>
</ref>
<ref id="r336">
<label>336</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pendyala</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Coiro</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Spartz</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Pad-mashri</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dunaevsky</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Maternal immune Activation causes Behavioral impairments and altered cerebellar cytokine and synaptic protein expression.</article-title>
<source/>Neuropsychopharmacology
          <year>2017</year>
<volume>42</volume>
<issue>7</issue>
<fpage>1435</fpage>
<lpage>1446</lpage>
<pub-id pub-id-type="pmid">28102228</pub-id>
</element-citation>
</ref>
<ref id="r337">
<label>337</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brennand</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Simone</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gelboin-Burkhart</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sangar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>McCarthy</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sebat</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gage</surname>
<given-names>F.H.</given-names>
</name>
</person-group>
<article-title>Modelling schizophrenia using human induced pluripotent stem cells.</article-title>
<source/>Nature
          <year>2011</year>
<volume>473</volume>
<issue>7346</issue>
<fpage>221</fpage>
<lpage>225</lpage>
<comment>[http://dx.doi.org/10.1038/nature09915]. [PMID: 21490598].</comment>
<pub-id pub-id-type="pmid">21490598</pub-id>
</element-citation>
</ref>
<ref id="r338">
<label>338</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sellgren</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Gracias</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Watmuff</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Biag</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Thanos</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Whittredge</surname>
<given-names>P.B.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Worringer</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>H.E.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kaykas</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Karmacharya</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Goold</surname>
<given-names>C.P.</given-names>
</name>
<name>
<surname>Sheridan</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Perlis</surname>
<given-names>R.H.</given-names>
</name>
</person-group>
<article-title>Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning.</article-title>
<source/>Nat. Neurosci.
          <year>2019</year>
<volume>22</volume>
<issue>3</issue>
<fpage>374</fpage>
<lpage>385</lpage>
<comment>[http://dx.doi.org/10.1038/s41593-018-0334-7]. [PMID: 30718903].</comment>
<pub-id pub-id-type="pmid">30718903</pub-id>
</element-citation>
</ref>
<ref id="r339">
<label>339</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Minocycline as adjunct therapy for a male patient with deficit schizophrenia.</article-title>
<source/>Neuropsychiatr. Dis. Treat.
          <year>2018</year>
<volume>14</volume>
<fpage>2697</fpage>
<lpage>2701</lpage>
<comment>[http://dx.doi.org/10.2147/NDT.S179658]. [PMID: 30349268].</comment>
<pub-id pub-id-type="pmid">30349268</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig fig-type="figure" id="F1" orientation="portrait" position="float">
<label>Fig. (1)</label>
<caption>
<p><bold>Main mechanisms of synaptic elimination during development.</bold> Recent data have indicated a relevant role of immune molecules in developmental synaptic pruning. As it is shown here, astrocytes secrete TGF-β3, leading to the downstream upregulation of the complement component C1q by neurons. Once in the plasma membrane, C1q triggers the activation of the classical complement cascade later culminating in C3 accumulation, which is recognized by microglia <italic>via</italic> CR3, thus prompting the phagocytosis of target synapses. IL-33, another astrocytic-secreted factor, is essential for synaptic engulfment by microglial cells. In addition, MHC I and its binding partner PirB have been demonstrated to promote synaptic elimination, while pre-synaptic CD47 signals <italic>via</italic> SIRPα, inhibiting synaptic uptake by microglial cells. Finally, LTD induction, following NMDAR and group I mGluRs activation, is also capable of promoting synapse loss, while LTP inhibits this phenomenon. mGluRI: group I metabotropic glutamate receptor; NMDAR: N-methyl-D-aspartate receptor; MHC I: major histocompatibility complex class I; PirB: paired immunoglobulin-like receptor B; CR3: complement receptor 3; CD47: cluster of differentiation 47; SIRPα: signal-regulatory protein α; IL-33: interleukin 33; TGF-β3: transforming growth factor β3. (<italic>A higher resolution / colour version of this figure is available in the electronic copy of the article</italic>).</p>
</caption>
<graphic xlink:href="CN-17-1071_F1"></graphic>
</fig>
<fig fig-type="figure" id="F2" orientation="portrait" position="float">
<label>Fig. (2)</label>
<caption>
<p><bold>Activation of synaptic pruning mechanisms is relevant for AD progression.</bold> Progressive synaptic loss is one of the main morphological features of Alzheimer’s disease, observed even earlier than senile plaque deposition. Several studies have demonstrated the prominent role of the classical complement cascade in such event. Indeed, it has been shown that ApoE4, a major AD risk factor, leads to C1q accumulation in animal models. Additionally, mGluR1 activation allows a greater C1q mRNA translation by promoting the dephosphorylation of FMRP, an RNA-binding protein that represses translation. These data provide a suitable explanation for the increased levels of C1q and its downstream complement factor C3 in AD, which, in turn, trigger targeted synapses phagocytosis by microglial cells. Moreover, NMDAR and group I mGluRs activation have also been involved in the excessive synaptic loss observed during AD. Interestingly, the activation of extrasynaptic NMDAR (eNMDAR) induces the production of the S-nitrosylation of Cdk5, another factor implicated in AD excessive synaptic elimination. mGluR1: metabotropic glutamate receptor 1; sNMDAR: synaptic N-methyl-D-aspartate receptor; eNMDAR: extrasynaptic N-methyl-D-aspartate receptor; FMRP: fragile X mental retardation protein; oAβ: oligomeric amyloid β; CR3: complement receptor 3; ApoE4: Apolipoprotein E ε4; Cdk5: cyclin-dependent kinase 5. (<italic>A higher resolution / colour version of this figure is available in the electronic copy of the article</italic>).</p>
</caption>
<graphic xlink:href="CN-17-1071_F2"></graphic>
</fig>
</floats-group>
</article>
</pmc-articleset>